studyid,siteid,usubjid,trta,trtan,age,agegr1,agegr1n,race,racen,sex,saffl,trtsdt,trtedt,astdt,astdtf,astdy,aendt,aendy,adurn,aduru,aeterm,aellt,aelltcd,aedecod,aeptcd,aehlt,aehltcd,aehlgt,aehlgtcd,aebodsys,aesoc,aesoccd,aesev,aeser,aescan,aescong,aesdisab,aesdth,aeshosp,aeslife,aesod,aerel,aeacn,aeout,aeseq,trtemfl,aoccfl,aoccsfl,aoccpfl,aocc02fl,aocc03fl,aocc04fl,cq01nam,aocc01fl
CDISCPILOT01,701,01-701-1015,Placebo,0,63,<65,1,WHITE,1,F,Y,2014-01-02,2014-07-02,2014-01-03,,2,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1015,Placebo,0,63,<65,1,WHITE,1,F,Y,2014-01-02,2014-07-02,2014-01-03,,2,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1015,Placebo,0,63,<65,1,WHITE,1,F,Y,2014-01-02,2014-07-02,2014-01-09,,8,2014-01-11,10,3,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1023,Placebo,0,64,<65,1,WHITE,1,M,Y,2012-08-05,2012-09-01,2012-08-07,,3,2012-08-30,26,24,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1023,Placebo,0,64,<65,1,WHITE,1,M,Y,2012-08-05,2012-09-01,2012-08-07,,3,NA,NA,NA,,ERYTHEMA,LOCALIZED ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1023,Placebo,0,64,<65,1,WHITE,1,M,Y,2012-08-05,2012-09-01,2012-08-26,,22,NA,NA,NA,,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,NA,HLT_0415,NA,HLGT_0086,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1023,Placebo,0,64,<65,1,WHITE,1,M,Y,2012-08-05,2012-09-01,2012-08-07,,3,2012-08-30,26,24,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1028,Xanomeline High Dose,81,71,65-80,2,WHITE,1,M,Y,2013-07-19,2014-01-14,2013-07-21,,3,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1028,Xanomeline High Dose,81,71,65-80,2,WHITE,1,M,Y,2013-07-19,2014-01-14,2013-08-08,,21,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1034,Xanomeline High Dose,81,77,65-80,2,WHITE,1,F,Y,2014-07-01,2014-12-30,2014-08-27,,58,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1034,Xanomeline High Dose,81,77,65-80,2,WHITE,1,F,Y,2014-07-01,2014-12-30,2014-11-02,,125,NA,NA,NA,,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1047,Placebo,0,85,>80,3,WHITE,1,F,Y,2013-02-12,2013-03-09,2013-02-12,,1,2013-02-12,1,1,DAY,HIATUS HERNIA,HERNIA HIATAL,NA,HIATUS HERNIA,NA,HLT_0159,NA,HLGT_0109,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1047,Placebo,0,85,>80,3,WHITE,1,F,Y,2013-02-12,2013-03-09,2013-02-12,,1,2013-02-12,1,1,DAY,HIATUS HERNIA,HERNIA HIATAL,NA,HIATUS HERNIA,NA,HLT_0159,NA,HLGT_0109,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,701,01-701-1047,Placebo,0,85,>80,3,WHITE,1,F,Y,2013-02-12,2013-03-09,2013-03-06,,23,NA,NA,NA,,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1047,Placebo,0,85,>80,3,WHITE,1,F,Y,2013-02-12,2013-03-09,2013-03-10,,27,NA,NA,NA,,BUNDLE BRANCH BLOCK LEFT,LEFT BUNDLE BRANCH BLOCK,NA,BUNDLE BRANCH BLOCK LEFT,NA,HLT_0281,NA,HLGT_0721,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2014-01-01,2014-07-09,2014-01-03,,3,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2014-01-01,2014-07-09,2014-02-20,,51,2014-02-20,51,1,DAY,PRURITUS GENERALISED,GENERALIZED PRURITUS,NA,PRURITUS GENERALISED,NA,HLT_0123,NA,HLGT_0689,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2014-01-01,2014-07-09,2014-02-20,,51,2014-02-22,53,3,DAY,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2014-01-01,2014-07-09,2014-02-21,,52,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2014-01-01,2014-07-09,2014-03-21,,80,2014-03-21,80,1,DAY,PRURITUS GENERALISED,GENERALIZED PRURITUS,NA,PRURITUS GENERALISED,NA,HLT_0123,NA,HLGT_0689,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2014-01-01,2014-07-09,2014-03-31,,90,2014-03-31,90,1,DAY,PRURITUS GENERALISED,GENERALIZED PRURITUS,NA,PRURITUS GENERALISED,NA,HLT_0123,NA,HLGT_0689,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2014-01-01,2014-07-09,2014-04-19,,109,2014-04-20,110,2,DAY,PRURITUS GENERALISED,GENERALIZED PRURITUS,NA,PRURITUS GENERALISED,NA,HLT_0123,NA,HLGT_0689,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2014-01-01,2014-07-09,2014-04-19,,109,2014-04-22,112,4,DAY,PHARYNGOLARYNGEAL PAIN,SORE THROAT,NA,PHARYNGOLARYNGEAL PAIN,NA,HLT_0130,NA,HLGT_0402,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2014-01-01,2014-07-09,2014-04-19,,109,2014-04-22,112,4,DAY,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,9,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1097,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2014-01-01,2014-07-09,2014-02-21,,52,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,10,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1111,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2012-09-07,2012-09-16,2012-09-02,,-5,2012-09-07,1,6,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1111,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2012-09-07,2012-09-16,2012-09-02,,-5,2012-09-07,1,6,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1111,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2012-09-07,2012-09-16,2012-07-08,,-61,NA,NA,NA,,LOCALISED INFECTION,LOCALIZED INFECTION,NA,LOCALISED INFECTION,NA,HLT_0435,NA,HLGT_0557,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,,,,,,,,,
CDISCPILOT01,701,01-701-1111,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2012-09-07,2012-09-16,2012-09-02,,-5,2012-09-07,1,6,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1111,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2012-09-07,2012-09-16,2012-09-02,,-5,2012-09-07,1,6,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1111,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2012-09-07,2012-09-16,2012-09-07,,1,NA,NA,NA,,MICTURITION URGENCY,URINARY URGENCY,NA,MICTURITION URGENCY,NA,HLT_0294,NA,HLGT_0483,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,6,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1111,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2012-09-07,2012-09-16,2012-09-13,,7,NA,NA,NA,,ARTHRALGIA,GENERALIZED JOINT PAIN,NA,ARTHRALGIA,NA,HLT_0375,NA,HLGT_0610,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1111,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2012-09-07,2012-09-16,2012-09-13,,7,NA,NA,NA,,CELLULITIS,CELLULITIS OF LEG,NA,CELLULITIS,NA,HLT_0613,NA,HLGT_0066,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1115,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,2012-11-30,2013-01-23,2012-12-02,,3,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1115,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,2012-11-30,2013-01-23,2012-12-02,,3,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1115,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,2012-11-30,2013-01-23,2012-12-26,,27,2012-12-26,27,1,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1115,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,2012-11-30,2013-01-23,2012-12-26,,27,2012-12-26,27,1,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1115,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,2012-11-30,2013-01-23,2012-12-02,,3,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1115,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,2012-11-30,2013-01-23,2012-12-02,,3,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1115,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,2012-11-30,2013-01-23,2013-01-14,,46,NA,NA,NA,,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1115,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,2012-11-30,2013-01-23,2013-01-19,,51,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1115,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,2012-11-30,2013-01-23,2013-01-19,,51,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,9,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1118,Placebo,0,52,<65,1,WHITE,1,M,Y,2014-03-12,2014-09-09,NA,,NA,NA,NA,NA,,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,,
CDISCPILOT01,701,01-701-1130,Placebo,0,84,>80,3,WHITE,1,M,Y,2014-02-15,2014-08-16,2014-03-09,,23,2014-03-16,30,8,DAY,URINARY TRACT INFECTION,URINARY TRACT INFECTION,NA,URINARY TRACT INFECTION,NA,HLT_0161,NA,HLGT_0093,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1130,Placebo,0,84,>80,3,WHITE,1,M,Y,2014-02-15,2014-08-16,2014-03-09,,23,2014-03-09,23,1,DAY,PYREXIA,FEVER,NA,PYREXIA,NA,HLT_0310,NA,HLGT_0652,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1130,Placebo,0,84,>80,3,WHITE,1,M,Y,2014-02-15,2014-08-16,2014-03-09,,23,2014-03-16,30,8,DAY,URINARY TRACT INFECTION,URINARY TRACT INFECTION,NA,URINARY TRACT INFECTION,NA,HLT_0161,NA,HLGT_0093,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,701,01-701-1130,Placebo,0,84,>80,3,WHITE,1,M,Y,2014-02-15,2014-08-16,2014-05-09,,84,2014-05-09,84,1,DAY,EYE SWELLING,EYES SWOLLEN,NA,EYE SWELLING,NA,HLT_0008,NA,HLGT_0466,NA,EYE DISORDERS,EYE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1130,Placebo,0,84,>80,3,WHITE,1,M,Y,2014-02-15,2014-08-16,2014-05-09,,84,2014-05-09,84,1,DAY,EYE ALLERGY,EYE ALLERGY,NA,EYE ALLERGY,NA,HLT_0256,NA,HLGT_0071,NA,EYE DISORDERS,EYE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1130,Placebo,0,84,>80,3,WHITE,1,M,Y,2014-02-15,2014-08-16,2014-05-22,,97,NA,NA,NA,,EYE PRURITUS,EYE ITCHING,NA,EYE PRURITUS,NA,HLT_0523,NA,HLGT_0240,NA,EYE DISORDERS,EYE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1130,Placebo,0,84,>80,3,WHITE,1,M,Y,2014-02-15,2014-08-16,2014-05-22,,97,NA,NA,NA,,PRURITUS,ITCHING BOTH HANDS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1130,Placebo,0,84,>80,3,WHITE,1,M,Y,2014-02-15,2014-08-16,2014-05-22,,97,NA,NA,NA,,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1133,Xanomeline High Dose,81,81,>80,3,WHITE,1,F,Y,2012-10-28,2013-04-28,2012-12-27,,61,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1133,Xanomeline High Dose,81,81,>80,3,WHITE,1,F,Y,2012-10-28,2013-04-28,2012-12-27,,61,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1133,Xanomeline High Dose,81,81,>80,3,WHITE,1,F,Y,2012-10-28,2013-04-28,2012-12-27,,61,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1133,Xanomeline High Dose,81,81,>80,3,WHITE,1,F,Y,2012-10-28,2013-04-28,2012-12-27,,61,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,2013-05-20,2013-06-26,2013-05-16,,-4,2013-06-02,14,18,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,2013-05-20,2013-06-26,2013-05-16,,-4,2013-06-02,14,18,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,2013-05-20,2013-06-26,2013-06-01,,13,2013-06-02,14,2,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,2013-05-20,2013-06-26,2013-06-03,,15,NA,NA,NA,,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,2013-05-20,2013-06-26,2013-06-10,,22,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,2013-05-20,2013-06-26,2013-06-10,,22,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,2013-05-20,2013-06-26,2013-06-10,,22,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,2013-05-20,2013-06-26,2013-06-10,,22,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,2013-05-20,2013-06-26,2013-06-22,,34,NA,NA,NA,,APPLICATION SITE PAIN,APPLICATION SITE PAIN,NA,APPLICATION SITE PAIN,NA,HLT_0342,NA,HLGT_0085,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,9,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,2013-05-20,2013-06-26,2013-06-26,,38,NA,NA,NA,,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,10,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1146,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,2013-05-20,2013-06-26,2013-06-26,,38,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,11,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1148,Xanomeline High Dose,81,57,<65,1,WHITE,1,M,Y,2013-08-23,2014-02-20,2013-08-25,,3,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1148,Xanomeline High Dose,81,57,<65,1,WHITE,1,M,Y,2013-08-23,2014-02-20,2013-08-25,,3,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1148,Xanomeline High Dose,81,57,<65,1,WHITE,1,M,Y,2013-08-23,2014-02-20,2013-10-12,,51,2013-11-10,80,30,DAY,LOWER RESPIRATORY TRACT INFECTION,CHEST COLD,NA,LOWER RESPIRATORY TRACT INFECTION,NA,HLT_0052,NA,HLGT_0217,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1148,Xanomeline High Dose,81,57,<65,1,WHITE,1,M,Y,2013-08-23,2014-02-20,2013-10-12,,51,2013-11-10,80,30,DAY,LOWER RESPIRATORY TRACT INFECTION,CHEST COLD,NA,LOWER RESPIRATORY TRACT INFECTION,NA,HLT_0052,NA,HLGT_0217,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,701,01-701-1148,Xanomeline High Dose,81,57,<65,1,WHITE,1,M,Y,2013-08-23,2014-02-20,2013-12-15,,115,2013-12-17,117,3,DAY,FLANK PAIN,FLANK PAIN,NA,FLANK PAIN,NA,HLT_0484,NA,HLGT_0543,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1148,Xanomeline High Dose,81,57,<65,1,WHITE,1,M,Y,2013-08-23,2014-02-20,2013-12-17,,117,2013-12-17,117,1,DAY,CALCULUS URETHRAL,URETHRAL CALCULUS,NA,CALCULUS URETHRAL,NA,HLT_0550,NA,HLGT_0414,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1148,Xanomeline High Dose,81,57,<65,1,WHITE,1,M,Y,2013-08-23,2014-02-20,2014-01-03,,134,2014-01-03,134,1,DAY,EPISTAXIS,NOSE BLEED,NA,EPISTAXIS,NA,HLT_0386,NA,HLGT_0577,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1148,Xanomeline High Dose,81,57,<65,1,WHITE,1,M,Y,2013-08-23,2014-02-20,2012-02-01,D,-569,NA,NA,NA,,DYSPEPSIA,INDIGESTION,NA,DYSPEPSIA,NA,HLT_0244,NA,HLGT_0716,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,8,,,,,,,,,
CDISCPILOT01,701,01-701-1148,Xanomeline High Dose,81,57,<65,1,WHITE,1,M,Y,2013-08-23,2014-02-20,2013-07-29,,-25,NA,NA,NA,,DEPRESSED MOOD,DEPRESSED MOOD,NA,DEPRESSED MOOD,NA,HLT_0784,NA,HLGT_0122,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,9,,,,,,,,,
CDISCPILOT01,701,01-701-1148,Xanomeline High Dose,81,57,<65,1,WHITE,1,M,Y,2013-08-23,2014-02-20,2014-02-12,,174,NA,NA,NA,,ACTINIC KERATOSIS,ACTINIC KERATOSIS,NA,ACTINIC KERATOSIS,NA,HLT_0609,NA,HLGT_0490,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,10,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1153,Placebo,0,79,65-80,2,WHITE,1,F,Y,2013-09-23,2014-03-16,2013-10-13,,21,2013-11-06,45,25,DAY,INCREASED APPETITE,INCREASED APPETITE,NA,INCREASED APPETITE,NA,HLT_0566,NA,HLGT_0769,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1153,Placebo,0,79,65-80,2,WHITE,1,F,Y,2013-09-23,2014-03-16,2013-10-13,,21,2013-11-06,45,25,DAY,INCREASED APPETITE,INCREASED APPETITE,NA,INCREASED APPETITE,NA,HLT_0566,NA,HLGT_0769,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,701,01-701-1180,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2013-02-12,2013-03-18,2013-02-12,,1,2013-02-12,1,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1180,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2013-02-12,2013-03-18,2013-02-12,,1,2013-02-12,1,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,701,01-701-1180,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2013-02-12,2013-03-18,2013-02-15,,4,2013-03-19,36,33,DAY,MICTURITION URGENCY,URINARY URGENCY,NA,MICTURITION URGENCY,NA,HLT_0294,NA,HLGT_0483,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1180,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2013-02-12,2013-03-18,NA,,NA,NA,NA,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,,,,,,,,,
CDISCPILOT01,701,01-701-1180,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2013-02-12,2013-03-18,2013-03-06,,23,2013-03-07,24,2,DAY,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1180,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2013-02-12,2013-03-18,2013-02-15,,4,2013-03-19,36,33,DAY,MICTURITION URGENCY,URINARY URGENCY,NA,MICTURITION URGENCY,NA,HLT_0294,NA,HLGT_0483,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,701,01-701-1180,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2013-02-12,2013-03-18,2013-03-19,,36,NA,NA,NA,,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1180,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2013-02-12,2013-03-18,2013-03-19,,36,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1180,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2013-02-12,2013-03-18,2013-03-19,,36,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,9,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1181,Xanomeline High Dose,81,79,65-80,2,WHITE,1,F,Y,2013-12-05,2013-12-09,2013-12-09,,5,2013-12-09,5,1,DAY,AGITATION,AGITATION,NA,AGITATION,NA,HLT_0140,NA,HLGT_0170,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1188,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2013-02-15,2013-03-24,2013-02-16,,2,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1188,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2013-02-15,2013-03-24,2013-02-16,,2,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1188,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2013-02-15,2013-03-24,2013-02-16,,2,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1188,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2013-02-15,2013-03-24,2013-02-16,,2,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1188,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2013-02-15,2013-03-24,2013-03-04,,18,NA,NA,NA,,URTICARIA,WELTS,NA,URTICARIA,NA,HLT_0420,NA,HLGT_0705,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1188,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2013-02-15,2013-03-24,2013-03-04,,18,NA,NA,NA,,URTICARIA,WELTS,NA,URTICARIA,NA,HLT_0420,NA,HLGT_0705,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1188,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2013-02-15,2013-03-24,2013-03-21,,35,NA,NA,NA,,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,NA,APPLICATION SITE URTICARIA,NA,HLT_0196,NA,HLGT_0233,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1188,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2013-02-15,2013-03-24,2013-03-21,,35,NA,NA,NA,,URTICARIA,WELTS,NA,URTICARIA,NA,HLT_0420,NA,HLGT_0705,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2012-07-22,2013-01-20,2012-08-03,,13,2012-08-03,13,1,DAY,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,NA,NASAL MUCOSA BIOPSY,NA,HLT_0680,NA,HLGT_0396,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2012-07-22,2013-01-20,2012-08-07,,17,2012-09-14,55,39,DAY,SECRETION DISCHARGE,SECRETION DISCHARGE,NA,SECRETION DISCHARGE,NA,HLT_0683,NA,HLGT_0575,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2012-07-22,2013-01-20,2012-08-07,,17,2012-09-14,55,39,DAY,ERYTHEMA,ERYTHEMA FACIAL,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2012-07-22,2013-01-20,2010-06-01,D,-782,NA,NA,NA,,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,,,,,,,,,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2012-07-22,2013-01-20,2012-08-07,,17,2012-09-14,55,39,DAY,SECRETION DISCHARGE,SECRETION DISCHARGE,NA,SECRETION DISCHARGE,NA,HLT_0683,NA,HLGT_0575,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2012-07-22,2013-01-20,2012-08-07,,17,2012-09-14,55,39,DAY,ERYTHEMA,ERYTHEMA FACIAL,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2012-07-22,2013-01-20,2012-09-07,,48,2012-10-06,77,30,DAY,PNEUMONIA,PNEUMONIA,NA,PNEUMONIA,NA,HLT_0251,NA,HLGT_0671,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,Y,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2012-07-22,2013-01-20,2012-09-07,,48,2012-09-30,71,24,DAY,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,NA,MUSCULAR WEAKNESS,NA,HLT_0444,NA,HLGT_0211,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2012-07-22,2013-01-20,2010-06-01,D,-782,NA,NA,NA,,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,9,,,,,,,,,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2012-07-22,2013-01-20,2012-09-07,,48,2012-10-06,77,30,DAY,PNEUMONIA,PNEUMONIA,NA,PNEUMONIA,NA,HLT_0251,NA,HLGT_0671,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,Y,N,N,NONE,,RECOVERED/RESOLVED,10,Y,,,,,,,,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2012-07-22,2013-01-20,2012-09-07,,48,2012-09-30,71,24,DAY,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,NA,MUSCULAR WEAKNESS,NA,HLT_0444,NA,HLGT_0211,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,11,Y,,,,,,,,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2012-07-22,2013-01-20,2012-12-05,,137,2012-12-16,148,12,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,12,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2012-07-22,2013-01-20,2012-12-05,,137,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,13,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2012-07-22,2013-01-20,2012-12-05,,137,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,14,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1192,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2012-07-22,2013-01-20,2012-12-05,,137,2012-12-16,148,12,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,15,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1203,Placebo,0,81,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-02-02,2013-08-03,2013-03-21,,48,2013-03-21,48,1,DAY,EYE LASER SURGERY,EYE LASER SURGERY,NA,EYE LASER SURGERY,NA,HLT_0355,NA,HLGT_0189,NA,SURGICAL AND MEDICAL PROCEDURES,SURGICAL AND MEDICAL PROCEDURES,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1211,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2012-11-15,2013-01-12,2012-11-16,,2,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1211,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2012-11-15,2013-01-12,2012-11-21,,7,2012-11-21,7,1,DAY,JOINT DISLOCATION,SHOULDER DISLOCATION,NA,JOINT DISLOCATION,NA,HLT_0035,NA,HLGT_0227,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1211,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2012-11-15,2013-01-12,2012-11-21,,7,NA,NA,NA,,SHOULDER PAIN,SHOULDER PAIN,NA,SHOULDER PAIN,NA,HLT_0527,NA,HLGT_0288,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1211,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2012-11-15,2013-01-12,2012-11-22,,8,NA,NA,NA,,INCONTINENCE,INCONTINENCE,NA,INCONTINENCE,NA,HLT_0560,NA,HLGT_0503,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1211,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2012-11-15,2013-01-12,2012-11-29,,15,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1211,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2012-11-15,2013-01-12,2012-12-09,,25,NA,NA,NA,,SKIN LACERATION,LACERATION OF FACE,NA,SKIN LACERATION,NA,HLT_0075,NA,HLGT_0118,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1211,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2012-11-15,2013-01-12,2013-01-11,,58,NA,NA,NA,,CONFUSIONAL STATE,CONFUSION,NA,CONFUSIONAL STATE,NA,HLT_0642,NA,HLGT_0329,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1211,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2012-11-15,2013-01-12,2013-01-11,,58,NA,NA,NA,,DYSPNOEA,SHORTNESS OF BREATH,NA,DYSPNOEA,NA,HLT_0296,NA,HLGT_0255,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1211,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2012-11-15,2013-01-12,2013-01-14,,61,2013-01-14,61,1,DAY,SUDDEN DEATH,SUDDEN DEATH,NA,SUDDEN DEATH,NA,HLT_0142,NA,HLGT_0272,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,Y,N,Y,N,NONE,,FATAL,9,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1239,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2014-01-11,2014-07-10,2014-01-12,,2,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1239,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2014-01-11,2014-07-10,2014-01-12,,2,NA,NA,NA,,SKIN ODOUR ABNORMAL,SKIN ODOR ABNORMAL,NA,SKIN ODOUR ABNORMAL,NA,HLT_0510,NA,HLGT_0184,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1239,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2014-01-11,2014-07-10,2014-01-13,,3,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1239,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2014-01-11,2014-07-10,2014-01-20,,10,2014-02-08,29,20,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1239,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2014-01-11,2014-07-10,2014-01-20,,10,2014-02-08,29,20,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1239,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2014-01-11,2014-07-10,2014-01-12,,2,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1239,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2014-01-11,2014-07-10,2014-02-20,,41,2014-03-12,61,21,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1239,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2014-01-11,2014-07-10,2014-02-20,,41,2014-03-12,61,21,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,701,01-701-1239,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2014-01-11,2014-07-10,2014-03-01,D,50,NA,NA,NA,,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,9,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1239,Xanomeline High Dose,81,56,<65,1,WHITE,1,M,Y,2014-01-11,2014-07-10,2014-04-01,D,81,NA,NA,NA,,HORDEOLUM,STYE,NA,HORDEOLUM,NA,HLT_0604,NA,HLGT_0290,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,10,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2014-02-07,2014-05-31,2014-02-13,,7,2014-06-03,117,111,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2014-02-07,2014-05-31,2014-02-23,,17,2014-02-23,17,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2014-02-07,2014-05-31,2014-02-24,,18,2014-06-12,126,109,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2014-02-07,2014-05-31,2014-02-24,,18,2014-06-03,117,100,DAY,SALIVARY HYPERSECRETION,HYPERSALIVATION,NA,SALIVARY HYPERSECRETION,NA,HLT_0374,NA,HLGT_0488,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2014-02-07,2014-05-31,2014-02-24,,18,2014-06-03,117,100,DAY,PAROSMIA,STRANGE SMELL SENSATION,NA,PAROSMIA,NA,HLT_0258,NA,HLGT_0471,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2014-02-07,2014-05-31,2014-02-24,,18,2014-06-12,126,109,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2014-02-07,2014-05-31,2014-03-12,,34,2014-03-27,49,16,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2014-02-07,2014-05-31,2014-03-12,,34,2014-03-27,49,16,DAY,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2014-02-07,2014-05-31,2014-03-12,,34,2014-03-27,49,16,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2014-02-07,2014-05-31,2014-03-12,,34,2014-03-27,49,16,DAY,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,10,Y,,,,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2014-02-07,2014-05-31,2014-02-13,,7,2014-06-03,117,111,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,11,Y,,,,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2014-02-07,2014-05-31,2014-02-24,,18,2014-06-12,126,109,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,12,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2014-02-07,2014-05-31,2014-02-24,,18,2014-06-03,117,100,DAY,SALIVARY HYPERSECRETION,HYPERSALIVATION,NA,SALIVARY HYPERSECRETION,NA,HLT_0374,NA,HLGT_0488,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,13,Y,,,,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2014-02-07,2014-05-31,2014-02-24,,18,2014-06-03,117,100,DAY,PAROSMIA,STRANGE SMELL SENSATION,NA,PAROSMIA,NA,HLT_0258,NA,HLGT_0471,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,14,Y,,,,,,,,
CDISCPILOT01,701,01-701-1275,Xanomeline High Dose,81,61,<65,1,AMERICAN INDIAN OR ALASKA NATIVE,6,M,Y,2014-02-07,2014-05-31,2014-02-24,,18,2014-06-12,126,109,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,15,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1287,Xanomeline High Dose,81,56,<65,1,WHITE,1,F,Y,2014-01-25,2014-07-26,2014-01-26,,2,NA,NA,NA,,SALIVARY HYPERSECRETION,INCREASED SALIVATION,NA,SALIVARY HYPERSECRETION,NA,HLT_0374,NA,HLGT_0488,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1287,Xanomeline High Dose,81,56,<65,1,WHITE,1,F,Y,2014-01-25,2014-07-26,2014-02-22,,29,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1287,Xanomeline High Dose,81,56,<65,1,WHITE,1,F,Y,2014-01-25,2014-07-26,2014-03-09,,44,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1287,Xanomeline High Dose,81,56,<65,1,WHITE,1,F,Y,2014-01-25,2014-07-26,2014-07-09,,166,2014-07-12,169,4,DAY,RHINORRHOEA,RUNNY NOSE,NA,RHINORRHOEA,NA,HLT_0635,NA,HLGT_0460,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1287,Xanomeline High Dose,81,56,<65,1,WHITE,1,F,Y,2014-01-25,2014-07-26,2014-07-09,,166,2014-07-12,169,4,DAY,RHINORRHOEA,RUNNY NOSE,NA,RHINORRHOEA,NA,HLT_0635,NA,HLGT_0460,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,701,01-701-1294,Xanomeline Low Dose,54,67,65-80,2,WHITE,1,M,Y,2013-03-24,2013-06-14,2013-03-22,,-2,2013-03-23,-1,2,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1294,Xanomeline Low Dose,54,67,65-80,2,WHITE,1,M,Y,2013-03-24,2013-06-14,2013-05-19,,57,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1294,Xanomeline Low Dose,54,67,65-80,2,WHITE,1,M,Y,2013-03-24,2013-06-14,2013-05-19,,57,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1294,Xanomeline Low Dose,54,67,65-80,2,WHITE,1,M,Y,2013-03-24,2013-06-14,2013-05-19,,57,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1294,Xanomeline Low Dose,54,67,65-80,2,WHITE,1,M,Y,2013-03-24,2013-06-14,2013-05-19,,57,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1294,Xanomeline Low Dose,54,67,65-80,2,WHITE,1,M,Y,2013-03-24,2013-06-14,2013-06-10,,79,NA,NA,NA,,RASH ERYTHEMATOUS,ERYTHEMATOUS RASH,NA,RASH ERYTHEMATOUS,NA,HLT_0336,NA,HLGT_0701,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-08-30,,2,NA,NA,NA,,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,NA,APPLICATION SITE PERSPIRATION,NA,HLT_0283,NA,HLGT_0403,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-08-30,,2,NA,NA,NA,,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-08-30,,2,NA,NA,NA,,STOMACH DISCOMFORT,STOMACH UPSET,NA,STOMACH DISCOMFORT,NA,HLT_0065,NA,HLGT_0183,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-08-31,,3,NA,NA,NA,,PAIN,STINGING,NA,PAIN,NA,HLT_0314,NA,HLGT_0478,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-09-01,,4,NA,NA,NA,,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-09-02,,5,NA,NA,NA,,PHARYNGOLARYNGEAL PAIN,SORE THROAT,NA,PHARYNGOLARYNGEAL PAIN,NA,HLT_0130,NA,HLGT_0402,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-09-02,,5,NA,NA,NA,,PRODUCTIVE COUGH,PRODUCTIVE COUGH,NA,PRODUCTIVE COUGH,NA,HLT_0545,NA,HLGT_0681,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-09-02,,5,NA,NA,NA,,MALAISE,MALAISE,NA,MALAISE,NA,HLT_0456,NA,HLGT_0178,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-09-02,,5,2013-09-03,6,2,DAY,DIZZINESS,DIZZY,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-09-02,,5,NA,NA,NA,,MYALGIA,MYALGIA,NA,MYALGIA,NA,HLT_0700,NA,HLGT_0121,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,10,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-09-04,,7,NA,NA,NA,,DIZZINESS,LIGHTHEADEDNESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,11,Y,,,,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-09-05,,8,2013-10-08,41,34,DAY,CONTUSION,BRUISE,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,12,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-09-15,,18,NA,NA,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,13,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-09-30,,33,NA,NA,NA,,EPISTAXIS,NOSE BLEED,NA,EPISTAXIS,NA,HLT_0386,NA,HLGT_0577,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,14,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-09-05,,8,2013-10-08,41,34,DAY,CONTUSION,BRUISE,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,15,Y,,,,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-10-15,,48,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,16,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-10-15,,48,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,17,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-09-02,,5,NA,NA,NA,,MALAISE,MALAISE,NA,MALAISE,NA,HLT_0456,NA,HLGT_0178,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,18,Y,,,,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-10-23,,56,NA,NA,NA,,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,NA,RESPIRATORY TRACT CONGESTION,NA,HLT_0330,NA,HLGT_0424,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,19,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-10-23,,56,NA,NA,NA,,RHINITIS,CORYZA,NA,RHINITIS,NA,HLT_0239,NA,HLGT_0322,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,20,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-10-24,,57,NA,NA,NA,,FEELING ABNORMAL,FOGGY FEELING IN HEAD,NA,FEELING ABNORMAL,NA,HLT_0524,NA,HLGT_0749,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,21,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-10-24,,57,NA,NA,NA,,LISTLESS,LISTLESSNESS,NA,LISTLESS,NA,HLT_0657,NA,HLGT_0124,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,22,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1302,Xanomeline High Dose,81,61,<65,1,WHITE,1,M,Y,2013-08-29,2013-11-05,2013-10-24,,57,NA,NA,NA,,LIBIDO DECREASED,LIBIDO DECREASED,NA,LIBIDO DECREASED,NA,HLT_0338,NA,HLGT_0496,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,23,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1317,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2014-05-22,2014-11-20,2014-05-13,,-9,NA,NA,NA,,ONYCHOMYCOSIS,ONYCHOMYCOSIS,NA,ONYCHOMYCOSIS,NA,HLT_0275,NA,HLGT_0243,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,,
CDISCPILOT01,701,01-701-1317,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2014-05-22,2014-11-20,2014-05-13,,-9,NA,NA,NA,,CYST,CYST,NA,CYST,NA,HLT_0763,NA,HLGT_0341,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,,,,,,,,,
CDISCPILOT01,701,01-701-1317,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2014-05-22,2014-11-20,2014-06-23,,33,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1317,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2014-05-22,2014-11-20,2014-06-23,,33,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1317,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2014-05-22,2014-11-20,2014-06-23,,33,NA,NA,NA,,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,NA,APPLICATION SITE URTICARIA,NA,HLT_0196,NA,HLGT_0233,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1317,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2014-05-22,2014-11-20,2014-07-04,,44,NA,NA,NA,,DEPRESSED MOOD,DEPRESSED MOOD,NA,DEPRESSED MOOD,NA,HLT_0784,NA,HLGT_0122,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1317,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2014-05-22,2014-11-20,2014-07-04,,44,NA,NA,NA,,DEPRESSED MOOD,DEPRESSED MOOD,NA,DEPRESSED MOOD,NA,HLT_0784,NA,HLGT_0122,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,701,01-701-1317,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2014-05-22,2014-11-20,2014-09-12,,114,NA,NA,NA,,FATIGUE,TIREDNESS,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1317,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2014-05-22,2014-11-20,2014-11-03,,166,NA,NA,NA,,DYSPHONIA,HOARSENESS,NA,DYSPHONIA,NA,HLT_0073,NA,HLGT_0274,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,9,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1324,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,M,Y,2012-10-02,2013-04-02,2012-10-22,,21,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1324,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,M,Y,2012-10-02,2013-04-02,2012-12-02,,62,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1324,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,M,Y,2012-10-02,2013-04-02,2012-12-25,,85,2013-01-16,107,23,DAY,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1324,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,M,Y,2012-10-02,2013-04-02,2012-12-25,,85,2013-01-16,107,23,DAY,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1341,Xanomeline Low Dose,54,51,<65,1,WHITE,1,M,Y,2013-01-05,2013-01-26,2013-01-19,,15,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1341,Xanomeline Low Dose,54,51,<65,1,WHITE,1,M,Y,2013-01-05,2013-01-26,2013-01-19,,15,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1341,Xanomeline Low Dose,54,51,<65,1,WHITE,1,M,Y,2013-01-05,2013-01-26,2013-01-26,,22,2013-01-30,26,5,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1341,Xanomeline Low Dose,54,51,<65,1,WHITE,1,M,Y,2013-01-05,2013-01-26,2013-01-26,,22,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1341,Xanomeline Low Dose,54,51,<65,1,WHITE,1,M,Y,2013-01-05,2013-01-26,2013-01-26,,22,2013-01-30,26,5,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1360,Xanomeline High Dose,81,67,65-80,2,WHITE,1,M,Y,2013-07-31,2013-08-05,2013-08-02,,3,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1360,Xanomeline High Dose,81,67,65-80,2,WHITE,1,M,Y,2013-07-31,2013-08-05,2013-08-02,,3,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1360,Xanomeline High Dose,81,67,65-80,2,WHITE,1,M,Y,2013-07-31,2013-08-05,2013-08-05,,6,NA,NA,NA,,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1363,Placebo,0,81,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-05-30,2013-11-27,2013-06-14,,16,2013-06-15,17,2,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1363,Placebo,0,81,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-05-30,2013-11-27,NA,,NA,NA,NA,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,,,,,,,,,
CDISCPILOT01,701,01-701-1363,Placebo,0,81,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-05-30,2013-11-27,2013-07-16,,48,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1363,Placebo,0,81,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-05-30,2013-11-27,NA,,NA,NA,NA,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,,,,,,,,,
CDISCPILOT01,701,01-701-1363,Placebo,0,81,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-05-30,2013-11-27,2013-10-13,,137,2013-10-15,139,3,DAY,BACK PAIN,BACKACHE,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1363,Placebo,0,81,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-05-30,2013-11-27,2013-10-13,,137,2013-10-15,139,3,DAY,BACK PAIN,BACKACHE,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-02-04,2013-08-06,2013-02-07,,4,2013-02-07,4,1,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-02-04,2013-08-06,2013-02-07,,4,2013-02-07,4,1,DAY,APPLICATION SITE PAIN,APPLICATION SITE PAIN,NA,APPLICATION SITE PAIN,NA,HLT_0342,NA,HLGT_0085,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-02-04,2013-08-06,2013-03-23,,48,2013-03-26,51,4,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-02-04,2013-08-06,2013-03-23,,48,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-02-04,2013-08-06,2013-04-12,,68,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-02-04,2013-08-06,2013-04-12,,68,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-02-04,2013-08-06,2013-03-23,,48,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-02-04,2013-08-06,2013-04-12,,68,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-02-04,2013-08-06,2013-05-07,,93,2013-05-24,110,18,DAY,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,9,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-02-04,2013-08-06,2013-06-24,,141,2013-06-24,141,1,DAY,CHEST DISCOMFORT,CHEST PRESSURE,NA,CHEST DISCOMFORT,NA,HLT_0593,NA,HLGT_0441,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,10,Y,,,Y,,,,,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-02-04,2013-08-06,2013-06-24,,141,2013-06-24,141,1,DAY,HEADACHE,FULLNESS HEAD,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,11,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1383,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-02-04,2013-08-06,2013-07-17,,164,2013-07-26,173,10,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,12,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1387,Placebo,0,87,>80,3,WHITE,1,F,Y,2014-03-12,2014-03-25,2014-03-18,,7,2014-03-18,7,1,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1387,Placebo,0,87,>80,3,WHITE,1,F,Y,2014-03-12,2014-03-25,2014-03-18,,7,2014-03-18,7,1,DAY,HYPERHIDROSIS,SWEATING,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1392,Placebo,0,78,65-80,2,WHITE,1,M,Y,2012-10-28,2013-04-28,2013-03-16,,140,2013-03-21,145,6,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1392,Placebo,0,78,65-80,2,WHITE,1,M,Y,2012-10-28,2013-04-28,2013-03-16,,140,2013-03-21,145,6,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,701,01-701-1415,Placebo,0,85,>80,3,WHITE,1,M,Y,2013-09-23,2014-03-24,2013-10-21,,29,2013-11-04,43,15,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,701,01-701-1415,Placebo,0,85,>80,3,WHITE,1,M,Y,2013-09-23,2014-03-24,2013-10-21,,29,2013-11-04,43,15,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,701,01-701-1415,Placebo,0,85,>80,3,WHITE,1,M,Y,2013-09-23,2014-03-24,2013-12-02,,71,NA,NA,NA,,MICTURITION URGENCY,URINARY URGENCY,NA,MICTURITION URGENCY,NA,HLT_0294,NA,HLGT_0483,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1415,Placebo,0,85,>80,3,WHITE,1,M,Y,2013-09-23,2014-03-24,2014-01-21,,121,2014-02-10,141,21,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,701,01-701-1415,Placebo,0,85,>80,3,WHITE,1,M,Y,2013-09-23,2014-03-24,2014-01-21,,121,2014-02-10,141,21,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,701,01-701-1415,Placebo,0,85,>80,3,WHITE,1,M,Y,2013-09-23,2014-03-24,2014-03-09,,168,2014-03-09,168,1,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1442,Xanomeline Low Dose,54,57,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-10-26,2014-04-26,2014-01-10,,77,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1444,Xanomeline High Dose,81,63,<65,1,WHITE,1,M,Y,2013-01-05,2013-02-12,2013-01-19,,15,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,701,01-701-1444,Xanomeline High Dose,81,63,<65,1,WHITE,1,M,Y,2013-01-05,2013-02-12,2013-01-19,,15,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1444,Xanomeline High Dose,81,63,<65,1,WHITE,1,M,Y,2013-01-05,2013-02-12,2013-01-19,,15,NA,NA,NA,,SALIVARY HYPERSECRETION,HYPERSALIVATION,NA,SALIVARY HYPERSECRETION,NA,HLT_0374,NA,HLGT_0488,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,701,01-701-1444,Xanomeline High Dose,81,63,<65,1,WHITE,1,M,Y,2013-01-05,2013-02-12,2013-01-19,,15,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1444,Xanomeline High Dose,81,63,<65,1,WHITE,1,M,Y,2013-01-05,2013-02-12,2013-01-19,,15,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1444,Xanomeline High Dose,81,63,<65,1,WHITE,1,M,Y,2013-01-05,2013-02-12,2013-02-04,,31,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1444,Xanomeline High Dose,81,63,<65,1,WHITE,1,M,Y,2013-01-05,2013-02-12,2013-02-04,,31,NA,NA,NA,,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,701,01-701-1444,Xanomeline High Dose,81,63,<65,1,WHITE,1,M,Y,2013-01-05,2013-02-12,2013-02-08,,35,2013-02-08,35,1,DAY,PARAESTHESIA,TINGLING,NA,PARAESTHESIA,NA,HLT_0481,NA,HLGT_0534,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,702,01-702-1082,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2013-07-26,2013-10-13,2013-07-07,,-19,2013-07-26,1,20,DAY,WHITE BLOOD CELL COUNT INCREASED,WBC INCREASED,NA,WHITE BLOOD CELL COUNT INCREASED,NA,HLT_0417,NA,HLGT_0465,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,,
CDISCPILOT01,702,01-702-1082,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2013-07-26,2013-10-13,2013-07-07,,-19,2013-07-26,1,20,DAY,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,NA,NEUTROPHIL COUNT INCREASED,NA,HLT_0326,NA,HLGT_0625,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,,,,,,,,,
CDISCPILOT01,702,01-702-1082,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2013-07-26,2013-10-13,2013-07-07,,-19,2013-07-24,-2,18,DAY,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,NA,URINE ANALYSIS ABNORMAL,NA,HLT_0783,NA,HLGT_0295,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,,,,,,,,,
CDISCPILOT01,702,01-702-1082,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2013-07-26,2013-10-13,2013-07-07,,-19,2013-07-24,-2,18,DAY,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,NA,URINE ANALYSIS ABNORMAL,NA,HLT_0783,NA,HLGT_0295,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,,,,,,,,,
CDISCPILOT01,702,01-702-1082,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2013-07-26,2013-10-13,2013-07-07,,-19,2013-07-26,1,20,DAY,WHITE BLOOD CELL COUNT INCREASED,WBC INCREASED,NA,WHITE BLOOD CELL COUNT INCREASED,NA,HLT_0417,NA,HLGT_0465,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,,,,,,,,,
CDISCPILOT01,702,01-702-1082,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2013-07-26,2013-10-13,2013-07-07,,-19,2013-07-26,1,20,DAY,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,NA,NEUTROPHIL COUNT INCREASED,NA,HLT_0326,NA,HLGT_0625,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,,,,,,,,,
CDISCPILOT01,702,01-702-1082,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2013-07-26,2013-10-13,2013-09-02,,39,2013-09-06,43,5,DAY,RECTAL HAEMORRHAGE,RECTAL BLEEDING,NA,RECTAL HAEMORRHAGE,NA,HLT_0353,NA,HLGT_0755,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,Y,Y,Y,,,,,
CDISCPILOT01,702,01-702-1082,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2013-07-26,2013-10-13,2013-09-02,,39,2013-09-06,43,5,DAY,RECTAL HAEMORRHAGE,RECTAL BLEEDING,NA,RECTAL HAEMORRHAGE,NA,HLT_0353,NA,HLGT_0755,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,702,01-702-1082,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2013-07-26,2013-10-13,2013-09-09,,46,2013-09-24,61,16,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,9,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,702,01-702-1082,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2013-07-26,2013-10-13,2013-10-12,,79,2013-10-31,98,20,DAY,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,10,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1042,Placebo,0,64,<65,1,WHITE,1,M,Y,2013-03-02,2013-08-31,2013-03-04,,3,2013-03-05,4,2,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,703,01-703-1042,Placebo,0,64,<65,1,WHITE,1,M,Y,2013-03-02,2013-08-31,2013-03-05,,4,2013-03-06,5,2,DAY,INSOMNIA,INSOMNIA,NA,INSOMNIA,NA,HLT_0297,NA,HLGT_0469,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1076,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,2013-10-25,2013-12-24,2013-11-16,,23,2013-11-16,23,1,DAY,BIOPSY PROSTATE,BIOPSY OF PROSTATE,NA,BIOPSY PROSTATE,NA,HLT_0553,NA,HLGT_0725,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,703,01-703-1076,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,2013-10-25,2013-12-24,2013-11-20,,27,NA,NA,NA,,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERTROPHY,NA,BENIGN PROSTATIC HYPERPLASIA,NA,HLT_0215,NA,HLGT_0568,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1076,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,2013-10-25,2013-12-24,NA,,NA,NA,NA,NA,,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLEMIA,NA,HYPERCHOLESTEROLAEMIA,NA,HLT_0025,NA,HLGT_0703,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,,,,,,,,,
CDISCPILOT01,703,01-703-1076,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,2013-10-25,2013-12-24,2013-11-23,,30,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,703,01-703-1076,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,2013-10-25,2013-12-24,2013-11-23,,30,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1076,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,2013-10-25,2013-12-24,2013-11-25,,32,NA,NA,NA,,HYPERHIDROSIS,SWEATING,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1076,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,2013-10-25,2013-12-24,2013-11-23,,30,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1086,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2012-09-02,2012-12-04,2012-09-13,,12,2013-01-02,123,112,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,703,01-703-1086,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2012-09-02,2012-12-04,2012-09-13,,12,2013-01-02,123,112,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1086,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2012-09-02,2012-12-04,2012-09-13,,12,2013-01-02,123,112,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1086,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2012-09-02,2012-12-04,2012-10-09,,38,2012-10-15,44,7,DAY,CHILLS,CHILLS,NA,CHILLS,NA,HLT_0586,NA,HLGT_0161,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,703,01-703-1086,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2012-09-02,2012-12-04,2012-10-09,,38,2012-10-15,44,7,DAY,CHILLS,CHILLS,NA,CHILLS,NA,HLT_0586,NA,HLGT_0161,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,703,01-703-1086,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,M,Y,2012-09-02,2012-12-04,2012-09-13,,12,2013-01-02,123,112,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1100,Placebo,0,84,>80,3,WHITE,1,F,Y,2013-03-13,2013-09-14,2013-04-05,,24,2013-04-16,35,12,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,703,01-703-1100,Placebo,0,84,>80,3,WHITE,1,F,Y,2013-03-13,2013-09-14,2013-04-05,,24,2013-04-16,35,12,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1100,Placebo,0,84,>80,3,WHITE,1,F,Y,2013-03-13,2013-09-14,2013-04-05,,24,2013-04-16,35,12,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1100,Placebo,0,84,>80,3,WHITE,1,F,Y,2013-03-13,2013-09-14,2013-04-25,,44,2013-04-25,44,1,DAY,CATARACT OPERATION,CATARACT EXTRACTION,NA,CATARACT OPERATION,NA,HLT_0432,NA,HLGT_0058,NA,SURGICAL AND MEDICAL PROCEDURES,SURGICAL AND MEDICAL PROCEDURES,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1100,Placebo,0,84,>80,3,WHITE,1,F,Y,2013-03-13,2013-09-14,2013-05-27,,76,2013-06-03,83,8,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1100,Placebo,0,84,>80,3,WHITE,1,F,Y,2013-03-13,2013-09-14,2013-02-28,,-13,2013-09-14,186,199,DAY,OEDEMA PERIPHERAL,LEG EDEMA,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,6,,,,,,,,,
CDISCPILOT01,703,01-703-1100,Placebo,0,84,>80,3,WHITE,1,F,Y,2013-03-13,2013-09-14,2013-07-17,,127,2013-09-14,186,60,DAY,OEDEMA PERIPHERAL,LEG EDEMA,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,,
CDISCPILOT01,703,01-703-1100,Placebo,0,84,>80,3,WHITE,1,F,Y,2013-03-13,2013-09-14,2013-02-28,,-13,2013-09-14,186,199,DAY,OEDEMA PERIPHERAL,LEG EDEMA,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,8,,,,,,,,,
CDISCPILOT01,703,01-703-1100,Placebo,0,84,>80,3,WHITE,1,F,Y,2013-03-13,2013-09-14,2013-07-17,,127,2013-09-14,186,60,DAY,OEDEMA PERIPHERAL,LEG EDEMA,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,703,01-703-1119,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2013-02-20,2013-06-13,2013-03-16,,25,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,703,01-703-1119,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2013-02-20,2013-06-13,2013-03-16,,25,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1119,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2013-02-20,2013-06-13,2013-05-04,,74,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1119,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2013-02-20,2013-06-13,2013-05-04,,74,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1175,Placebo,0,75,65-80,2,WHITE,1,M,Y,2013-12-20,2013-12-26,2013-12-18,,-2,NA,NA,NA,,ATRIOVENTRICULAR BLOCK SECOND DEGREE,HEART BLOCK SECOND DEGREE,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,NA,HLT_0415,NA,HLGT_0086,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,,
CDISCPILOT01,703,01-703-1182,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,2013-10-17,2013-12-11,2013-10-31,,15,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,703,01-703-1182,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,2013-10-17,2013-12-11,2013-10-31,,15,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1182,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,2013-10-17,2013-12-11,2013-11-22,,37,NA,NA,NA,,SOMNOLENCE,DROWSINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1182,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,2013-10-17,2013-12-11,2013-11-22,,37,NA,NA,NA,,SOMNOLENCE,DROWSINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,703,01-703-1210,Placebo,0,72,65-80,2,WHITE,1,F,Y,2013-03-16,2013-09-06,2013-04-02,,18,NA,NA,NA,,DISORIENTATION,DISORIENTATION,NA,DISORIENTATION,NA,HLT_0299,NA,HLGT_0307,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,703,01-703-1210,Placebo,0,72,65-80,2,WHITE,1,F,Y,2013-03-16,2013-09-06,2013-05-04,,50,NA,NA,NA,,DECREASED APPETITE,DECREASED APPETITE,NA,DECREASED APPETITE,NA,HLT_0574,NA,HLGT_0231,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1210,Placebo,0,72,65-80,2,WHITE,1,F,Y,2013-03-16,2013-09-06,2013-05-04,,50,NA,NA,NA,,DECREASED APPETITE,DECREASED APPETITE,NA,DECREASED APPETITE,NA,HLT_0574,NA,HLGT_0231,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,703,01-703-1258,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,2012-07-20,2013-01-11,2012-08-11,,23,2012-08-19,31,9,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,703,01-703-1258,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,2012-07-20,2013-01-11,NA,,NA,NA,NA,NA,,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,,,,,,,,,
CDISCPILOT01,703,01-703-1258,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,2012-07-20,2013-01-11,2012-08-11,,23,2012-08-19,31,9,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,703,01-703-1258,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,2012-07-20,2013-01-11,2012-09-04,,47,2013-01-25,190,144,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,703,01-703-1258,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,2012-07-20,2013-01-11,NA,,NA,NA,NA,NA,,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,,,,,,,,,
CDISCPILOT01,703,01-703-1258,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,2012-07-20,2013-01-11,2012-09-04,,47,2013-01-25,190,144,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1258,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,2012-07-20,2013-01-11,2012-09-04,,47,2013-01-25,190,144,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,703,01-703-1295,Xanomeline High Dose,81,88,>80,3,WHITE,1,F,Y,2013-11-21,2014-04-19,2013-12-28,,38,NA,NA,NA,,ARTHRITIS,ARTHRITIS,NA,ARTHRITIS,NA,HLT_0019,NA,HLGT_0587,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,703,01-703-1299,Placebo,0,81,>80,3,WHITE,1,F,Y,2012-09-12,2013-03-13,2012-09-27,,16,2012-10-06,25,10,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,703,01-703-1299,Placebo,0,81,>80,3,WHITE,1,F,Y,2012-09-12,2013-03-13,2012-09-27,,16,2012-10-06,25,10,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,703,01-703-1299,Placebo,0,81,>80,3,WHITE,1,F,Y,2012-09-12,2013-03-13,NA,,NA,NA,NA,NA,,GLAUCOMA,GLAUCOMA,NA,GLAUCOMA,NA,HLT_0556,NA,HLGT_0734,NA,EYE DISORDERS,EYE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,,,,,,,,,
CDISCPILOT01,703,01-703-1299,Placebo,0,81,>80,3,WHITE,1,F,Y,2012-09-12,2013-03-13,2013-03-01,,171,NA,NA,NA,,HYPOTENSION,HYPOTENSION,NA,HYPOTENSION,NA,HLT_0761,NA,HLGT_0412,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1299,Placebo,0,81,>80,3,WHITE,1,F,Y,2012-09-12,2013-03-13,2013-03-01,,171,NA,NA,NA,,TACHYCARDIA,TACHYCARDIA,NA,TACHYCARDIA,NA,HLT_0082,NA,HLGT_0574,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1299,Placebo,0,81,>80,3,WHITE,1,F,Y,2012-09-12,2013-03-13,2013-03-01,,171,NA,NA,NA,,HYPOTENSION,HYPOTENSION,NA,HYPOTENSION,NA,HLT_0761,NA,HLGT_0412,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,703,01-703-1299,Placebo,0,81,>80,3,WHITE,1,F,Y,2012-09-12,2013-03-13,2013-03-01,,171,NA,NA,NA,,TACHYCARDIA,TACHYCARDIA,NA,TACHYCARDIA,NA,HLT_0082,NA,HLGT_0574,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,703,01-703-1299,Placebo,0,81,>80,3,WHITE,1,F,Y,2012-09-12,2013-03-13,2013-03-13,,183,NA,NA,NA,,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,Y,,,,,
CDISCPILOT01,703,01-703-1335,Xanomeline High Dose,81,67,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2014-03-17,2014-05-07,2014-03-15,,-2,2014-03-30,14,16,DAY,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,NA,HLT_0415,NA,HLGT_0086,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,,
CDISCPILOT01,703,01-703-1335,Xanomeline High Dose,81,67,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2014-03-17,2014-05-07,2014-03-15,,-2,2014-03-30,14,16,DAY,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,NA,HLT_0415,NA,HLGT_0086,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,,,,,,,,,
CDISCPILOT01,703,01-703-1403,Xanomeline High Dose,81,67,65-80,2,WHITE,1,M,Y,2012-12-12,2012-12-13,2012-12-12,,1,2012-12-19,8,8,DAY,WEIGHT DECREASED,WEIGHT LOSS,NA,WEIGHT DECREASED,NA,HLT_0158,NA,HLGT_0778,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,703,01-703-1403,Xanomeline High Dose,81,67,65-80,2,WHITE,1,M,Y,2012-12-12,2012-12-13,2012-12-13,,2,2012-12-14,3,2,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1403,Xanomeline High Dose,81,67,65-80,2,WHITE,1,M,Y,2012-12-12,2012-12-13,2012-12-13,,2,2012-12-14,3,2,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,703,01-703-1403,Xanomeline High Dose,81,67,65-80,2,WHITE,1,M,Y,2012-12-12,2012-12-13,2012-12-15,,4,2012-12-16,5,2,DAY,CHEST DISCOMFORT,CHEST TIGHTNESS,NA,CHEST DISCOMFORT,NA,HLT_0593,NA,HLGT_0441,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,703,01-703-1403,Xanomeline High Dose,81,67,65-80,2,WHITE,1,M,Y,2012-12-12,2012-12-13,2012-12-12,,1,2012-12-19,8,8,DAY,WEIGHT DECREASED,WEIGHT LOSS,NA,WEIGHT DECREASED,NA,HLT_0158,NA,HLGT_0778,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,703,01-703-1439,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,2014-03-12,2014-09-11,2014-04-24,,44,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,703,01-703-1439,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,2014-03-12,2014-09-11,2014-04-24,,44,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1008,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,2013-01-13,2013-02-21,2013-01-30,,18,NA,NA,NA,,HYPERHIDROSIS,SWEATING INCREASED,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1008,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,2013-01-13,2013-02-21,2013-02-21,,40,2013-02-21,40,1,DAY,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHEMIC ATTACKS,NA,TRANSIENT ISCHAEMIC ATTACK,NA,HLT_0041,NA,HLGT_0433,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,N,N,N,N,Y,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1008,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,2013-01-13,2013-02-21,2013-02-25,,44,NA,NA,NA,,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1009,Xanomeline Low Dose,54,83,>80,3,WHITE,1,M,Y,2013-08-27,2013-09-25,2013-09-05,,10,NA,NA,NA,,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1009,Xanomeline Low Dose,54,83,>80,3,WHITE,1,M,Y,2013-08-27,2013-09-25,2013-09-05,,10,2013-09-27,32,23,DAY,MALAISE,MALAISE,NA,MALAISE,NA,HLT_0456,NA,HLGT_0178,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1009,Xanomeline Low Dose,54,83,>80,3,WHITE,1,M,Y,2013-08-27,2013-09-25,2013-09-14,,19,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1009,Xanomeline Low Dose,54,83,>80,3,WHITE,1,M,Y,2013-08-27,2013-09-25,2013-09-05,,10,2013-09-27,32,23,DAY,MALAISE,MALAISE,NA,MALAISE,NA,HLT_0456,NA,HLGT_0178,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,704,01-704-1009,Xanomeline Low Dose,54,83,>80,3,WHITE,1,M,Y,2013-08-27,2013-09-25,2013-09-17,,22,NA,NA,NA,,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1009,Xanomeline Low Dose,54,83,>80,3,WHITE,1,M,Y,2013-08-27,2013-09-25,2013-09-22,,27,2013-09-23,28,2,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1010,Placebo,0,80,65-80,2,WHITE,1,M,Y,2014-02-21,2014-07-08,2014-02-27,,7,2014-03-06,14,8,DAY,CYSTITIS,BLADDER INFECTION,NA,CYSTITIS,NA,HLT_0739,NA,HLGT_0129,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1010,Placebo,0,80,65-80,2,WHITE,1,M,Y,2014-02-21,2014-07-08,2014-07-05,,135,2014-07-06,136,2,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1010,Placebo,0,80,65-80,2,WHITE,1,M,Y,2014-02-21,2014-07-08,2014-07-05,,135,2014-07-06,136,2,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1010,Placebo,0,80,65-80,2,WHITE,1,M,Y,2014-02-21,2014-07-08,2014-07-06,,136,NA,NA,NA,,EXCORIATION,ABRASION NOS,NA,EXCORIATION,NA,HLT_0738,NA,HLGT_0511,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1010,Placebo,0,80,65-80,2,WHITE,1,M,Y,2014-02-21,2014-07-08,2014-07-06,,136,NA,NA,NA,,SKIN LACERATION,SKIN TEAR,NA,SKIN LACERATION,NA,HLT_0075,NA,HLGT_0118,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1010,Placebo,0,80,65-80,2,WHITE,1,M,Y,2014-02-21,2014-07-08,2014-07-06,,136,NA,NA,NA,,ARTHRALGIA,KNEE PAIN,NA,ARTHRALGIA,NA,HLT_0375,NA,HLGT_0610,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1010,Placebo,0,80,65-80,2,WHITE,1,M,Y,2014-02-21,2014-07-08,2014-07-06,,136,NA,NA,NA,,CONTUSION,BRUISE OF HEAD,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1017,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-10-06,2013-11-18,2013-10-19,,14,NA,NA,NA,,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1017,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-10-06,2013-11-18,2013-10-19,,14,NA,NA,NA,,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,NA,VENTRICULAR SEPTAL DEFECT,NA,HLT_0589,NA,HLGT_0747,NA,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS","CONGENITAL, FAMILIAL AND GENETIC DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1017,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-10-06,2013-11-18,2013-11-01,,27,2013-11-08,34,8,DAY,INFLUENZA,FLU,NA,INFLUENZA,NA,HLT_0125,NA,HLGT_0081,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1017,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-10-06,2013-11-18,2013-11-01,,27,NA,NA,NA,,CARDIAC DISORDER,CARDIAC DISORDER,NA,CARDIAC DISORDER,NA,HLT_0507,NA,HLGT_0126,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1017,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-10-06,2013-11-18,2013-11-05,,31,2013-11-22,48,18,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1017,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-10-06,2013-11-18,2013-11-05,,31,2013-11-22,48,18,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1017,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-10-06,2013-11-18,2013-11-05,,31,2013-11-22,48,18,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1017,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-10-06,2013-11-18,2013-11-05,,31,2013-11-22,48,18,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1025,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2013-09-27,2013-10-24,2013-09-28,,2,2013-09-30,4,3,DAY,VERTIGO,VERTIGO,NA,VERTIGO,NA,HLT_0255,NA,HLGT_0147,NA,EAR AND LABYRINTH DISORDERS,EAR AND LABYRINTH DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1025,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2013-09-27,2013-10-24,2013-09-28,,2,2013-09-30,4,3,DAY,PALPITATIONS,PALPITATIONS,NA,PALPITATIONS,NA,HLT_0493,NA,HLGT_0593,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1025,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2013-09-27,2013-10-24,2013-10-11,,15,2013-10-25,29,15,DAY,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ST SEGMENT DEPRESSED,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,NA,HLT_0610,NA,HLGT_0220,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1025,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2013-09-27,2013-10-24,2013-10-25,,29,2013-11-29,64,36,DAY,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,NA,WOLFF-PARKINSON-WHITE SYNDROME,NA,HLT_0612,NA,HLGT_0218,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1025,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2013-09-27,2013-10-24,2013-10-11,,15,2013-10-25,29,15,DAY,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ST SEGMENT DEPRESSED,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,NA,HLT_0610,NA,HLGT_0220,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,704,01-704-1025,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2013-09-27,2013-10-24,2013-10-25,,29,2013-11-29,64,36,DAY,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,NA,WOLFF-PARKINSON-WHITE SYNDROME,NA,HLT_0612,NA,HLGT_0218,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,704,01-704-1065,Xanomeline High Dose,81,75,65-80,2,WHITE,1,M,Y,2013-10-24,2013-12-22,2013-10-26,,3,NA,NA,NA,,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,NA,ABDOMINAL DISCOMFORT,NA,HLT_0012,NA,HLGT_0332,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1065,Xanomeline High Dose,81,75,65-80,2,WHITE,1,M,Y,2013-10-24,2013-12-22,2013-10-27,,4,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1065,Xanomeline High Dose,81,75,65-80,2,WHITE,1,M,Y,2013-10-24,2013-12-22,2013-10-27,,4,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1065,Xanomeline High Dose,81,75,65-80,2,WHITE,1,M,Y,2013-10-24,2013-12-22,2013-11-09,,17,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1065,Xanomeline High Dose,81,75,65-80,2,WHITE,1,M,Y,2013-10-24,2013-12-22,2013-11-09,,17,NA,NA,NA,,MALAISE,MALAISE,NA,MALAISE,NA,HLT_0456,NA,HLGT_0178,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1065,Xanomeline High Dose,81,75,65-80,2,WHITE,1,M,Y,2013-10-24,2013-12-22,2013-11-09,,17,NA,NA,NA,,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1065,Xanomeline High Dose,81,75,65-80,2,WHITE,1,M,Y,2013-10-24,2013-12-22,2013-11-17,,25,2013-11-17,25,1,DAY,CHILLS,CHILLS,NA,CHILLS,NA,HLT_0586,NA,HLGT_0161,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,7,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1065,Xanomeline High Dose,81,75,65-80,2,WHITE,1,M,Y,2013-10-24,2013-12-22,2013-11-17,,25,2013-11-17,25,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1065,Xanomeline High Dose,81,75,65-80,2,WHITE,1,M,Y,2013-10-24,2013-12-22,2013-12-15,,53,2013-12-15,53,1,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1065,Xanomeline High Dose,81,75,65-80,2,WHITE,1,M,Y,2013-10-24,2013-12-22,2013-12-24,,62,NA,NA,NA,,SINUS BRADYCARDIA,BRADYCARDIA SINUS,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,10,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1074,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,2014-01-22,2014-03-20,2014-01-22,,1,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1074,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,2014-01-22,2014-03-20,2014-02-09,,19,NA,NA,NA,,ERYTHEMA,SKIN RED,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1093,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,2013-03-15,2013-06-17,2013-03-30,,16,2013-04-13,30,15,DAY,BLOOD GLUCOSE INCREASED,GLUCOSE INCREASED,NA,BLOOD GLUCOSE INCREASED,NA,HLT_0450,NA,HLGT_0188,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1093,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,2013-03-15,2013-06-17,2013-03-30,,16,2013-04-13,30,15,DAY,BLOOD GLUCOSE INCREASED,GLUCOSE INCREASED,NA,BLOOD GLUCOSE INCREASED,NA,HLT_0450,NA,HLGT_0188,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,704,01-704-1093,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,2013-03-15,2013-06-17,2013-05-04,,51,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1093,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,2013-03-15,2013-06-17,2013-05-04,,51,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1114,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2013-01-23,2013-07-07,2013-02-21,,30,2013-02-23,32,3,DAY,ERYTHEMA,REDNESS,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1114,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2013-01-23,2013-07-07,2013-02-23,,32,NA,NA,NA,,OEDEMA,EDEMA,NA,OEDEMA,NA,HLT_0656,NA,HLGT_0036,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1114,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2013-01-23,2013-07-07,2013-03-23,,60,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1114,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2013-01-23,2013-07-07,2013-03-23,,60,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1114,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2013-01-23,2013-07-07,2013-06-07,,136,2013-06-13,142,7,DAY,INFLUENZA,FLU,NA,INFLUENZA,NA,HLT_0125,NA,HLGT_0081,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1120,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,2013-12-02,2014-02-01,2013-12-23,,22,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1120,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,2013-12-02,2014-02-01,2013-12-28,,27,2014-02-03,64,38,DAY,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1120,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,2013-12-02,2014-02-01,2013-12-23,,22,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1120,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,2013-12-02,2014-02-01,2014-01-27,,57,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1120,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,2013-12-02,2014-02-01,2014-01-27,,57,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1120,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,2013-12-02,2014-02-01,2013-12-28,,27,2014-02-03,64,38,DAY,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,704,01-704-1135,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,2013-10-31,2014-05-16,2013-12-08,,39,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1135,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,2013-10-31,2014-05-16,2013-12-08,,39,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,,,NOT RECOVERED/NOT RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1164,Placebo,0,67,65-80,2,WHITE,1,F,Y,2012-09-19,2013-04-04,2012-09-27,,9,2012-10-07,19,11,DAY,INFLUENZA,FLU,NA,INFLUENZA,NA,HLT_0125,NA,HLGT_0081,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1164,Placebo,0,67,65-80,2,WHITE,1,F,Y,2012-09-19,2013-04-04,2012-09-27,,9,2012-10-07,19,11,DAY,INFLUENZA,FLU,NA,INFLUENZA,NA,HLT_0125,NA,HLGT_0081,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,704,01-704-1164,Placebo,0,67,65-80,2,WHITE,1,F,Y,2012-09-19,2013-04-04,2013-02-04,,139,2013-02-13,148,10,DAY,OEDEMA PERIPHERAL,SWELLING OF FEET,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1218,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2012-11-19,2013-05-27,2012-12-30,,42,NA,NA,NA,,BLOOD GLUCOSE INCREASED,GLUCOSE INCREASED,NA,BLOOD GLUCOSE INCREASED,NA,HLT_0450,NA,HLGT_0188,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1241,Xanomeline High Dose,81,86,>80,3,WHITE,1,M,Y,2013-08-25,2013-10-09,2013-08-14,,-11,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1241,Xanomeline High Dose,81,86,>80,3,WHITE,1,M,Y,2013-08-25,2013-10-09,2013-09-28,,35,NA,NA,NA,,DYSPNOEA,RESPIRATION LABORED,NA,DYSPNOEA,NA,HLT_0296,NA,HLGT_0255,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2013-10-13,2013-12-06,2013-10-06,,-7,NA,NA,NA,,SEASONAL ALLERGY,HAY FEVER,NA,SEASONAL ALLERGY,NA,HLT_0714,NA,HLGT_0782,NA,IMMUNE SYSTEM DISORDERS,IMMUNE SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2013-10-13,2013-12-06,2013-10-17,,5,2013-12-23,72,68,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2013-10-13,2013-12-06,2013-10-27,,15,2013-11-08,27,13,DAY,ATRIAL FLUTTER,ATRIAL FLUTTER,NA,ATRIAL FLUTTER,NA,HLT_0477,NA,HLGT_0627,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2013-10-13,2013-12-06,2013-11-08,,27,2013-12-06,55,29,DAY,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2013-10-13,2013-12-06,2013-10-27,,15,2013-11-08,27,13,DAY,ATRIAL FLUTTER,ATRIAL FLUTTER,NA,ATRIAL FLUTTER,NA,HLT_0477,NA,HLGT_0627,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2013-10-13,2013-12-06,2013-11-09,,28,2013-12-04,53,26,DAY,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2013-10-13,2013-12-06,2013-11-15,,34,2013-12-14,63,30,DAY,BLISTER,BLISTERING,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2013-10-13,2013-12-06,2013-11-15,,34,2013-12-23,72,39,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2013-10-13,2013-12-06,2013-10-17,,5,2013-12-23,72,68,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,9,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2013-10-13,2013-12-06,2013-11-09,,28,2013-12-04,53,26,DAY,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,10,Y,,,,,,,,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2013-10-13,2013-12-06,2013-12-06,,55,2013-12-23,72,18,DAY,ERYTHEMA,REDNESS,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,11,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2013-10-13,2013-12-06,2013-10-17,,5,2013-12-23,72,68,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,12,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2013-10-13,2013-12-06,2013-11-08,,27,2013-12-06,55,29,DAY,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,13,Y,,,,,,,,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2013-10-13,2013-12-06,2013-11-15,,34,2013-12-14,63,30,DAY,BLISTER,BLISTERING,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,14,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2013-10-13,2013-12-06,2013-11-15,,34,2013-12-23,72,39,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,15,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1266,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2013-10-13,2013-12-06,2013-12-06,,55,2013-12-23,72,18,DAY,ERYTHEMA,REDNESS,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,16,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1323,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,F,Y,2013-07-08,2013-08-05,2013-07-30,,23,2013-08-03,27,5,DAY,VIRAL INFECTION,VIRAL INFECTION,NA,VIRAL INFECTION,NA,HLT_0733,NA,HLGT_0408,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1323,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,F,Y,2013-07-08,2013-08-05,2013-08-04,,28,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1323,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,F,Y,2013-07-08,2013-08-05,2013-08-04,,28,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1323,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,F,Y,2013-07-08,2013-08-05,2013-08-04,,28,NA,NA,NA,,OEDEMA,EDEMA,NA,OEDEMA,NA,HLT_0656,NA,HLGT_0036,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1325,Xanomeline Low Dose,54,81,>80,3,WHITE,1,M,Y,2014-04-23,2014-07-04,2014-05-23,,31,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1325,Xanomeline Low Dose,54,81,>80,3,WHITE,1,M,Y,2014-04-23,2014-07-04,2014-07-04,,73,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1332,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,2013-12-09,2014-02-14,2013-12-10,,2,2014-02-24,78,77,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,704,01-704-1332,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,2013-12-09,2014-02-14,2014-01-18,,41,2014-02-24,78,38,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1332,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,2013-12-09,2014-02-14,2013-12-10,,2,2014-02-24,78,77,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1332,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,2013-12-09,2014-02-14,2014-02-03,,57,NA,NA,NA,,BURNING SENSATION,BURNING SENSATION,NA,BURNING SENSATION,NA,HLT_0775,NA,HLGT_0456,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1332,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,2013-12-09,2014-02-14,2013-12-10,,2,2014-02-24,78,77,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1332,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,2013-12-09,2014-02-14,2014-01-18,,41,2014-02-24,78,38,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,704,01-704-1351,Placebo,0,70,65-80,2,WHITE,1,M,Y,2013-10-12,2014-04-18,2013-10-27,,16,2014-04-04,175,160,DAY,POLLAKIURIA,URINARY FREQUENCY,NA,POLLAKIURIA,NA,HLT_0393,NA,HLGT_0560,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1351,Placebo,0,70,65-80,2,WHITE,1,M,Y,2013-10-12,2014-04-18,2013-10-27,,16,2014-04-04,175,160,DAY,FLATULENCE,GAS,NA,FLATULENCE,NA,HLT_0356,NA,HLGT_0504,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,704,01-704-1351,Placebo,0,70,65-80,2,WHITE,1,M,Y,2013-10-12,2014-04-18,2013-10-27,,16,2014-04-04,175,160,DAY,POLLAKIURIA,URINARY FREQUENCY,NA,POLLAKIURIA,NA,HLT_0393,NA,HLGT_0560,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,704,01-704-1351,Placebo,0,70,65-80,2,WHITE,1,M,Y,2013-10-12,2014-04-18,2013-10-27,,16,2014-04-04,175,160,DAY,FLATULENCE,GAS,NA,FLATULENCE,NA,HLT_0356,NA,HLGT_0504,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,704,01-704-1388,Placebo,0,81,>80,3,WHITE,1,M,Y,2012-12-07,2013-06-11,2012-08-23,,-106,NA,NA,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,,
CDISCPILOT01,704,01-704-1435,Placebo,0,74,65-80,2,WHITE,1,M,Y,2012-11-17,2013-01-09,2013-01-06,,51,NA,NA,NA,,PARKINSON'S DISEASE,DISEASE PARKINSON'S,NA,PARKINSON'S DISEASE,NA,HLT_0279,NA,HLGT_0313,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,704,01-704-1445,Placebo,0,75,65-80,2,WHITE,1,M,Y,2014-05-11,2014-11-01,2014-10-31,,174,2014-10-31,174,1,DAY,COMPLETED SUICIDE,SUICIDE,NA,COMPLETED SUICIDE,NA,HLT_0625,NA,HLGT_0013,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,SEVERE,N,N,N,N,Y,N,N,N,NONE,,FATAL,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,705,01-705-1031,Xanomeline Low Dose,54,56,<65,1,WHITE,1,F,Y,2013-11-27,2014-05-11,2013-12-25,,29,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,705,01-705-1059,Placebo,0,66,65-80,2,WHITE,1,F,Y,2013-08-05,2013-12-05,2013-11-02,,90,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,705,01-705-1186,Placebo,0,84,>80,3,WHITE,1,F,Y,2014-01-08,2014-01-26,2014-01-26,,19,NA,NA,NA,,HYPERBILIRUBINAEMIA,HYPERBILIRUBINEMIA,NA,HYPERBILIRUBINAEMIA,NA,HLT_0478,NA,HLGT_0087,NA,HEPATOBILIARY DISORDERS,HEPATOBILIARY DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,705,01-705-1199,Xanomeline Low Dose,54,87,>80,3,WHITE,1,M,Y,2013-09-16,2013-09-28,2013-09-17,,2,2013-09-29,14,13,DAY,DYSPEPSIA,PYROSIS,NA,DYSPEPSIA,NA,HLT_0244,NA,HLGT_0716,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,705,01-705-1199,Xanomeline Low Dose,54,87,>80,3,WHITE,1,M,Y,2013-09-16,2013-09-28,2013-09-17,,2,2013-09-29,14,13,DAY,DYSPEPSIA,PYROSIS,NA,DYSPEPSIA,NA,HLT_0244,NA,HLGT_0716,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,705,01-705-1280,Xanomeline High Dose,81,56,<65,1,WHITE,1,F,Y,2014-01-17,2014-07-25,2014-04-20,,94,NA,NA,NA,,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,705,01-705-1281,Xanomeline High Dose,81,73,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-11-28,2014-02-27,2014-01-30,,64,NA,NA,NA,,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,705,01-705-1281,Xanomeline High Dose,81,73,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-11-28,2014-02-27,2014-01-30,,64,NA,NA,NA,,EXCORIATION,ABRASIONS,NA,EXCORIATION,NA,HLT_0738,NA,HLGT_0511,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,705,01-705-1281,Xanomeline High Dose,81,73,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-11-28,2014-02-27,2014-01-30,,64,NA,NA,NA,,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,705,01-705-1292,Xanomeline Low Dose,54,60,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-10-14,2014-05-13,2013-10-28,,15,NA,NA,NA,,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,705,01-705-1292,Xanomeline Low Dose,54,60,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-10-14,2014-05-13,2014-02-13,,123,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,705,01-705-1303,Xanomeline High Dose,81,72,65-80,2,WHITE,1,M,Y,2013-12-16,2014-06-02,2014-02-05,,52,2014-03-03,78,27,DAY,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,705,01-705-1303,Xanomeline High Dose,81,72,65-80,2,WHITE,1,M,Y,2013-12-16,2014-06-02,2014-02-05,,52,2014-03-03,78,27,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,705,01-705-1303,Xanomeline High Dose,81,72,65-80,2,WHITE,1,M,Y,2013-12-16,2014-06-02,2014-02-05,,52,2014-03-03,78,27,DAY,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,705,01-705-1303,Xanomeline High Dose,81,72,65-80,2,WHITE,1,M,Y,2013-12-16,2014-06-02,2014-02-05,,52,2014-03-03,78,27,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,705,01-705-1310,Xanomeline High Dose,81,74,65-80,2,WHITE,1,F,Y,2013-11-02,2014-01-23,2013-11-14,,13,NA,NA,NA,,RASH PRURITIC,PRURITIC RASH,NA,RASH PRURITIC,NA,HLT_0127,NA,HLGT_0753,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,705,01-705-1310,Xanomeline High Dose,81,74,65-80,2,WHITE,1,F,Y,2013-11-02,2014-01-23,2014-01-09,,69,NA,NA,NA,,WOUND HAEMORRHAGE,WOUND BLEEDING,NA,WOUND HAEMORRHAGE,NA,HLT_0154,NA,HLGT_0162,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,705,01-705-1349,Placebo,0,86,>80,3,WHITE,1,F,Y,2013-03-10,2013-09-08,2013-04-08,,30,2013-04-08,30,1,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,705,01-705-1349,Placebo,0,86,>80,3,WHITE,1,F,Y,2013-03-10,2013-09-08,2013-04-11,,33,2013-04-11,33,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,705,01-705-1349,Placebo,0,86,>80,3,WHITE,1,F,Y,2013-03-10,2013-09-08,2013-08-25,,169,NA,NA,NA,,VENTRICULAR HYPERTROPHY,LEFT VENTRICULAR HYPERTROPHY,NA,VENTRICULAR HYPERTROPHY,NA,HLT_0104,NA,HLGT_0259,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,705,01-705-1349,Placebo,0,86,>80,3,WHITE,1,F,Y,2013-03-10,2013-09-08,2013-08-25,,169,NA,NA,NA,,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ST SEGMENT DEPRESSED,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,NA,HLT_0610,NA,HLGT_0220,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,705,01-705-1393,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2012-09-07,2013-02-01,2012-09-19,,13,2012-09-24,18,6,DAY,ABDOMINAL PAIN,ABDOMINAL CRAMPS,NA,ABDOMINAL PAIN,NA,HLT_0217,NA,HLGT_0419,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,705,01-705-1393,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2012-09-07,2013-02-01,2011-12-05,,-277,2013-02-20,167,444,DAY,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,705,01-705-1393,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2012-09-07,2013-02-01,2013-01-21,,137,2013-01-24,140,4,DAY,COLON CANCER,COLON CANCER,NA,COLON CANCER,NA,HLT_0597,NA,HLGT_0339,NA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)","NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",NA,SEVERE,N,Y,N,N,N,Y,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,705,01-705-1393,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2012-09-07,2013-02-01,2011-12-05,,-277,2013-02-20,167,444,DAY,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,705,01-705-1431,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,F,Y,2013-06-23,2013-12-19,2013-06-22,,-1,NA,NA,NA,,RASH ERYTHEMATOUS,ERYTHEMATOUS RASH,NA,RASH ERYTHEMATOUS,NA,HLT_0336,NA,HLGT_0701,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,705,01-705-1431,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,F,Y,2013-06-23,2013-12-19,2013-07-04,,12,2013-07-06,14,3,DAY,ANXIETY,FEELING ANXIOUS,NA,ANXIETY,NA,HLT_0559,NA,HLGT_0570,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,Y,Y,Y,,,,,
CDISCPILOT01,706,01-706-1041,Placebo,0,64,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-12-31,2014-07-28,2012-05-01,D,-609,NA,NA,NA,,ANXIETY,ANXIETY ATTACK,NA,ANXIETY,NA,HLT_0559,NA,HLGT_0570,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,,
CDISCPILOT01,706,01-706-1041,Placebo,0,64,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-12-31,2014-07-28,2014-01-07,,8,2014-01-08,9,2,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,Y,Y,Y,,,,,
CDISCPILOT01,706,01-706-1041,Placebo,0,64,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-12-31,2014-07-28,2014-01-14,,15,2014-01-28,29,15,DAY,EXCORIATION,ABRASIONS,NA,EXCORIATION,NA,HLT_0738,NA,HLGT_0511,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,706,01-706-1041,Placebo,0,64,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-12-31,2014-07-28,2014-01-15,,16,2014-07-29,211,196,DAY,IRRITABILITY,IRRITABILITY,NA,IRRITABILITY,NA,HLT_0627,NA,HLGT_0461,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,706,01-706-1041,Placebo,0,64,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-12-31,2014-07-28,2014-01-14,,15,2014-01-28,29,15,DAY,EXCORIATION,ABRASIONS,NA,EXCORIATION,NA,HLT_0738,NA,HLGT_0511,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,706,01-706-1041,Placebo,0,64,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-12-31,2014-07-28,2014-03-04,,64,2014-07-29,211,148,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,706,01-706-1041,Placebo,0,64,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-12-31,2014-07-28,2012-05-01,D,-609,NA,NA,NA,,ANXIETY,ANXIETY ATTACK,NA,ANXIETY,NA,HLT_0559,NA,HLGT_0570,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,7,,,,,,,,,
CDISCPILOT01,706,01-706-1041,Placebo,0,64,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-12-31,2014-07-28,2014-01-15,,16,2014-07-29,211,196,DAY,IRRITABILITY,IRRITABILITY,NA,IRRITABILITY,NA,HLT_0627,NA,HLGT_0461,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,706,01-706-1041,Placebo,0,64,<65,1,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-12-31,2014-07-28,2014-03-04,,64,2014-07-29,211,148,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,9,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,706,01-706-1049,Xanomeline High Dose,81,60,<65,1,WHITE,1,F,Y,2013-05-14,2013-06-18,2013-06-03,,21,2013-06-03,21,1,DAY,SYNCOPE,FAINTING,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,706,01-706-1049,Xanomeline High Dose,81,60,<65,1,WHITE,1,F,Y,2013-05-14,2013-06-18,2013-06-18,,36,2013-06-18,36,1,DAY,SYNCOPE,SYNCOPAL ATTACK,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,N,N,N,N,Y,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,2012-09-15,2012-09-24,2012-09-15,,1,2012-09-29,15,15,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,2012-09-15,2012-09-24,2012-09-15,,1,2012-09-29,15,15,DAY,PRURITUS,PRURITIS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,2012-09-15,2012-09-24,2012-09-15,,1,2012-09-29,15,15,DAY,EXCORIATION,ABRASIONS,NA,EXCORIATION,NA,HLT_0738,NA,HLGT_0511,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,2012-09-15,2012-09-24,2012-09-23,,9,2012-09-29,15,7,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,2012-09-15,2012-09-24,2012-09-23,,9,2012-09-29,15,7,DAY,PRURITUS,PRURITIS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,2012-09-15,2012-09-24,2012-09-15,,1,2012-09-29,15,15,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,2012-09-15,2012-09-24,2012-09-15,,1,2012-09-29,15,15,DAY,PRURITUS,PRURITIS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,2012-09-15,2012-09-24,2012-09-15,,1,2012-09-29,15,15,DAY,EXCORIATION,ABRASIONS,NA,EXCORIATION,NA,HLT_0738,NA,HLGT_0511,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,2012-09-15,2012-09-24,2012-09-23,,9,2012-09-29,15,7,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,9,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,706,01-706-1384,Xanomeline Low Dose,54,74,65-80,2,WHITE,1,F,Y,2012-09-15,2012-09-24,2012-09-23,,9,2012-09-29,15,7,DAY,PRURITUS,PRURITIS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,10,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,707,01-707-1206,Placebo,0,65,65-80,2,WHITE,1,M,Y,2013-10-28,2014-04-26,2013-11-25,,29,2013-12-23,57,29,DAY,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,NA,SINUS ARRHYTHMIA,NA,HLT_0094,NA,HLGT_0630,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,707,01-707-1206,Placebo,0,65,65-80,2,WHITE,1,M,Y,2013-10-28,2014-04-26,2013-11-26,,30,2013-12-09,43,14,DAY,BLOOD CREATINE PHOSPHOKINASE INCREASED,CPK INCREASE,NA,BLOOD CREATINE PHOSPHOKINASE INCREASED,NA,HLT_0404,NA,HLGT_0008,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,707,01-707-1206,Placebo,0,65,65-80,2,WHITE,1,M,Y,2013-10-28,2014-04-26,2013-12-03,,37,2013-12-10,44,8,DAY,POSTNASAL DRIP,POSTNASAL DRIP,NA,POSTNASAL DRIP,NA,HLT_0172,NA,HLGT_0032,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,707,01-707-1206,Placebo,0,65,65-80,2,WHITE,1,M,Y,2013-10-28,2014-04-26,2013-11-26,,30,2013-12-09,43,14,DAY,BLOOD CREATINE PHOSPHOKINASE INCREASED,CPK INCREASE,NA,BLOOD CREATINE PHOSPHOKINASE INCREASED,NA,HLT_0404,NA,HLGT_0008,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,707,01-707-1206,Placebo,0,65,65-80,2,WHITE,1,M,Y,2013-10-28,2014-04-26,2013-12-03,,37,2013-12-10,44,8,DAY,POSTNASAL DRIP,POSTNASAL DRIP,NA,POSTNASAL DRIP,NA,HLT_0172,NA,HLGT_0032,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,707,01-707-1206,Placebo,0,65,65-80,2,WHITE,1,M,Y,2013-10-28,2014-04-26,2013-11-25,,29,2013-12-23,57,29,DAY,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,NA,SINUS ARRHYTHMIA,NA,HLT_0094,NA,HLGT_0630,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,707,01-707-1206,Placebo,0,65,65-80,2,WHITE,1,M,Y,2013-10-28,2014-04-26,2014-02-08,,104,2014-02-22,118,15,DAY,CONJUNCTIVITIS,CONJUNCTIVITIS,NA,CONJUNCTIVITIS,NA,HLT_0584,NA,HLGT_0335,NA,EYE DISORDERS,EYE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,707,01-707-1206,Placebo,0,65,65-80,2,WHITE,1,M,Y,2013-10-28,2014-04-26,2014-02-08,,104,2014-02-22,118,15,DAY,CONJUNCTIVITIS,CONJUNCTIVITIS,NA,CONJUNCTIVITIS,NA,HLT_0584,NA,HLGT_0335,NA,EYE DISORDERS,EYE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,708,01-708-1019,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2013-12-20,2014-01-01,2013-12-31,,12,2013-12-31,12,1,DAY,HEADACHE,FRONTAL HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1019,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2013-12-20,2014-01-01,2014-01-01,,13,2014-01-01,13,1,DAY,STUPOR,STUPOR,NA,STUPOR,NA,HLT_0595,NA,HLGT_0513,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,708,01-708-1019,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2013-12-20,2014-01-01,2014-01-01,,13,2014-01-01,13,1,DAY,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHEMIC ATTACKS,NA,TRANSIENT ISCHAEMIC ATTACK,NA,HLT_0041,NA,HLGT_0433,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,708,01-708-1019,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2013-12-20,2014-01-01,2014-01-01,,13,2014-01-01,13,1,DAY,VISION BLURRED,BLURRED VISION,NA,VISION BLURRED,NA,HLT_0120,NA,HLGT_0598,NA,EYE DISORDERS,EYE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1019,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2013-12-20,2014-01-01,2014-01-01,,13,2014-01-01,13,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,708,01-708-1032,Xanomeline Low Dose,54,62,<65,1,WHITE,1,M,Y,2013-02-09,2013-03-01,2013-02-26,,18,2013-03-09,29,12,DAY,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1084,Xanomeline Low Dose,54,73,65-80,2,WHITE,1,F,Y,2013-05-09,2013-11-11,2013-05-23,,15,2013-05-23,15,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1084,Xanomeline Low Dose,54,73,65-80,2,WHITE,1,F,Y,2013-05-09,2013-11-11,2013-05-23,,15,2013-05-23,15,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,708,01-708-1084,Xanomeline Low Dose,54,73,65-80,2,WHITE,1,F,Y,2013-05-09,2013-11-11,2013-06-09,,32,2013-06-09,32,1,DAY,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1084,Xanomeline Low Dose,54,73,65-80,2,WHITE,1,F,Y,2013-05-09,2013-11-11,2013-06-09,,32,2013-06-09,32,1,DAY,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,708,01-708-1084,Xanomeline Low Dose,54,73,65-80,2,WHITE,1,F,Y,2013-05-09,2013-11-11,2013-06-23,,46,2013-06-23,46,1,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,708,01-708-1084,Xanomeline Low Dose,54,73,65-80,2,WHITE,1,F,Y,2013-05-09,2013-11-11,2013-06-23,,46,2013-06-23,46,1,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,708,01-708-1087,Placebo,0,74,65-80,2,WHITE,1,F,Y,2012-10-22,2013-04-28,2013-01-19,,90,2013-01-19,90,1,DAY,HEART RATE IRREGULAR,HEARTBEATS IRREGULAR,NA,HEART RATE IRREGULAR,NA,HLT_0765,NA,HLGT_0140,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1087,Placebo,0,74,65-80,2,WHITE,1,F,Y,2012-10-22,2013-04-28,2013-01-19,,90,2013-01-19,90,1,DAY,HEART RATE IRREGULAR,HEARTBEATS IRREGULAR,NA,HEART RATE IRREGULAR,NA,HLT_0765,NA,HLGT_0140,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,708,01-708-1087,Placebo,0,74,65-80,2,WHITE,1,F,Y,2012-10-22,2013-04-28,2013-02-04,,106,2013-02-08,110,5,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1087,Placebo,0,74,65-80,2,WHITE,1,F,Y,2012-10-22,2013-04-28,2013-02-16,,118,NA,NA,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,708,01-708-1087,Placebo,0,74,65-80,2,WHITE,1,F,Y,2012-10-22,2013-04-28,2013-03-16,,146,2013-03-16,146,1,DAY,HEART RATE IRREGULAR,HEARTBEATS IRREGULAR,NA,HEART RATE IRREGULAR,NA,HLT_0765,NA,HLGT_0140,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,708,01-708-1087,Placebo,0,74,65-80,2,WHITE,1,F,Y,2012-10-22,2013-04-28,2013-03-16,,146,2013-03-16,146,1,DAY,HEART RATE IRREGULAR,HEARTBEATS IRREGULAR,NA,HEART RATE IRREGULAR,NA,HLT_0765,NA,HLGT_0140,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,708,01-708-1158,Placebo,0,81,>80,3,WHITE,1,F,Y,2014-02-08,2014-03-21,2014-02-25,,18,NA,NA,NA,,AGITATION,AGITATION,NA,AGITATION,NA,HLT_0140,NA,HLGT_0170,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1158,Placebo,0,81,>80,3,WHITE,1,F,Y,2014-02-08,2014-03-21,2014-03-22,,43,2014-03-22,43,1,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1178,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-12-29,2014-04-06,2013-12-19,,-10,NA,NA,NA,,FLANK PAIN,FLANK PAIN,NA,FLANK PAIN,NA,HLT_0484,NA,HLGT_0543,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,,
CDISCPILOT01,708,01-708-1178,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-12-29,2014-04-06,2014-03-01,,63,2014-03-08,70,8,DAY,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1178,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-12-29,2014-04-06,2014-03-09,,71,2014-04-06,99,29,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1178,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-12-29,2014-04-06,2014-03-09,,71,NA,NA,NA,,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,NA,VENTRICULAR SEPTAL DEFECT,NA,HLT_0589,NA,HLGT_0747,NA,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS","CONGENITAL, FAMILIAL AND GENETIC DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1178,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-12-29,2014-04-06,2014-03-09,,71,2014-04-06,99,29,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1178,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-12-29,2014-04-06,2014-03-24,,86,2014-03-26,88,3,DAY,DIZZINESS,LIGHT-HEADED,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,N,N,N,N,Y,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1178,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-12-29,2014-04-06,2014-03-24,,86,2014-03-26,88,3,DAY,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,SEVERE,N,N,N,N,N,Y,N,N,POSSIBLE,,RECOVERED/RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1178,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-12-29,2014-04-06,2014-03-24,,86,2014-03-28,90,5,DAY,CYSTITIS,BLADDER INFECTION,NA,CYSTITIS,NA,HLT_0739,NA,HLGT_0129,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,8,Y,,,Y,,,,,
CDISCPILOT01,708,01-708-1178,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-12-29,2014-04-06,2014-03-24,,86,2014-03-24,86,1,DAY,ALCOHOL USE,ALCOHOL USE,NA,ALCOHOL USE,NA,HLT_0138,NA,HLGT_0182,NA,SOCIAL CIRCUMSTANCES,SOCIAL CIRCUMSTANCES,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,9,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1213,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,2013-02-09,2013-02-22,2013-02-22,,14,2013-02-22,14,1,DAY,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1213,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,2013-02-09,2013-02-22,2013-02-22,,14,2013-02-22,14,1,DAY,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,708,01-708-1216,Xanomeline High Dose,81,78,65-80,2,WHITE,1,M,Y,2012-10-24,2012-11-29,2012-11-06,,14,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1216,Xanomeline High Dose,81,78,65-80,2,WHITE,1,M,Y,2012-10-24,2012-11-29,2012-11-06,,14,2012-12-13,51,38,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1216,Xanomeline High Dose,81,78,65-80,2,WHITE,1,M,Y,2012-10-24,2012-11-29,2012-11-22,,30,NA,NA,NA,,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,NA,APPLICATION SITE SWELLING,NA,HLT_0105,NA,HLGT_0236,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1216,Xanomeline High Dose,81,78,65-80,2,WHITE,1,M,Y,2012-10-24,2012-11-29,2012-11-06,,14,2012-12-13,51,38,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1253,Placebo,0,61,<65,1,WHITE,1,M,Y,2013-05-07,2013-11-05,2013-05-06,,-1,2013-05-16,10,11,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,,
CDISCPILOT01,708,01-708-1253,Placebo,0,61,<65,1,WHITE,1,M,Y,2013-05-07,2013-11-05,2013-05-06,,-1,2013-05-16,10,11,DAY,CONJUNCTIVITIS,CONJUNCTIVITIS,NA,CONJUNCTIVITIS,NA,HLT_0584,NA,HLGT_0335,NA,EYE DISORDERS,EYE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,,,,,,,,,
CDISCPILOT01,708,01-708-1253,Placebo,0,61,<65,1,WHITE,1,M,Y,2013-05-07,2013-11-05,2013-05-07,,1,2013-05-10,4,4,DAY,HEART RATE INCREASED,HEART RATE INCREASED,NA,HEART RATE INCREASED,NA,HLT_0646,NA,HLGT_0673,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1253,Placebo,0,61,<65,1,WHITE,1,M,Y,2013-05-07,2013-11-05,2013-05-06,,-1,2013-05-16,10,11,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,,,,,,,,,
CDISCPILOT01,708,01-708-1253,Placebo,0,61,<65,1,WHITE,1,M,Y,2013-05-07,2013-11-05,2013-05-06,,-1,2013-05-16,10,11,DAY,CONJUNCTIVITIS,CONJUNCTIVITIS,NA,CONJUNCTIVITIS,NA,HLT_0584,NA,HLGT_0335,NA,EYE DISORDERS,EYE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,,,,,,,,,
CDISCPILOT01,708,01-708-1253,Placebo,0,61,<65,1,WHITE,1,M,Y,2013-05-07,2013-11-05,2013-05-07,,1,2013-05-10,4,4,DAY,HEART RATE INCREASED,HEART RATE INCREASED,NA,HEART RATE INCREASED,NA,HLT_0646,NA,HLGT_0673,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,708,01-708-1253,Placebo,0,61,<65,1,WHITE,1,M,Y,2013-05-07,2013-11-05,2013-06-07,,32,2013-06-07,32,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1253,Placebo,0,61,<65,1,WHITE,1,M,Y,2013-05-07,2013-11-05,2013-06-07,,32,2013-06-07,32,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2013-02-06,2013-03-22,2013-02-11,,6,2013-02-11,6,1,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2013-02-06,2013-03-22,2013-02-18,,13,2013-02-18,13,1,DAY,MUSCLE SPASMS,LEG CRAMPS,NA,MUSCLE SPASMS,NA,HLT_0078,NA,HLGT_0750,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2013-02-06,2013-03-22,2013-02-21,,16,2013-03-20,43,28,DAY,VENTRICULAR EXTRASYSTOLES,VENTRICULAR BIGEMINY,NA,VENTRICULAR EXTRASYSTOLES,NA,HLT_0050,NA,HLGT_0594,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2013-02-06,2013-03-22,2013-02-27,,22,2013-02-27,22,1,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2013-02-06,2013-03-22,2013-03-01,,24,2013-03-07,30,7,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2013-02-06,2013-03-22,2013-03-01,,24,2013-03-07,30,7,DAY,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2013-02-06,2013-03-22,2013-03-07,,30,2013-03-07,30,1,DAY,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2013-02-06,2013-03-22,2013-03-01,,24,2013-03-07,30,7,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2013-02-06,2013-03-22,2013-03-01,,24,2013-03-07,30,7,DAY,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2013-02-06,2013-03-22,2013-03-07,,30,2013-03-07,30,1,DAY,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,10,Y,,,,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2013-02-06,2013-03-22,2013-03-19,,42,2013-03-19,42,1,DAY,HOT FLUSH,HOT FLASHES,NA,HOT FLUSH,NA,HLT_0737,NA,HLGT_0773,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,11,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1272,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2013-02-06,2013-03-22,2013-02-21,,16,2013-03-20,43,28,DAY,VENTRICULAR EXTRASYSTOLES,VENTRICULAR BIGEMINY,NA,VENTRICULAR EXTRASYSTOLES,NA,HLT_0050,NA,HLGT_0594,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,12,Y,,,,,,,,
CDISCPILOT01,708,01-708-1286,Placebo,0,80,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-09-10,2014-03-08,2013-09-12,,3,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1286,Placebo,0,80,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-09-10,2014-03-08,2013-09-23,,14,NA,NA,NA,,MYOCARDIAL INFARCTION,INFERIOR MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1286,Placebo,0,80,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-09-10,2014-03-08,2014-02-18,,162,2014-02-18,162,1,DAY,ABDOMINAL PAIN,ABDOMINAL PAIN,NA,ABDOMINAL PAIN,NA,HLT_0217,NA,HLGT_0419,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1286,Placebo,0,80,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-09-10,2014-03-08,2014-02-18,,162,2014-02-18,162,1,DAY,CONSTIPATION,CONSTIPATION,NA,CONSTIPATION,NA,HLT_0402,NA,HLGT_0635,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,708,01-708-1296,Placebo,0,57,<65,1,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-06-14,2013-12-12,2013-06-27,,14,2013-06-27,14,1,DAY,ATRIAL HYPERTROPHY,LEFT ATRIAL HYPERTROPHY,NA,ATRIAL HYPERTROPHY,NA,HLT_0271,NA,HLGT_0067,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1296,Placebo,0,57,<65,1,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-06-14,2013-12-12,2013-06-27,,14,2013-06-27,14,1,DAY,ATRIAL HYPERTROPHY,LEFT ATRIAL HYPERTROPHY,NA,ATRIAL HYPERTROPHY,NA,HLT_0271,NA,HLGT_0067,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,708,01-708-1296,Placebo,0,57,<65,1,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-06-14,2013-12-12,2013-09-04,,83,2013-09-18,97,15,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1296,Placebo,0,57,<65,1,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-06-14,2013-12-12,2013-09-04,,83,2013-09-18,97,15,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1296,Placebo,0,57,<65,1,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-06-14,2013-12-12,2013-10-04,,113,2013-10-30,139,27,DAY,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1296,Placebo,0,57,<65,1,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-06-14,2013-12-12,2013-10-04,,113,2013-10-30,139,27,DAY,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1296,Placebo,0,57,<65,1,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-06-14,2013-12-12,2013-12-07,,177,2013-12-07,177,1,DAY,PAIN IN EXTREMITY,PAIN IN THIGH,NA,PAIN IN EXTREMITY,NA,HLT_0213,NA,HLGT_0764,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1297,Xanomeline Low Dose,54,61,<65,1,WHITE,1,M,Y,2013-01-25,2013-05-03,2013-04-02,,68,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1297,Xanomeline Low Dose,54,61,<65,1,WHITE,1,M,Y,2013-01-25,2013-05-03,2013-04-02,,68,NA,NA,NA,,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,NA,APPLICATION SITE SWELLING,NA,HLT_0105,NA,HLGT_0236,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1297,Xanomeline Low Dose,54,61,<65,1,WHITE,1,M,Y,2013-01-25,2013-05-03,2013-05-08,,104,NA,NA,NA,,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1316,Placebo,0,74,65-80,2,WHITE,1,F,Y,2013-08-23,2014-03-01,2014-01-29,,160,NA,NA,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1316,Placebo,0,74,65-80,2,WHITE,1,F,Y,2013-08-23,2014-03-01,2014-02-15,,177,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1336,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,2012-12-07,2013-06-05,2012-12-18,,12,2012-12-18,12,1,DAY,DIZZINESS,LIGHTHEADEDNESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1336,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,2012-12-07,2013-06-05,2013-01-12,,37,2013-01-12,37,1,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1336,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,2012-12-07,2013-06-05,2013-02-02,,58,2013-02-02,58,1,DAY,DIZZINESS,LIGHT HEADEDNESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,708,01-708-1336,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,2012-12-07,2013-06-05,2013-04-10,,125,2013-06-05,181,57,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1336,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,2012-12-07,2013-06-05,2013-04-10,,125,2013-06-05,181,57,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1336,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,2012-12-07,2013-06-05,2013-04-10,,125,2013-06-05,181,57,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1336,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,2012-12-07,2013-06-05,2013-04-10,,125,2013-06-05,181,57,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1347,Xanomeline High Dose,81,61,<65,1,WHITE,1,F,Y,2013-04-20,2013-06-18,2013-06-13,,55,2013-06-25,67,13,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1347,Xanomeline High Dose,81,61,<65,1,WHITE,1,F,Y,2013-04-20,2013-06-18,2013-06-13,,55,2013-06-25,67,13,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1347,Xanomeline High Dose,81,61,<65,1,WHITE,1,F,Y,2013-04-20,2013-06-18,2013-06-13,,55,2013-06-25,67,13,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1347,Xanomeline High Dose,81,61,<65,1,WHITE,1,F,Y,2013-04-20,2013-06-18,2013-06-13,,55,2013-06-25,67,13,DAY,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,NA,APPLICATION SITE SWELLING,NA,HLT_0105,NA,HLGT_0236,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1347,Xanomeline High Dose,81,61,<65,1,WHITE,1,F,Y,2013-04-20,2013-06-18,2013-06-13,,55,2013-06-25,67,13,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1347,Xanomeline High Dose,81,61,<65,1,WHITE,1,F,Y,2013-04-20,2013-06-18,2013-06-13,,55,2013-06-25,67,13,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1347,Xanomeline High Dose,81,61,<65,1,WHITE,1,F,Y,2013-04-20,2013-06-18,2013-06-13,,55,2013-06-25,67,13,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1347,Xanomeline High Dose,81,61,<65,1,WHITE,1,F,Y,2013-04-20,2013-06-18,2013-06-13,,55,2013-06-25,67,13,DAY,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,NA,APPLICATION SITE SWELLING,NA,HLT_0105,NA,HLGT_0236,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1348,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,2013-08-05,2014-02-13,2013-08-18,,14,2013-08-31,27,14,DAY,MYOCARDIAL INFARCTION,ANTEROSEPTAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1348,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,2013-08-05,2014-02-13,2013-08-18,,14,2013-08-31,27,14,DAY,MYOCARDIAL INFARCTION,ANTEROSEPTAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,708,01-708-1348,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,2013-08-05,2014-02-13,2013-12-01,,119,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1353,Xanomeline Low Dose,54,87,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-07-04,2013-08-28,2013-08-18,,46,2013-09-10,69,24,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1353,Xanomeline Low Dose,54,87,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-07-04,2013-08-28,2013-08-18,,46,2013-09-10,69,24,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,708,01-708-1353,Xanomeline Low Dose,54,87,>80,3,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-07-04,2013-08-28,2013-08-28,,56,2013-09-10,69,14,DAY,HYPOTENSION,LOW BLOOD PRESSURE,NA,HYPOTENSION,NA,HLT_0761,NA,HLGT_0412,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,708,01-708-1372,Xanomeline High Dose,81,84,>80,3,WHITE,1,M,Y,2013-04-12,2013-04-19,2013-04-10,,-2,NA,NA,NA,,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,NA,HLT_0415,NA,HLGT_0086,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,,
CDISCPILOT01,708,01-708-1406,Xanomeline High Dose,81,71,65-80,2,WHITE,1,F,Y,2013-12-26,2014-07-02,2014-06-16,,173,NA,NA,NA,,OEDEMA PERIPHERAL,SWELLING OF LEGS,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1406,Xanomeline High Dose,81,71,65-80,2,WHITE,1,F,Y,2013-12-26,2014-07-02,2014-06-16,,173,NA,NA,NA,,OEDEMA PERIPHERAL,SWELLING OF LEGS,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,708,01-708-1428,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2013-11-09,2013-12-14,2013-11-22,,14,2013-11-22,14,1,DAY,EPISTAXIS,NOSE BLEED,NA,EPISTAXIS,NA,HLT_0386,NA,HLGT_0577,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,708,01-708-1428,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2013-11-09,2013-12-14,2013-12-10,,32,2013-12-21,43,12,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,708,01-708-1428,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2013-11-09,2013-12-14,2013-12-10,,32,2013-12-21,43,12,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1428,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2013-11-09,2013-12-14,2013-12-10,,32,2013-12-21,43,12,DAY,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,NA,APPLICATION SITE WARMTH,NA,HLT_0260,NA,HLGT_0301,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1428,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2013-11-09,2013-12-14,2013-12-10,,32,2013-12-21,43,12,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1428,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2013-11-09,2013-12-14,2013-12-10,,32,2013-12-21,43,12,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,708,01-708-1428,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2013-11-09,2013-12-14,2013-12-10,,32,2013-12-21,43,12,DAY,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,NA,APPLICATION SITE WARMTH,NA,HLT_0260,NA,HLGT_0301,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1007,Xanomeline Low Dose,54,54,<65,1,WHITE,1,F,Y,2012-07-31,2012-08-28,2012-08-16,,17,2012-08-19,20,4,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1007,Xanomeline Low Dose,54,54,<65,1,WHITE,1,F,Y,2012-07-31,2012-08-28,2012-08-16,,17,2012-08-19,20,4,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1007,Xanomeline Low Dose,54,54,<65,1,WHITE,1,F,Y,2012-07-31,2012-08-28,2012-08-21,,22,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1007,Xanomeline Low Dose,54,54,<65,1,WHITE,1,F,Y,2012-07-31,2012-08-28,2012-08-30,,31,2012-08-30,31,1,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1020,Xanomeline Low Dose,54,72,65-80,2,WHITE,1,F,Y,2012-12-01,2013-06-01,2012-12-27,,27,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1020,Xanomeline Low Dose,54,72,65-80,2,WHITE,1,F,Y,2012-12-01,2013-06-01,2013-01-03,,34,2013-01-11,42,9,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1020,Xanomeline Low Dose,54,72,65-80,2,WHITE,1,F,Y,2012-12-01,2013-06-01,2013-01-03,,34,2013-01-11,42,9,DAY,ABDOMINAL PAIN,ABDOMINAL PAIN,NA,ABDOMINAL PAIN,NA,HLT_0217,NA,HLGT_0419,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,709,01-709-1020,Xanomeline Low Dose,54,72,65-80,2,WHITE,1,F,Y,2012-12-01,2013-06-01,2013-01-15,,46,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2012-12-25,2013-06-26,2013-01-09,,16,2013-02-19,57,42,DAY,MYOCARDIAL INFARCTION,SEPTAL MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2012-12-25,2013-06-26,2013-01-17,,24,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2012-12-25,2013-06-26,2013-01-24,,31,2013-02-27,65,35,DAY,MUSCLE SPASMS,CRAMP,NA,MUSCLE SPASMS,NA,HLT_0078,NA,HLGT_0750,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2012-12-25,2013-06-26,2013-01-09,,16,2013-02-19,57,42,DAY,MYOCARDIAL INFARCTION,SEPTAL MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2012-12-25,2013-06-26,2013-01-24,,31,2013-02-27,65,35,DAY,MUSCLE SPASMS,CRAMP,NA,MUSCLE SPASMS,NA,HLT_0078,NA,HLGT_0750,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2012-12-25,2013-06-26,2013-03-20,,86,2013-04-16,113,28,DAY,MYOCARDIAL INFARCTION,SEPTAL MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2012-12-25,2013-06-26,2013-03-20,,86,2013-04-16,113,28,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2012-12-25,2013-06-26,2013-03-20,,86,2013-04-16,113,28,DAY,MYOCARDIAL INFARCTION,SEPTAL MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2012-12-25,2013-06-26,2013-03-20,,86,2013-04-16,113,28,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2012-12-25,2013-06-26,2013-05-12,,139,2013-05-19,146,8,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,10,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2012-12-25,2013-06-26,2013-05-12,,139,2013-05-19,146,8,DAY,PHARYNGEAL ERYTHEMA,RED THROAT,NA,PHARYNGEAL ERYTHEMA,NA,HLT_0591,NA,HLGT_0398,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,11,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2012-12-25,2013-06-26,2013-05-15,,142,NA,NA,NA,,MYOCARDIAL INFARCTION,SEPTAL MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,12,Y,,,,,,,,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2012-12-25,2013-06-26,2013-05-12,,139,2013-05-19,146,8,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,13,Y,,,,,,,,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2012-12-25,2013-06-26,2013-05-12,,139,2013-05-19,146,8,DAY,PHARYNGEAL ERYTHEMA,RED THROAT,NA,PHARYNGEAL ERYTHEMA,NA,HLT_0591,NA,HLGT_0398,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,14,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2012-12-25,2013-06-26,2013-06-12,,170,NA,NA,NA,,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,15,Y,,,,,,,,
CDISCPILOT01,709,01-709-1029,Xanomeline High Dose,81,82,>80,3,WHITE,1,M,Y,2012-12-25,2013-06-26,2013-06-19,,177,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,16,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1081,Xanomeline Low Dose,54,86,>80,3,WHITE,1,F,Y,2014-01-18,2014-04-27,2014-04-07,,80,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1081,Xanomeline Low Dose,54,86,>80,3,WHITE,1,F,Y,2014-01-18,2014-04-27,2014-05-01,,104,NA,NA,NA,,OEDEMA PERIPHERAL,PERIPHERAL SWELLING,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1088,Placebo,0,69,65-80,2,WHITE,1,M,Y,2014-04-12,2014-10-09,2014-05-08,,27,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1088,Placebo,0,69,65-80,2,WHITE,1,M,Y,2014-04-12,2014-10-09,2014-08-02,,113,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1099,Xanomeline High Dose,81,79,65-80,2,WHITE,1,F,Y,2013-10-25,2014-04-25,2013-11-06,,13,2013-11-17,24,12,DAY,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,709,01-709-1099,Xanomeline High Dose,81,79,65-80,2,WHITE,1,F,Y,2013-10-25,2014-04-25,2013-11-12,,19,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1099,Xanomeline High Dose,81,79,65-80,2,WHITE,1,F,Y,2013-10-25,2014-04-25,2013-11-12,,19,NA,NA,NA,,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1099,Xanomeline High Dose,81,79,65-80,2,WHITE,1,F,Y,2013-10-25,2014-04-25,2013-11-12,,19,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1099,Xanomeline High Dose,81,79,65-80,2,WHITE,1,F,Y,2013-10-25,2014-04-25,2013-11-06,,13,2013-11-17,24,12,DAY,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,709,01-709-1099,Xanomeline High Dose,81,79,65-80,2,WHITE,1,F,Y,2013-10-25,2014-04-25,2013-11-12,,19,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1099,Xanomeline High Dose,81,79,65-80,2,WHITE,1,F,Y,2013-10-25,2014-04-25,2013-11-12,,19,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1099,Xanomeline High Dose,81,79,65-80,2,WHITE,1,F,Y,2013-10-25,2014-04-25,2014-03-23,,150,2014-03-23,150,1,DAY,ACROCHORDON EXCISION,SKIN TAG REMOVAL,NA,ACROCHORDON EXCISION,NA,HLT_0629,NA,HLGT_0103,NA,SURGICAL AND MEDICAL PROCEDURES,SURGICAL AND MEDICAL PROCEDURES,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1102,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,2013-01-15,2013-03-27,2013-02-11,,28,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1102,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,2013-01-15,2013-03-27,2013-02-11,,28,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1102,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,2013-01-15,2013-03-27,2013-02-11,,28,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1102,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,2013-01-15,2013-03-27,2013-02-11,,28,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1102,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,2013-01-15,2013-03-27,2013-03-20,,65,2013-03-26,71,7,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1102,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,2013-01-15,2013-03-27,2013-03-26,,71,2013-03-27,72,2,DAY,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1168,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-08-02,2013-09-26,2013-08-17,,16,2013-09-06,36,21,DAY,SKIN IRRITATION,IRRITATION SKIN,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1168,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-08-02,2013-09-26,2013-08-17,,16,2013-09-06,36,21,DAY,SKIN IRRITATION,IRRITATION SKIN,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1168,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-08-02,2013-09-26,2013-09-06,,36,2013-10-11,71,36,DAY,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1168,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-08-02,2013-09-26,2013-09-06,,36,2013-10-11,71,36,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1168,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-08-02,2013-09-26,2013-09-06,,36,2013-10-11,71,36,DAY,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1168,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-08-02,2013-09-26,2013-09-06,,36,2013-10-11,71,36,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2013-03-04,2013-06-11,2013-03-06,,3,2013-03-06,3,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2013-03-04,2013-06-11,2013-03-20,,17,NA,NA,NA,,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2013-03-04,2013-06-11,2013-03-26,,23,2013-06-18,107,85,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2013-03-04,2013-06-11,2013-03-27,,24,2013-03-27,24,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2013-03-04,2013-06-11,2013-03-30,,27,NA,NA,NA,,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERTED,NA,ELECTROCARDIOGRAM T WAVE INVERSION,NA,HLT_0289,NA,HLGT_0130,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2013-03-04,2013-06-11,2013-04-01,,29,2013-04-11,39,11,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2013-03-04,2013-06-11,2013-04-01,,29,2013-04-11,39,11,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2013-03-04,2013-06-11,2013-03-26,,23,2013-06-18,107,85,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2013-03-04,2013-06-11,2013-05-17,,75,2013-05-18,76,2,DAY,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,,Y,,,,,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2013-03-04,2013-06-11,2013-03-26,,23,2013-06-18,107,85,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,10,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1217,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2013-03-04,2013-06-11,2013-05-27,,85,2013-06-18,107,23,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,11,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1238,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,2013-05-15,2013-08-06,2013-05-28,,14,2013-05-28,14,1,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,709,01-709-1238,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,2013-05-15,2013-08-06,2013-05-30,,16,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1238,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,2013-05-15,2013-08-06,2013-05-30,,16,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1238,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,2013-05-15,2013-08-06,2013-05-30,,16,NA,NA,NA,,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,NA,APPLICATION SITE DISCHARGE,NA,HLT_0200,NA,HLGT_0457,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1238,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,2013-05-15,2013-08-06,2013-05-31,,17,2013-05-31,17,1,DAY,HIP FRACTURE,HIP FRACTURE,NA,HIP FRACTURE,NA,HLT_0097,NA,HLGT_0131,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1238,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,2013-05-15,2013-08-06,2013-06-09,,26,NA,NA,NA,,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1238,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,2013-05-15,2013-08-06,2013-06-09,,26,NA,NA,NA,,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1238,Xanomeline High Dose,81,69,65-80,2,WHITE,1,M,Y,2013-05-15,2013-08-06,2013-06-28,,45,2013-06-28,45,1,DAY,SKIN LESION EXCISION,SKIN LESION EXCISION,NA,SKIN LESION EXCISION,NA,HLT_0498,NA,HLGT_0450,NA,SURGICAL AND MEDICAL PROCEDURES,SURGICAL AND MEDICAL PROCEDURES,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,2013-01-26,2013-06-13,2013-02-05,,11,2013-02-13,19,9,DAY,LOCALISED INFECTION,INFECTED FINGER,NA,LOCALISED INFECTION,NA,HLT_0435,NA,HLGT_0557,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,2013-01-26,2013-06-13,2013-02-05,,11,2013-02-13,19,9,DAY,LOCALISED INFECTION,INFECTED FINGER,NA,LOCALISED INFECTION,NA,HLT_0435,NA,HLGT_0557,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,2013-01-26,2013-06-13,2013-03-14,,48,NA,NA,NA,,BLOOD URINE PRESENT,BLOOD IN URINE,NA,BLOOD URINE PRESENT,NA,HLT_0458,NA,HLGT_0289,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,2013-01-26,2013-06-13,2013-03-17,,51,2013-03-17,51,1,DAY,CYSTOSCOPY,CYSTOSCOPY,NA,CYSTOSCOPY,NA,HLT_0436,NA,HLGT_0041,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,2013-01-26,2013-06-13,2013-03-17,,51,2013-03-30,64,14,DAY,BENIGN PROSTATIC HYPERPLASIA,ENLARGED PROSTATE,NA,BENIGN PROSTATIC HYPERPLASIA,NA,HLT_0215,NA,HLGT_0568,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,MILD,N,N,N,N,N,Y,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,2013-01-26,2013-06-13,2013-03-17,,51,2013-03-30,64,14,DAY,BENIGN PROSTATIC HYPERPLASIA,ENLARGED PROSTATE,NA,BENIGN PROSTATIC HYPERPLASIA,NA,HLT_0215,NA,HLGT_0568,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,SEVERE,N,N,N,N,N,Y,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,2013-01-26,2013-06-13,2013-04-13,,78,2013-04-14,79,2,DAY,PYREXIA,FEVER,NA,PYREXIA,NA,HLT_0310,NA,HLGT_0652,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,2013-01-26,2013-06-13,2013-04-13,,78,2013-04-14,79,2,DAY,DEHYDRATION,DEHYDRATION,NA,DEHYDRATION,NA,HLT_0533,NA,HLGT_0011,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,2013-01-26,2013-06-13,2013-04-13,,78,2013-04-14,79,2,DAY,HYPOTENSION,LOW BLOOD PRESSURE,NA,HYPOTENSION,NA,HLT_0761,NA,HLGT_0412,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MILD,N,N,N,N,N,Y,N,N,POSSIBLE,,RECOVERED/RESOLVED,9,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,2013-01-26,2013-06-13,2013-04-20,,85,2013-06-13,139,55,DAY,ORTHOSTATIC HYPOTENSION,POSTURAL HYPOTENSION,NA,ORTHOSTATIC HYPOTENSION,NA,HLT_0194,NA,HLGT_0111,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,10,Y,,,Y,,,,,
CDISCPILOT01,709,01-709-1259,Placebo,0,82,>80,3,WHITE,1,M,Y,2013-01-26,2013-06-13,2013-04-20,,85,2013-06-13,139,55,DAY,ORTHOSTATIC HYPOTENSION,POSTURAL HYPOTENSION,NA,ORTHOSTATIC HYPOTENSION,NA,HLT_0194,NA,HLGT_0111,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,11,Y,,,,,,,,
CDISCPILOT01,709,01-709-1285,Xanomeline Low Dose,54,87,>80,3,WHITE,1,M,Y,2013-03-24,2013-05-23,2013-04-14,,22,NA,NA,NA,,HEMIANOPIA HOMONYMOUS,HOMONYMOUS HEMIANOPSIA,NA,HEMIANOPIA HOMONYMOUS,NA,HLT_0639,NA,HLGT_0547,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,Y,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,709,01-709-1285,Xanomeline Low Dose,54,87,>80,3,WHITE,1,M,Y,2013-03-24,2013-05-23,2013-04-19,,27,2013-05-31,69,43,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1285,Xanomeline Low Dose,54,87,>80,3,WHITE,1,M,Y,2013-03-24,2013-05-23,2013-04-19,,27,2013-05-31,69,43,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1285,Xanomeline Low Dose,54,87,>80,3,WHITE,1,M,Y,2013-03-24,2013-05-23,2013-05-19,,57,NA,NA,NA,,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1285,Xanomeline Low Dose,54,87,>80,3,WHITE,1,M,Y,2013-03-24,2013-05-23,2013-04-19,,27,2013-05-31,69,43,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1285,Xanomeline Low Dose,54,87,>80,3,WHITE,1,M,Y,2013-03-24,2013-05-23,2013-04-19,,27,2013-05-31,69,43,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1301,Placebo,0,62,<65,1,WHITE,1,F,Y,2013-07-19,2014-01-17,2013-08-30,,43,NA,NA,NA,,DIABETES MELLITUS,DIABETES,NA,DIABETES MELLITUS,NA,HLT_0447,NA,HLGT_0572,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,709,01-709-1306,Placebo,0,60,<65,1,WHITE,1,F,Y,2014-02-03,2014-06-16,2014-04-20,,77,2014-06-23,141,65,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1306,Placebo,0,60,<65,1,WHITE,1,F,Y,2014-02-03,2014-06-16,2014-04-20,,77,2014-06-23,141,65,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1306,Placebo,0,60,<65,1,WHITE,1,F,Y,2014-02-03,2014-06-16,2014-04-20,,77,2014-06-23,141,65,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1306,Placebo,0,60,<65,1,WHITE,1,F,Y,2014-02-03,2014-06-16,2014-04-20,,77,2014-06-23,141,65,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1306,Placebo,0,60,<65,1,WHITE,1,F,Y,2014-02-03,2014-06-16,2014-05-04,,91,2014-06-23,141,51,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1306,Placebo,0,60,<65,1,WHITE,1,F,Y,2014-02-03,2014-06-16,2014-05-20,,107,2014-05-23,110,4,DAY,DRUG ERUPTION,DRUG RASH,NA,DRUG ERUPTION,NA,HLT_0430,NA,HLGT_0253,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1306,Placebo,0,60,<65,1,WHITE,1,F,Y,2014-02-03,2014-06-16,2014-04-20,,77,2014-06-23,141,65,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1306,Placebo,0,60,<65,1,WHITE,1,F,Y,2014-02-03,2014-06-16,2014-04-20,,77,2014-06-23,141,65,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1306,Placebo,0,60,<65,1,WHITE,1,F,Y,2014-02-03,2014-06-16,2014-05-04,,91,2014-06-23,141,51,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,9,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,2013-06-19,2013-12-19,2013-06-10,,-9,2013-07-01,13,22,DAY,RASH MACULO-PAPULAR,MACULOPAPULAR RASH,NA,RASH MACULO-PAPULAR,NA,HLT_0500,NA,HLGT_0097,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,2013-06-19,2013-12-19,2013-06-18,,-1,2013-07-16,28,29,DAY,RASH PAPULAR,PAPULAR RASH,NA,RASH PAPULAR,NA,HLT_0549,NA,HLGT_0007,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,2013-06-19,2013-12-19,2013-06-19,,1,2013-06-19,1,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,Y,Y,Y,,,,,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,2013-06-19,2013-12-19,2013-06-19,,1,2013-06-19,1,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,2013-06-19,2013-12-19,2013-06-19,,1,2013-06-20,2,2,DAY,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,2013-06-19,2013-12-19,2013-06-19,,1,2013-06-20,2,2,DAY,NIGHTMARE,NIGHTMARE,NA,NIGHTMARE,NA,HLT_0186,NA,HLGT_0049,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,2013-06-19,2013-12-19,2013-06-20,,2,NA,NA,NA,,RASH MACULO-PAPULAR,MACULOPAPULAR RASH,NA,RASH MACULO-PAPULAR,NA,HLT_0500,NA,HLGT_0097,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,2013-06-19,2013-12-19,2013-06-26,,8,2013-06-26,8,1,DAY,BIOPSY,BIOPSY,NA,BIOPSY,NA,HLT_0685,NA,HLGT_0076,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,2013-06-19,2013-12-19,2013-07-01,,13,2013-07-01,13,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,9,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,2013-06-19,2013-12-19,2013-06-10,,-9,2013-07-01,13,22,DAY,RASH MACULO-PAPULAR,MACULOPAPULAR RASH,NA,RASH MACULO-PAPULAR,NA,HLT_0500,NA,HLGT_0097,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,10,,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,2013-06-19,2013-12-19,2013-07-01,,13,2013-07-01,13,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,11,Y,,,,,,,,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,2013-06-19,2013-12-19,2013-07-04,,16,2013-07-04,16,1,DAY,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOSIS,NA,ALLERGIC GRANULOMATOUS ANGIITIS,NA,HLT_0114,NA,HLGT_0157,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,12,Y,,,Y,,,,,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,2013-06-19,2013-12-19,2013-06-18,,-1,2013-07-16,28,29,DAY,RASH PAPULAR,PAPULAR RASH,NA,RASH PAPULAR,NA,HLT_0549,NA,HLGT_0007,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,13,,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,2013-06-19,2013-12-19,2013-07-28,,40,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,14,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1309,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,2013-06-19,2013-12-19,2013-09-06,,80,NA,NA,NA,,FEELING COLD,FEELING COLD,NA,FEELING COLD,NA,HLT_0340,NA,HLGT_0717,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,15,Y,,,Y,,,,,
CDISCPILOT01,709,01-709-1312,Placebo,0,68,65-80,2,WHITE,1,F,Y,2014-04-20,2014-10-19,2014-05-17,,28,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1312,Placebo,0,68,65-80,2,WHITE,1,F,Y,2014-04-20,2014-10-19,2014-10-19,,183,NA,NA,NA,,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ST SEGMENT DEPRESSED,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,NA,HLT_0610,NA,HLGT_0220,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1326,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,2013-04-05,2013-10-02,2013-05-01,,27,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,709,01-709-1326,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,2013-04-05,2013-10-02,2013-05-01,,27,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1326,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,2013-04-05,2013-10-02,2013-05-21,,47,2013-05-21,47,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1326,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,2013-04-05,2013-10-02,2013-05-21,,47,2013-05-21,47,1,DAY,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,Y,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1326,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,2013-04-05,2013-10-02,2013-06-07,,64,2013-06-17,74,11,DAY,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,NA,APPLICATION SITE BLEEDING,NA,HLT_0718,NA,HLGT_0324,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,709,01-709-1326,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,2013-04-05,2013-10-02,2013-07-12,,99,NA,NA,NA,,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1329,Xanomeline High Dose,81,70,65-80,2,WHITE,1,M,Y,2013-08-15,2013-08-25,2013-08-25,,11,2013-08-25,11,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,709,01-709-1329,Xanomeline High Dose,81,70,65-80,2,WHITE,1,M,Y,2013-08-15,2013-08-25,2013-08-25,,11,2013-08-25,11,1,DAY,PYREXIA,FEVER,NA,PYREXIA,NA,HLT_0310,NA,HLGT_0652,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,709,01-709-1339,Placebo,0,81,>80,3,WHITE,1,M,Y,2012-12-23,2013-06-24,2011-11-01,D,-418,NA,NA,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,,
CDISCPILOT01,709,01-709-1339,Placebo,0,81,>80,3,WHITE,1,M,Y,2012-12-23,2013-06-24,2013-05-12,,141,NA,NA,NA,,BLOOD ALKALINE PHOSPHATASE INCREASED,ALK PHOS RAISED,NA,BLOOD ALKALINE PHOSPHATASE INCREASED,NA,HLT_0615,NA,HLGT_0298,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,Y,Y,Y,,,,,
CDISCPILOT01,709,01-709-1424,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-03-03,2013-03-07,2013-03-07,,5,2013-03-07,5,1,DAY,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,Y,N,N,N,N,N,Y,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,Y,Y,Y,,
CDISCPILOT01,710,01-710-1002,Xanomeline Low Dose,54,88,>80,3,WHITE,1,M,Y,2014-01-14,2014-01-18,2014-01-16,,3,2014-01-20,7,5,DAY,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHEMIC ATTACKS,NA,TRANSIENT ISCHAEMIC ATTACK,NA,HLT_0041,NA,HLGT_0433,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,Y,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1002,Xanomeline Low Dose,54,88,>80,3,WHITE,1,M,Y,2014-01-14,2014-01-18,2014-01-16,,3,2014-01-20,7,5,DAY,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHEMIC ATTACKS,NA,TRANSIENT ISCHAEMIC ATTACK,NA,HLT_0041,NA,HLGT_0433,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,Y,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-02-10,2013-08-09,2013-02-18,,9,2013-02-19,10,2,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-02-10,2013-08-09,2013-03-01,,20,NA,NA,NA,,SALIVARY HYPERSECRETION,SALIVATION,NA,SALIVARY HYPERSECRETION,NA,HLT_0374,NA,HLGT_0488,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-02-10,2013-08-09,2013-03-01,,20,NA,NA,NA,,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-02-10,2013-08-09,2013-04-16,,66,2013-04-16,66,1,DAY,DIZZINESS,FELT FAINT,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-02-10,2013-08-09,2013-04-17,,67,2013-04-19,69,3,DAY,URINARY TRACT INFECTION,URINARY INFECTION,NA,URINARY TRACT INFECTION,NA,HLT_0161,NA,HLGT_0093,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-02-10,2013-08-09,2013-04-17,,67,2013-04-17,67,1,DAY,NEPHROLITHIASIS,KIDNEY STONE,NA,NEPHROLITHIASIS,NA,HLT_0439,NA,HLGT_0546,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-02-10,2013-08-09,2013-05-18,,98,NA,NA,NA,,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-02-10,2013-08-09,2013-06-29,,140,2013-07-04,145,6,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-02-10,2013-08-09,2013-06-29,,140,2013-07-04,145,6,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-02-10,2013-08-09,2013-08-08,,180,2013-08-08,180,1,DAY,FALL,FALL,NA,FALL,NA,HLT_0168,NA,HLGT_0446,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,10,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-02-10,2013-08-09,2013-08-08,,180,NA,NA,NA,,FACIAL BONES FRACTURE,FRACTURED NOSE,NA,FACIAL BONES FRACTURE,NA,HLT_0305,NA,HLGT_0585,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,11,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1006,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-02-10,2013-08-09,2013-08-08,,180,NA,NA,NA,,CONTUSION,BRUISING OF FACE,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,12,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1021,Xanomeline High Dose,81,79,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-09-27,2013-10-29,2013-10-10,,14,2013-10-10,14,1,DAY,CHEST PAIN,CHEST PAIN,NA,CHEST PAIN,NA,HLT_0717,NA,HLGT_0195,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1021,Xanomeline High Dose,81,79,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-09-27,2013-10-29,2013-10-21,,25,2013-10-31,35,11,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1021,Xanomeline High Dose,81,79,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-09-27,2013-10-29,2013-10-21,,25,2013-10-31,35,11,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1027,Placebo,0,83,>80,3,WHITE,1,M,Y,2014-02-28,2014-08-29,2014-05-09,,71,2014-06-01,94,24,DAY,HAEMOPTYSIS,COUGHING BLOOD,NA,HAEMOPTYSIS,NA,HLT_0192,NA,HLGT_0680,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1027,Placebo,0,83,>80,3,WHITE,1,M,Y,2014-02-28,2014-08-29,2014-05-23,,85,2014-06-20,113,29,DAY,RALES,RALES,NA,RALES,NA,HLT_0020,NA,HLGT_0410,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1027,Placebo,0,83,>80,3,WHITE,1,M,Y,2014-02-28,2014-08-29,2014-05-09,,71,2014-06-01,94,24,DAY,HAEMOPTYSIS,COUGHING BLOOD,NA,HAEMOPTYSIS,NA,HLT_0192,NA,HLGT_0680,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,710,01-710-1027,Placebo,0,83,>80,3,WHITE,1,M,Y,2014-02-28,2014-08-29,2014-05-23,,85,2014-06-20,113,29,DAY,RALES,RALES,NA,RALES,NA,HLT_0020,NA,HLGT_0410,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2013-06-03,2013-08-13,2013-06-22,,20,2013-06-22,20,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2013-06-03,2013-08-13,2013-07-02,,30,2013-07-09,37,8,DAY,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2013-06-03,2013-08-13,2013-07-02,,30,2013-08-17,76,47,DAY,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2013-06-03,2013-08-13,2013-07-02,,30,2013-08-17,76,47,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2013-06-03,2013-08-13,2013-07-02,,30,2013-07-09,37,8,DAY,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2013-06-03,2013-08-13,2013-07-22,,50,2013-08-17,76,27,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2013-06-03,2013-08-13,2013-08-03,,62,2013-08-17,76,15,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2013-06-03,2013-08-13,2013-08-13,,72,2013-08-17,76,5,DAY,SKIN EXFOLIATION,SKIN PEELING,NA,SKIN EXFOLIATION,NA,HLT_0236,NA,HLGT_0726,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2013-06-03,2013-08-13,2013-07-02,,30,2013-08-17,76,47,DAY,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,9,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2013-06-03,2013-08-13,2013-07-02,,30,2013-08-17,76,47,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,10,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2013-06-03,2013-08-13,2013-07-22,,50,2013-08-17,76,27,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,11,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2013-06-03,2013-08-13,2013-08-03,,62,2013-08-17,76,15,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,12,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1045,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2013-06-03,2013-08-13,2013-08-13,,72,2013-08-17,76,5,DAY,SKIN EXFOLIATION,SKIN PEELING,NA,SKIN EXFOLIATION,NA,HLT_0236,NA,HLGT_0726,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,13,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1053,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2012-12-26,2013-02-10,2013-01-28,,34,2013-02-11,48,15,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1053,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2012-12-26,2013-02-10,2013-01-28,,34,2013-02-11,48,15,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1053,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2012-12-26,2013-02-10,2013-01-28,,34,2013-02-11,48,15,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1053,Xanomeline Low Dose,54,84,>80,3,WHITE,1,F,Y,2012-12-26,2013-02-10,2013-01-28,,34,2013-02-11,48,15,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1060,Placebo,0,82,>80,3,WHITE,1,M,Y,2013-01-01,2013-07-05,2013-01-02,,2,2013-01-02,2,1,DAY,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1060,Placebo,0,82,>80,3,WHITE,1,M,Y,2013-01-01,2013-07-05,2013-01-04,,4,2013-01-15,15,12,DAY,INSOMNIA,DIFFICULTY SLEEPING,NA,INSOMNIA,NA,HLT_0297,NA,HLGT_0469,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1060,Placebo,0,82,>80,3,WHITE,1,M,Y,2013-01-01,2013-07-05,2013-01-04,,4,2013-01-15,15,12,DAY,INSOMNIA,DIFFICULTY SLEEPING,NA,INSOMNIA,NA,HLT_0297,NA,HLGT_0469,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,710,01-710-1060,Placebo,0,82,>80,3,WHITE,1,M,Y,2013-01-01,2013-07-05,2013-01-21,,21,2013-01-21,21,1,DAY,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,NA,APPLICATION SITE INDURATION,NA,HLT_0696,NA,HLGT_0715,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1060,Placebo,0,82,>80,3,WHITE,1,M,Y,2013-01-01,2013-07-05,2013-01-23,,23,2013-01-23,23,1,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1060,Placebo,0,82,>80,3,WHITE,1,M,Y,2013-01-01,2013-07-05,2013-01-31,,31,2013-01-31,31,1,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1060,Placebo,0,82,>80,3,WHITE,1,M,Y,2013-01-01,2013-07-05,2013-02-08,,39,2013-02-08,39,1,DAY,FALL,FALLING DOWN,NA,FALL,NA,HLT_0168,NA,HLGT_0446,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1060,Placebo,0,82,>80,3,WHITE,1,M,Y,2013-01-01,2013-07-05,2013-02-09,,40,2013-02-09,40,1,DAY,FALL,FALLING DOWN,NA,FALL,NA,HLT_0168,NA,HLGT_0446,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,710,01-710-1070,Xanomeline High Dose,81,85,>80,3,WHITE,1,F,Y,2012-09-08,2013-01-22,2012-10-06,,29,NA,NA,NA,,SUPRAVENTRICULAR EXTRASYSTOLES,PREMATURE ATRIAL CONTRACTION,NA,SUPRAVENTRICULAR EXTRASYSTOLES,NA,HLT_0188,NA,HLGT_0279,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1070,Xanomeline High Dose,81,85,>80,3,WHITE,1,F,Y,2012-09-08,2013-01-22,2012-12-12,,96,NA,NA,NA,,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1070,Xanomeline High Dose,81,85,>80,3,WHITE,1,F,Y,2012-09-08,2013-01-22,2012-12-12,,96,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1070,Xanomeline High Dose,81,85,>80,3,WHITE,1,F,Y,2012-09-08,2013-01-22,2012-12-12,,96,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1070,Xanomeline High Dose,81,85,>80,3,WHITE,1,F,Y,2012-09-08,2013-01-22,2013-01-22,,137,2013-01-25,140,4,DAY,HIP FRACTURE,HIP FRACTURE,NA,HIP FRACTURE,NA,HLT_0097,NA,HLGT_0131,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,SEVERE,N,N,N,N,N,Y,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1070,Xanomeline High Dose,81,85,>80,3,WHITE,1,F,Y,2012-09-08,2013-01-22,2013-02-05,,151,2013-02-10,156,6,DAY,GASTROINTESTINAL HAEMORRHAGE,GI BLEED,NA,GASTROINTESTINAL HAEMORRHAGE,NA,HLT_0354,NA,HLGT_0020,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,SEVERE,N,N,N,N,N,Y,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1077,Placebo,0,76,65-80,2,WHITE,1,F,Y,2013-11-17,2014-05-18,2013-12-12,,26,2013-12-12,26,1,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1077,Placebo,0,76,65-80,2,WHITE,1,F,Y,2013-11-17,2014-05-18,2013-12-27,,41,NA,NA,NA,,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1077,Placebo,0,76,65-80,2,WHITE,1,F,Y,2013-11-17,2014-05-18,2014-01-12,,57,NA,NA,NA,,AGITATION,AGITATION,NA,AGITATION,NA,HLT_0140,NA,HLGT_0170,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1077,Placebo,0,76,65-80,2,WHITE,1,F,Y,2013-11-17,2014-05-18,NA,,NA,NA,NA,NA,,ARTHRITIS,ARTHRITIS,NA,ARTHRITIS,NA,HLT_0019,NA,HLGT_0587,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,,,,,,,,,
CDISCPILOT01,710,01-710-1077,Placebo,0,76,65-80,2,WHITE,1,F,Y,2013-11-17,2014-05-18,NA,,NA,NA,NA,NA,,ARTHRITIS,ARTHRITIS,NA,ARTHRITIS,NA,HLT_0019,NA,HLGT_0587,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,,,,,,,,,
CDISCPILOT01,710,01-710-1083,Placebo,0,89,>80,3,WHITE,1,F,Y,2013-07-22,2013-08-01,2013-08-02,,12,2013-08-02,12,1,DAY,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCT,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,SEVERE,N,N,N,N,Y,Y,Y,N,POSSIBLE,,FATAL,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1137,Xanomeline High Dose,81,79,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-10-11,2013-11-13,2013-10-13,,3,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1137,Xanomeline High Dose,81,79,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-10-11,2013-11-13,2013-10-13,,3,NA,NA,NA,,ERYTHEMA,REDNESS,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1137,Xanomeline High Dose,81,79,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-10-11,2013-11-13,2013-11-04,,25,NA,NA,NA,,VERTIGO,VERTIGO,NA,VERTIGO,NA,HLT_0255,NA,HLGT_0147,NA,EAR AND LABYRINTH DISORDERS,EAR AND LABYRINTH DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1137,Xanomeline High Dose,81,79,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2013-10-11,2013-11-13,2013-11-13,,34,NA,NA,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1142,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,2012-10-02,2012-10-20,2012-10-04,,3,2012-10-06,5,3,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1142,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,2012-10-02,2012-10-20,2012-10-04,,3,2012-10-06,5,3,DAY,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1142,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,2012-10-02,2012-10-20,2012-10-14,,13,2012-10-14,13,1,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1142,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,2012-10-02,2012-10-20,2012-10-19,,18,2012-10-19,18,1,DAY,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,Y,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1142,Xanomeline High Dose,81,76,65-80,2,WHITE,1,F,Y,2012-10-02,2012-10-20,2012-10-19,,18,2012-10-19,18,1,DAY,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,NA,SYNCOPE VASOVAGAL,NA,HLT_0003,NA,HLGT_0687,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1154,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,2014-03-29,2014-04-27,2014-04-18,,21,NA,NA,NA,,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1154,Xanomeline Low Dose,54,84,>80,3,WHITE,1,M,Y,2014-03-29,2014-04-27,2014-04-18,,21,NA,NA,NA,,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1166,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2012-11-30,2013-03-19,2013-03-19,,110,2013-03-19,110,1,DAY,FALL,FALL,NA,FALL,NA,HLT_0168,NA,HLGT_0446,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1166,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2012-11-30,2013-03-19,2013-03-19,,110,2013-03-19,110,1,DAY,SKIN LACERATION,LACERATION OF HEAD,NA,SKIN LACERATION,NA,HLT_0075,NA,HLGT_0118,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1166,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2012-11-30,2013-03-19,2013-03-19,,110,2013-03-19,110,1,DAY,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1166,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2012-11-30,2013-03-19,2013-03-19,,110,2013-03-20,111,2,DAY,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,NA,COMPLEX PARTIAL SEIZURES,NA,HLT_0558,NA,HLGT_0656,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,Y,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1166,Xanomeline Low Dose,54,81,>80,3,WHITE,1,F,Y,2012-11-30,2013-03-19,2013-03-20,,111,2013-03-20,111,1,DAY,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,Y,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,710,01-710-1183,Placebo,0,80,65-80,2,WHITE,1,F,Y,2013-11-16,2014-05-17,2014-03-10,,115,NA,NA,NA,,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1183,Placebo,0,80,65-80,2,WHITE,1,F,Y,2013-11-16,2014-05-17,2014-03-10,,115,NA,NA,NA,,ATRIOVENTRICULAR BLOCK FIRST DEGREE,FIRST DEGREE ATRIOVENTRICULAR BLOCK,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,NA,HLT_0419,NA,HLGT_0464,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1187,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,2012-11-10,2013-05-12,2012-12-23,,44,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1235,Xanomeline Low Dose,54,56,<65,1,WHITE,1,F,Y,2012-09-26,2013-03-27,2012-11-22,,58,2012-12-14,80,23,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1235,Xanomeline Low Dose,54,56,<65,1,WHITE,1,F,Y,2012-09-26,2013-03-27,2013-01-13,,110,NA,NA,NA,,SHOULDER PAIN,SHOULDER PAIN,NA,SHOULDER PAIN,NA,HLT_0527,NA,HLGT_0288,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1235,Xanomeline Low Dose,54,56,<65,1,WHITE,1,F,Y,2012-09-26,2013-03-27,2013-01-29,,126,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1249,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,2013-12-28,2014-06-28,2014-02-11,,46,2014-02-11,46,1,DAY,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1249,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,2013-12-28,2014-06-28,2014-02-18,,53,2014-02-18,53,1,DAY,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1249,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,2013-12-28,2014-06-28,2014-02-23,,58,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1249,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,2013-12-28,2014-06-28,2014-04-24,,118,NA,NA,NA,,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1264,Placebo,0,78,65-80,2,WHITE,1,M,Y,2013-06-13,2013-10-11,2013-07-03,,21,2013-07-05,23,3,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1264,Placebo,0,78,65-80,2,WHITE,1,M,Y,2013-06-13,2013-10-11,2013-08-21,,70,NA,NA,NA,,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1264,Placebo,0,78,65-80,2,WHITE,1,M,Y,2013-06-13,2013-10-11,2013-08-21,,70,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1264,Placebo,0,78,65-80,2,WHITE,1,M,Y,2013-06-13,2013-10-11,2013-09-29,,109,2013-09-29,109,1,DAY,COLD SWEAT,COLD SWEAT,NA,COLD SWEAT,NA,HLT_0124,NA,HLGT_0208,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1264,Placebo,0,78,65-80,2,WHITE,1,M,Y,2013-06-13,2013-10-11,2013-09-29,,109,2013-09-29,109,1,DAY,CHILLS,CHILLS,NA,CHILLS,NA,HLT_0586,NA,HLGT_0161,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1264,Placebo,0,78,65-80,2,WHITE,1,M,Y,2013-06-13,2013-10-11,2013-10-09,,119,2013-10-09,119,1,DAY,COLD SWEAT,COLD SWEAT,NA,COLD SWEAT,NA,HLT_0124,NA,HLGT_0208,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,710,01-710-1264,Placebo,0,78,65-80,2,WHITE,1,M,Y,2013-06-13,2013-10-11,2013-10-09,,119,2013-10-09,119,1,DAY,CHILLS,CHILLS,NA,CHILLS,NA,HLT_0586,NA,HLGT_0161,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,710,01-710-1264,Placebo,0,78,65-80,2,WHITE,1,M,Y,2013-06-13,2013-10-11,2013-10-11,,121,2013-10-11,121,1,DAY,COLD SWEAT,COLD SWEAT,NA,COLD SWEAT,NA,HLT_0124,NA,HLGT_0208,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,710,01-710-1264,Placebo,0,78,65-80,2,WHITE,1,M,Y,2013-06-13,2013-10-11,2013-10-11,,121,2013-10-11,121,1,DAY,CHILLS,CHILLS,NA,CHILLS,NA,HLT_0586,NA,HLGT_0161,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,710,01-710-1270,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2014-02-12,2014-03-01,2014-02-23,,12,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1270,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2014-02-12,2014-03-01,2014-02-23,,12,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1271,Placebo,0,86,>80,3,WHITE,1,F,Y,2012-09-27,2012-11-21,2012-11-21,,56,2012-11-21,56,1,DAY,DYSPNOEA,SHORTNESS OF BREATH,NA,DYSPNOEA,NA,HLT_0296,NA,HLGT_0255,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,N,N,N,N,Y,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1271,Placebo,0,86,>80,3,WHITE,1,F,Y,2012-09-27,2012-11-21,2012-11-21,,56,2012-11-21,56,1,DAY,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCT,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,SEVERE,N,N,N,N,N,Y,Y,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1271,Placebo,0,86,>80,3,WHITE,1,F,Y,2012-09-27,2012-11-21,2012-11-21,,56,2012-11-26,61,6,DAY,ATRIAL FIBRILLATION,PAROXYSMAL ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,Y,Y,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1271,Placebo,0,86,>80,3,WHITE,1,F,Y,2012-09-27,2012-11-21,2012-11-22,,57,NA,NA,NA,,CARDIAC FAILURE CONGESTIVE,CONGESTIVE HEART FAILURE,NA,CARDIAC FAILURE CONGESTIVE,NA,HLT_0511,NA,HLGT_0413,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,Y,Y,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1271,Placebo,0,86,>80,3,WHITE,1,F,Y,2012-09-27,2012-11-21,2012-11-22,,57,2012-11-26,61,5,DAY,HYPONATRAEMIA,HYPONATREMIA,NA,HYPONATRAEMIA,NA,HLT_0688,NA,HLGT_0102,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MODERATE,N,N,N,N,N,Y,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1278,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,2012-12-24,2013-02-26,2013-01-13,,21,2013-01-19,27,7,DAY,SOMNOLENCE,DROWSINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1278,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,2012-12-24,2013-02-26,2013-02-07,,46,2013-03-03,70,25,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1278,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,2012-12-24,2013-02-26,2013-02-24,,63,2013-03-03,70,8,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1278,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,2012-12-24,2013-02-26,2013-02-24,,63,2013-02-26,65,3,DAY,BURNING SENSATION,BURNING SENSATION,NA,BURNING SENSATION,NA,HLT_0775,NA,HLGT_0456,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1278,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,2012-12-24,2013-02-26,2013-03-02,,69,2013-03-02,69,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1278,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,2012-12-24,2013-02-26,2013-02-07,,46,2013-03-03,70,25,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1278,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,2012-12-24,2013-02-26,2013-02-24,,63,2013-03-03,70,8,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1300,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,2012-12-15,2013-02-15,2013-01-31,,48,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1300,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,2012-12-15,2013-02-15,2013-02-10,,58,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1300,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,2012-12-15,2013-02-15,2013-02-10,,58,NA,NA,NA,,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1300,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,2012-12-15,2013-02-15,2013-02-13,,61,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1314,Placebo,0,78,65-80,2,WHITE,1,F,Y,2013-04-24,2013-05-23,2013-05-20,,27,2013-05-24,31,5,DAY,NASOPHARYNGITIS,COMMON COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1314,Placebo,0,78,65-80,2,WHITE,1,F,Y,2013-04-24,2013-05-23,2013-05-20,,27,2013-05-24,31,5,DAY,NASOPHARYNGITIS,COMMON COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,710,01-710-1315,Placebo,0,83,>80,3,WHITE,1,F,Y,2013-02-27,2013-07-06,2013-02-26,,-1,2013-02-26,-1,1,DAY,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,,,,,,,,,
CDISCPILOT01,710,01-710-1315,Placebo,0,83,>80,3,WHITE,1,F,Y,2013-02-27,2013-07-06,2013-05-14,,77,2013-07-07,131,55,DAY,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1315,Placebo,0,83,>80,3,WHITE,1,F,Y,2013-02-27,2013-07-06,2013-06-18,,112,2013-07-07,131,20,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1315,Placebo,0,83,>80,3,WHITE,1,F,Y,2013-02-27,2013-07-06,2013-06-18,,112,2013-07-07,131,20,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1315,Placebo,0,83,>80,3,WHITE,1,F,Y,2013-02-27,2013-07-06,2013-05-14,,77,2013-07-07,131,55,DAY,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1315,Placebo,0,83,>80,3,WHITE,1,F,Y,2013-02-27,2013-07-06,2013-06-18,,112,2013-07-07,131,20,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1315,Placebo,0,83,>80,3,WHITE,1,F,Y,2013-02-27,2013-07-06,2013-06-18,,112,2013-07-07,131,20,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1354,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,2012-11-11,2013-05-01,2012-12-30,,50,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1354,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,2012-11-11,2013-05-01,2013-02-14,,96,NA,NA,NA,,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1358,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2012-09-17,2013-02-09,2012-12-22,,97,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1358,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2012-09-17,2013-02-09,2012-12-22,,97,NA,NA,NA,,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1358,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2012-09-17,2013-02-09,2013-01-24,,130,NA,NA,NA,,APPLICATION SITE DESQUAMATION,APPLICATION SITE DESQUAMATION,NA,APPLICATION SITE DESQUAMATION,NA,HLT_0351,NA,HLGT_0193,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1368,Placebo,0,88,>80,3,WHITE,1,F,Y,2013-10-23,2014-04-24,2013-12-25,,64,2014-04-24,184,121,DAY,HIP FRACTURE,FRACTURED HIP,NA,HIP FRACTURE,NA,HLT_0097,NA,HLGT_0131,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,SEVERE,N,N,N,N,N,Y,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1368,Placebo,0,88,>80,3,WHITE,1,F,Y,2013-10-23,2014-04-24,2014-03-26,,155,NA,NA,NA,,DELUSION,DELUSIONS,NA,DELUSION,NA,HLT_0198,NA,HLGT_0565,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1368,Placebo,0,88,>80,3,WHITE,1,F,Y,2013-10-23,2014-04-24,2014-03-26,,155,NA,NA,NA,,PSYCHOMOTOR HYPERACTIVITY,INCREASED ACTIVITY,NA,PSYCHOMOTOR HYPERACTIVITY,NA,HLT_0383,NA,HLGT_0277,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1368,Placebo,0,88,>80,3,WHITE,1,F,Y,2013-10-23,2014-04-24,2013-12-25,,64,2014-04-24,184,121,DAY,HIP FRACTURE,FRACTURED HIP,NA,HIP FRACTURE,NA,HLT_0097,NA,HLGT_0131,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,SEVERE,N,N,N,N,N,Y,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,710,01-710-1385,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2012-10-29,2013-02-18,2012-11-12,,15,2012-11-13,16,2,DAY,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,NA,SUPRAVENTRICULAR TACHYCARDIA,NA,HLT_0692,NA,HLGT_0619,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1385,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2012-10-29,2013-02-18,2012-11-12,,15,2012-11-13,16,2,DAY,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,NA,SUPRAVENTRICULAR TACHYCARDIA,NA,HLT_0692,NA,HLGT_0619,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,710,01-710-1385,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2012-10-29,2013-02-18,2012-11-26,,29,NA,NA,NA,,ATRIOVENTRICULAR BLOCK FIRST DEGREE,FIRST DEGREE ATRIOVENTRICULAR BLOCK,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,NA,HLT_0419,NA,HLGT_0464,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1385,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2012-10-29,2013-02-18,2012-12-18,,51,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1385,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2012-10-29,2013-02-18,2012-12-27,,60,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1385,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2012-10-29,2013-02-18,2012-12-27,,60,NA,NA,NA,,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,710,01-710-1385,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2012-10-29,2013-02-18,2013-02-18,,113,NA,NA,NA,,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,,
CDISCPILOT01,710,01-710-1385,Xanomeline Low Dose,54,77,65-80,2,WHITE,1,M,Y,2012-10-29,2013-02-18,2013-02-18,,113,NA,NA,NA,,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,T WAVE FLATTENING OF,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,NA,HLT_0037,NA,HLGT_0030,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,710,01-710-1408,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,2013-01-05,2013-07-12,2013-01-31,,27,2013-02-09,36,10,DAY,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,710,01-710-1408,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,2013-01-05,2013-07-12,2013-01-31,,27,2013-02-09,36,10,DAY,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,710,01-710-1408,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,2013-01-05,2013-07-12,2013-02-24,,51,2013-05-31,147,97,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,710,01-710-1408,Xanomeline High Dose,81,80,65-80,2,WHITE,1,M,Y,2013-01-05,2013-07-12,2013-02-24,,51,2013-05-31,147,97,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,711,01-711-1012,Xanomeline High Dose,81,67,65-80,2,WHITE,1,F,Y,2013-04-03,2013-04-29,2013-04-16,,14,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,711,01-711-1012,Xanomeline High Dose,81,67,65-80,2,WHITE,1,F,Y,2013-04-03,2013-04-29,2013-04-16,,14,2013-05-02,30,17,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,711,01-711-1012,Xanomeline High Dose,81,67,65-80,2,WHITE,1,F,Y,2013-04-03,2013-04-29,2013-04-16,,14,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,711,01-711-1012,Xanomeline High Dose,81,67,65-80,2,WHITE,1,F,Y,2013-04-03,2013-04-29,2013-04-16,,14,2013-05-02,30,17,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,711,01-711-1012,Xanomeline High Dose,81,67,65-80,2,WHITE,1,F,Y,2013-04-03,2013-04-29,2013-04-27,,25,NA,NA,NA,,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,711,01-711-1012,Xanomeline High Dose,81,67,65-80,2,WHITE,1,F,Y,2013-04-03,2013-04-29,2013-04-29,,27,2013-05-01,29,3,DAY,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,NA,APPLICATION SITE URTICARIA,NA,HLT_0196,NA,HLGT_0233,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,711,01-711-1012,Xanomeline High Dose,81,67,65-80,2,WHITE,1,F,Y,2013-04-03,2013-04-29,2013-04-16,,14,2013-05-02,30,17,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,711,01-711-1036,Placebo,0,70,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,2012-07-29,2013-02-10,2012-07-29,,1,NA,NA,NA,,HEADACHE,INTERMITTENT HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,711,01-711-1036,Placebo,0,70,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,2012-07-29,2013-02-10,2012-08-04,,7,2012-08-12,15,9,DAY,EAR INFECTION,EAR INFECTION,NA,EAR INFECTION,NA,HLT_0757,NA,HLGT_0760,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,711,01-711-1036,Placebo,0,70,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,2012-07-29,2013-02-10,2012-08-12,,15,NA,NA,NA,,GLOSSITIS,GLOSSITIS,NA,GLOSSITIS,NA,HLT_0250,NA,HLGT_0427,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,711,01-711-1036,Placebo,0,70,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,2012-07-29,2013-02-10,2012-08-04,,7,2012-08-12,15,9,DAY,EAR INFECTION,EAR INFECTION,NA,EAR INFECTION,NA,HLT_0757,NA,HLGT_0760,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-03,2013-05-30,2007-10-01,D,-2011,NA,NA,NA,,TINNITUS,TINNITUS,NA,TINNITUS,NA,HLT_0570,NA,HLGT_0180,NA,EAR AND LABYRINTH DISORDERS,EAR AND LABYRINTH DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-03,2013-05-30,2013-04-11,,9,NA,NA,NA,,PARAESTHESIA ORAL,TINGLING MOUTH,NA,PARAESTHESIA ORAL,NA,HLT_0727,NA,HLGT_0035,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,Y,Y,Y,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-03,2013-05-30,2013-04-28,,26,2013-05-11,39,14,DAY,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,SEVERE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-03,2013-05-30,2013-04-29,,27,2013-05-15,43,17,DAY,SUPRAVENTRICULAR EXTRASYSTOLES,ECTOPIC ATRIAL BEATS,NA,SUPRAVENTRICULAR EXTRASYSTOLES,NA,HLT_0188,NA,HLGT_0279,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-03,2013-05-30,2013-04-28,,26,2013-05-11,39,14,DAY,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-03,2013-05-30,2013-04-28,,26,2013-05-11,39,14,DAY,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-03,2013-05-30,2013-04-29,,27,2013-05-15,43,17,DAY,SUPRAVENTRICULAR EXTRASYSTOLES,ECTOPIC ATRIAL BEATS,NA,SUPRAVENTRICULAR EXTRASYSTOLES,NA,HLT_0188,NA,HLGT_0279,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-03,2013-05-30,2013-05-18,,46,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-03,2013-05-30,2013-05-27,,55,2013-05-31,59,5,DAY,RASH PRURITIC,ITCHY RASH,NA,RASH PRURITIC,NA,HLT_0127,NA,HLGT_0753,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,9,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-03,2013-05-30,2013-05-28,,56,2013-06-01,60,5,DAY,VENTRICULAR EXTRASYSTOLES,PREMATURE VENTRICULAR CONTRACTIONS,NA,VENTRICULAR EXTRASYSTOLES,NA,HLT_0050,NA,HLGT_0594,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,10,Y,,,Y,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-03,2013-05-30,2013-05-27,,55,2013-05-31,59,5,DAY,RASH PRURITIC,ITCHY RASH,NA,RASH PRURITIC,NA,HLT_0127,NA,HLGT_0753,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,11,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-03,2013-05-30,2013-05-30,,58,NA,NA,NA,,CONJUNCTIVAL HAEMORRHAGE,SUBCONJUNCTIVAL HEMORRHAGE,NA,CONJUNCTIVAL HAEMORRHAGE,NA,HLT_0013,NA,HLGT_0720,NA,EYE DISORDERS,EYE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,12,Y,,Y,Y,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-03,2013-05-30,2013-06-01,,60,NA,NA,NA,,CERUMEN IMPACTION,CERUMEN IMPACTION,NA,CERUMEN IMPACTION,NA,HLT_0018,NA,HLGT_0158,NA,EAR AND LABYRINTH DISORDERS,EAR AND LABYRINTH DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,13,Y,,Y,Y,,,,,
CDISCPILOT01,711,01-711-1143,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-03,2013-05-30,2013-05-28,,56,2013-06-01,60,5,DAY,VENTRICULAR EXTRASYSTOLES,PREMATURE VENTRICULAR CONTRACTIONS,NA,VENTRICULAR EXTRASYSTOLES,NA,HLT_0050,NA,HLGT_0594,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,14,Y,,,,,,,,
CDISCPILOT01,711,01-711-1433,Xanomeline High Dose,81,84,>80,3,WHITE,1,F,Y,2013-01-27,2013-02-05,2012-07-23,,-188,NA,NA,NA,,HYPERTENSION,HYPERTENSION,NA,HYPERTENSION,NA,HLT_0228,NA,HLGT_0476,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,,
CDISCPILOT01,711,01-711-1433,Xanomeline High Dose,81,84,>80,3,WHITE,1,F,Y,2013-01-27,2013-02-05,2012-07-23,,-188,NA,NA,NA,,HYPERTENSION,HYPERTENSION,NA,HYPERTENSION,NA,HLT_0228,NA,HLGT_0476,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,,,,,,,,,
CDISCPILOT01,711,01-711-1433,Xanomeline High Dose,81,84,>80,3,WHITE,1,F,Y,2013-01-27,2013-02-05,2013-02-05,,10,NA,NA,NA,,ASTHENIA,WEAKNESS,NA,ASTHENIA,NA,HLT_0205,NA,HLGT_0614,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,Y,Y,Y,,,,,
CDISCPILOT01,713,01-713-1043,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,2013-09-15,2014-03-24,2013-09-26,,12,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,713,01-713-1043,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,2013-09-15,2014-03-24,2013-10-11,,27,2013-10-11,27,1,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1043,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,2013-09-15,2014-03-24,2013-10-11,,27,2013-10-11,27,1,DAY,VOMITING,EMESIS,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,713,01-713-1043,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,2013-09-15,2014-03-24,2013-09-26,,12,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,713,01-713-1043,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,2013-09-15,2014-03-24,2013-10-11,,27,2013-10-11,27,1,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,713,01-713-1043,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,2013-09-15,2014-03-24,2013-10-11,,27,2013-10-11,27,1,DAY,VOMITING,EMESIS,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,713,01-713-1043,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,F,Y,2013-09-15,2014-03-24,2014-03-08,,175,2014-03-08,175,1,DAY,CATARACT OPERATION,CATARACT EXTRACTION,NA,CATARACT OPERATION,NA,HLT_0432,NA,HLGT_0058,NA,SURGICAL AND MEDICAL PROCEDURES,SURGICAL AND MEDICAL PROCEDURES,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1073,Xanomeline Low Dose,54,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2014-03-30,2014-10-05,2014-07-14,,107,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,713,01-713-1141,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,2013-05-31,2013-07-01,2013-06-21,,22,2013-07-15,46,25,DAY,RASH PRURITIC,PRURITIC RASH,NA,RASH PRURITIC,NA,HLT_0127,NA,HLGT_0753,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,713,01-713-1141,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,2013-05-31,2013-07-01,2013-06-21,,22,2013-07-15,46,25,DAY,RASH PRURITIC,PRURITIC RASH,NA,RASH PRURITIC,NA,HLT_0127,NA,HLGT_0753,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,713,01-713-1141,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,2013-05-31,2013-07-01,2013-06-30,,31,NA,NA,NA,,BACK PAIN,BACK PAIN,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1141,Xanomeline High Dose,81,79,65-80,2,WHITE,1,M,Y,2013-05-31,2013-07-01,2013-07-01,,32,2013-07-15,46,15,DAY,DELIRIUM,DELIRIUM,NA,DELIRIUM,NA,HLT_0376,NA,HLGT_0176,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,Y,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,2013-08-09,2014-02-05,2013-08-19,,11,2013-08-23,15,5,DAY,DYSURIA,MICTURITION BURNING,NA,DYSURIA,NA,HLT_0637,NA,HLGT_0210,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,2013-08-09,2014-02-05,2013-08-22,,14,2013-08-22,14,1,DAY,DYSPEPSIA,HEARTBURN,NA,DYSPEPSIA,NA,HLT_0244,NA,HLGT_0716,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,2013-08-09,2014-02-05,2013-08-28,,20,2013-09-08,31,12,DAY,URINARY TRACT INFECTION,URINARY TRACT INFECTION,NA,URINARY TRACT INFECTION,NA,HLT_0161,NA,HLGT_0093,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,2013-08-09,2014-02-05,2013-09-05,,28,NA,NA,NA,,ASTHENIA,LOWER EXTREMITIES WEAKNESS OF,NA,ASTHENIA,NA,HLT_0205,NA,HLGT_0614,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,2013-08-09,2014-02-05,2013-08-28,,20,2013-09-08,31,12,DAY,URINARY TRACT INFECTION,URINARY TRACT INFECTION,NA,URINARY TRACT INFECTION,NA,HLT_0161,NA,HLGT_0093,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,2013-08-09,2014-02-05,2013-09-05,,28,NA,NA,NA,,ASTHENIA,LOWER EXTREMITIES WEAKNESS OF,NA,ASTHENIA,NA,HLT_0205,NA,HLGT_0614,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,2013-08-09,2014-02-05,2013-09-12,,35,NA,NA,NA,,DYSPEPSIA,INDIGESTION,NA,DYSPEPSIA,NA,HLT_0244,NA,HLGT_0716,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,2013-08-09,2014-02-05,2013-10-10,,63,2014-01-18,163,101,DAY,PELVIC PAIN,PELVIC PAIN,NA,PELVIC PAIN,NA,HLT_0189,NA,HLGT_0691,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,2013-08-09,2014-02-05,2013-10-10,,63,2013-10-13,66,4,DAY,GASTROENTERITIS VIRAL,STOMACH FLU,NA,GASTROENTERITIS VIRAL,NA,HLT_0211,NA,HLGT_0385,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,Y,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,2013-08-09,2014-02-05,2013-10-10,,63,NA,NA,NA,,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,NA,GASTROOESOPHAGEAL REFLUX DISEASE,NA,HLT_0407,NA,HLGT_0304,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,10,Y,,,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,2013-08-09,2014-02-05,2013-11-23,,107,2013-12-02,116,10,DAY,VAGINAL MYCOSIS,VAGINAL YEAST INFECTION,NA,VAGINAL MYCOSIS,NA,HLT_0508,NA,HLGT_0643,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,11,Y,,,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,2013-08-09,2014-02-05,2013-11-23,,107,2013-12-02,116,10,DAY,CERVICITIS,CERVICITIS,NA,CERVICITIS,NA,HLT_0651,NA,HLGT_0282,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,12,Y,,,Y,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,2013-08-09,2014-02-05,2013-11-23,,107,2013-12-02,116,10,DAY,VAGINAL MYCOSIS,VAGINAL YEAST INFECTION,NA,VAGINAL MYCOSIS,NA,HLT_0508,NA,HLGT_0643,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,13,Y,,,,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,2013-08-09,2014-02-05,2013-11-23,,107,2013-12-02,116,10,DAY,CERVICITIS,CERVICITIS,NA,CERVICITIS,NA,HLT_0651,NA,HLGT_0282,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,14,Y,,,,,,,,
CDISCPILOT01,713,01-713-1179,Placebo,0,64,<65,1,WHITE,1,F,Y,2013-08-09,2014-02-05,2013-10-10,,63,2014-01-18,163,101,DAY,PELVIC PAIN,PELVIC PAIN,NA,PELVIC PAIN,NA,HLT_0189,NA,HLGT_0691,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,15,Y,,,,,,,,
CDISCPILOT01,713,01-713-1209,Xanomeline High Dose,81,77,65-80,2,WHITE,1,F,Y,2013-05-27,2013-11-22,2013-05-30,,4,NA,NA,NA,,ABDOMINAL PAIN,ABDOMINAL PAIN,NA,ABDOMINAL PAIN,NA,HLT_0217,NA,HLGT_0419,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,713,01-713-1209,Xanomeline High Dose,81,77,65-80,2,WHITE,1,F,Y,2013-05-27,2013-11-22,2013-06-02,,7,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,713,01-713-1209,Xanomeline High Dose,81,77,65-80,2,WHITE,1,F,Y,2013-05-27,2013-11-22,2013-05-30,,4,NA,NA,NA,,ABDOMINAL PAIN,ABDOMINAL PAIN,NA,ABDOMINAL PAIN,NA,HLT_0217,NA,HLGT_0419,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,713,01-713-1209,Xanomeline High Dose,81,77,65-80,2,WHITE,1,F,Y,2013-05-27,2013-11-22,2013-10-31,,158,NA,NA,NA,,DIZZINESS,LIGHTHEADEDNESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1256,Placebo,0,71,65-80,2,WHITE,1,M,Y,2012-09-19,2013-03-25,2012-10-30,,42,2012-10-31,43,2,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,713,01-713-1256,Placebo,0,71,65-80,2,WHITE,1,M,Y,2012-09-19,2013-03-25,2012-10-30,,42,2012-10-31,43,2,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,713,01-713-1269,Placebo,0,73,65-80,2,WHITE,1,M,Y,2014-01-27,2014-07-28,2014-02-02,,7,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,713,01-713-1269,Placebo,0,73,65-80,2,WHITE,1,M,Y,2014-01-27,2014-07-28,2014-04-18,,82,NA,NA,NA,,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1269,Placebo,0,73,65-80,2,WHITE,1,M,Y,2014-01-27,2014-07-28,2014-06-01,,126,NA,NA,NA,,SHOULDER PAIN,SHOULDER PAIN,NA,SHOULDER PAIN,NA,HLT_0527,NA,HLGT_0288,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1269,Placebo,0,73,65-80,2,WHITE,1,M,Y,2014-01-27,2014-07-28,2014-07-10,,165,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,713,01-713-1269,Placebo,0,73,65-80,2,WHITE,1,M,Y,2014-01-27,2014-07-28,2014-06-01,,126,NA,NA,NA,,SHOULDER PAIN,SHOULDER PAIN,NA,SHOULDER PAIN,NA,HLT_0527,NA,HLGT_0288,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,713,01-713-1269,Placebo,0,73,65-80,2,WHITE,1,M,Y,2014-01-27,2014-07-28,2014-07-10,,165,NA,NA,NA,,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,713,01-713-1448,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,2014-01-19,2014-05-16,2014-03-19,,60,2014-05-23,125,66,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,713,01-713-1448,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,2014-01-19,2014-05-16,2014-03-27,,68,2014-05-23,125,58,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,713,01-713-1448,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,2014-01-19,2014-05-16,2014-03-19,,60,2014-05-23,125,66,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,713,01-713-1448,Xanomeline Low Dose,54,71,65-80,2,WHITE,1,F,Y,2014-01-19,2014-05-16,2014-03-27,,68,2014-05-23,125,58,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,714,01-714-1035,Placebo,0,88,>80,3,WHITE,1,F,Y,2014-04-17,2014-10-16,2014-05-26,,40,2014-06-04,49,10,DAY,BUNDLE BRANCH BLOCK RIGHT,INCOMPLETE RIGHT BUNDLE BRANCH BLOCK,NA,BUNDLE BRANCH BLOCK RIGHT,NA,HLT_0751,NA,HLGT_0597,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,714,01-714-1035,Placebo,0,88,>80,3,WHITE,1,F,Y,2014-04-17,2014-10-16,2014-05-26,,40,NA,NA,NA,,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERSION,NA,ELECTROCARDIOGRAM T WAVE INVERSION,NA,HLT_0289,NA,HLGT_0130,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1035,Placebo,0,88,>80,3,WHITE,1,F,Y,2014-04-17,2014-10-16,2014-06-04,,49,2014-06-17,62,14,DAY,SUPRAVENTRICULAR EXTRASYSTOLES,PREMATURE ATRIAL CONTRACTION,NA,SUPRAVENTRICULAR EXTRASYSTOLES,NA,HLT_0188,NA,HLGT_0279,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,714,01-714-1035,Placebo,0,88,>80,3,WHITE,1,F,Y,2014-04-17,2014-10-16,2014-06-04,,49,NA,NA,NA,,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ST SEGMENT DEPRESSED,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,NA,HLT_0610,NA,HLGT_0220,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,714,01-714-1035,Placebo,0,88,>80,3,WHITE,1,F,Y,2014-04-17,2014-10-16,2014-05-26,,40,2014-06-04,49,10,DAY,BUNDLE BRANCH BLOCK RIGHT,INCOMPLETE RIGHT BUNDLE BRANCH BLOCK,NA,BUNDLE BRANCH BLOCK RIGHT,NA,HLT_0751,NA,HLGT_0597,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,714,01-714-1035,Placebo,0,88,>80,3,WHITE,1,F,Y,2014-04-17,2014-10-16,2014-06-04,,49,2014-06-17,62,14,DAY,SUPRAVENTRICULAR EXTRASYSTOLES,PREMATURE ATRIAL CONTRACTION,NA,SUPRAVENTRICULAR EXTRASYSTOLES,NA,HLT_0188,NA,HLGT_0279,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,714,01-714-1035,Placebo,0,88,>80,3,WHITE,1,F,Y,2014-04-17,2014-10-16,2014-07-18,,93,2014-07-24,99,7,DAY,BRONCHITIS,BRONCHITIS,NA,BRONCHITIS,NA,HLT_0634,NA,HLGT_0523,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1068,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,2013-08-08,2013-10-08,2013-08-12,,5,2013-08-22,15,11,DAY,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,714,01-714-1068,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,2013-08-08,2013-10-08,2013-08-12,,5,2013-08-22,15,11,DAY,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1068,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,2013-08-08,2013-10-08,2013-09-20,,44,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1068,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,2013-08-08,2013-10-08,2013-09-20,,44,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1068,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,2013-08-08,2013-10-08,2013-09-20,,44,NA,NA,NA,,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1068,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,2013-08-08,2013-10-08,2013-09-20,,44,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1195,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,M,Y,2013-04-26,2013-10-23,2013-05-12,,17,2013-07-17,83,67,DAY,DIARRHOEA,LOOSE STOOLS,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,714,01-714-1195,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,M,Y,2013-04-26,2013-10-23,2013-05-12,,17,2013-07-17,83,67,DAY,HYPERHIDROSIS,SWEATING,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1195,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,M,Y,2013-04-26,2013-10-23,2013-05-13,,18,2013-07-17,83,66,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,714,01-714-1195,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,M,Y,2013-04-26,2013-10-23,2013-05-14,,19,NA,NA,NA,,SOMNOLENCE,DROWSINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1195,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,M,Y,2013-04-26,2013-10-23,2013-05-17,,22,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1195,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,M,Y,2013-04-26,2013-10-23,2013-05-12,,17,2013-07-17,83,67,DAY,DIARRHOEA,LOOSE STOOLS,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,714,01-714-1195,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,M,Y,2013-04-26,2013-10-23,2013-05-12,,17,2013-07-17,83,67,DAY,HYPERHIDROSIS,SWEATING,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,714,01-714-1195,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,M,Y,2013-04-26,2013-10-23,2013-05-13,,18,2013-07-17,83,66,DAY,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1195,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,M,Y,2013-04-26,2013-10-23,2013-07-25,,91,2013-08-06,103,13,DAY,DYSURIA,URINATION DIFFICULTY,NA,DYSURIA,NA,HLT_0637,NA,HLGT_0210,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1288,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-12-04,2014-06-17,2013-12-13,,10,2013-12-13,10,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,714,01-714-1288,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-12-04,2014-06-17,2013-12-14,,11,2013-12-15,12,2,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1288,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-12-04,2014-06-17,2014-01-11,,39,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,714,01-714-1288,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-12-04,2014-06-17,2014-01-22,,50,2014-01-25,53,4,DAY,NASOPHARYNGITIS,HEAD COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1288,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-12-04,2014-06-17,2014-01-22,,50,2014-01-25,53,4,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1288,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-12-04,2014-06-17,2014-02-24,,83,2014-04-08,126,44,DAY,BACK PAIN,LOW BACK PAIN,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1288,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-12-04,2014-06-17,2014-03-08,,95,NA,NA,NA,,ARTHRALGIA,KNEE PAIN,NA,ARTHRALGIA,NA,HLT_0375,NA,HLGT_0610,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,Y,,,,,
CDISCPILOT01,714,01-714-1288,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-12-04,2014-06-17,2014-02-24,,83,2014-04-08,126,44,DAY,BACK PAIN,LOW BACK PAIN,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,714,01-714-1288,Xanomeline High Dose,81,77,65-80,2,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-12-04,2014-06-17,2014-05-27,,175,NA,NA,NA,,SINUS BRADYCARDIA,BRADYCARDIA SINUS,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,9,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1375,Placebo,0,78,65-80,2,WHITE,1,F,Y,2013-02-26,2013-09-07,2013-03-30,,33,2013-04-06,40,8,DAY,SKIN IRRITATION,IRRITATION SKIN,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,714,01-714-1375,Placebo,0,78,65-80,2,WHITE,1,F,Y,2013-02-26,2013-09-07,2013-04-04,,38,2013-04-15,49,12,DAY,EAR PAIN,EAR PAIN,NA,EAR PAIN,NA,HLT_0631,NA,HLGT_0432,NA,EAR AND LABYRINTH DISORDERS,EAR AND LABYRINTH DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,714,01-714-1375,Placebo,0,78,65-80,2,WHITE,1,F,Y,2013-02-26,2013-09-07,2013-03-30,,33,2013-04-06,40,8,DAY,SKIN IRRITATION,IRRITATION SKIN,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1375,Placebo,0,78,65-80,2,WHITE,1,F,Y,2013-02-26,2013-09-07,2013-04-04,,38,2013-04-15,49,12,DAY,EAR PAIN,EAR PAIN,NA,EAR PAIN,NA,HLT_0631,NA,HLGT_0432,NA,EAR AND LABYRINTH DISORDERS,EAR AND LABYRINTH DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,714,01-714-1375,Placebo,0,78,65-80,2,WHITE,1,F,Y,2013-02-26,2013-09-07,2013-05-29,,93,NA,NA,NA,,PRURITUS,PRURITIS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1375,Placebo,0,78,65-80,2,WHITE,1,F,Y,2013-02-26,2013-09-07,2013-06-16,,111,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1375,Placebo,0,78,65-80,2,WHITE,1,F,Y,2013-02-26,2013-09-07,2013-05-29,,93,NA,NA,NA,,PRURITUS,PRURITIS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1375,Placebo,0,78,65-80,2,WHITE,1,F,Y,2013-02-26,2013-09-07,2013-06-16,,111,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,714,01-714-1425,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,2013-08-15,2013-08-19,2013-08-13,,-2,NA,NA,NA,,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,NA,HLT_0415,NA,HLGT_0086,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,,
CDISCPILOT01,715,01-715-1107,Xanomeline Low Dose,54,65,65-80,2,WHITE,1,M,Y,2013-02-26,2013-05-07,2013-05-07,,71,2013-05-21,85,15,DAY,DERMATITIS CONTACT,CONTACT DERMATITIS,NA,DERMATITIS CONTACT,NA,HLT_0056,NA,HLGT_0331,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,715,01-715-1107,Xanomeline Low Dose,54,65,65-80,2,WHITE,1,M,Y,2013-02-26,2013-05-07,2013-05-13,,77,NA,NA,NA,,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,715,01-715-1107,Xanomeline Low Dose,54,65,65-80,2,WHITE,1,M,Y,2013-02-26,2013-05-07,2013-05-07,,71,2013-05-21,85,15,DAY,DERMATITIS CONTACT,CONTACT DERMATITIS,NA,DERMATITIS CONTACT,NA,HLT_0056,NA,HLGT_0331,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,715,01-715-1207,Placebo,0,78,65-80,2,WHITE,1,F,Y,2012-11-18,2013-05-27,2013-01-10,,54,2013-01-10,54,1,DAY,NEPHROLITHIASIS,KIDNEY STONES,NA,NEPHROLITHIASIS,NA,HLT_0439,NA,HLGT_0546,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,715,01-715-1319,Xanomeline High Dose,81,65,65-80,2,WHITE,1,M,Y,2013-02-17,2013-03-05,2013-03-18,,30,2013-03-18,30,1,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,715,01-715-1321,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,2014-02-11,2014-04-21,2014-03-14,,32,2014-03-14,32,1,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,715,01-715-1321,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,2014-02-11,2014-04-21,2014-03-14,,32,2014-03-14,32,1,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,715,01-715-1321,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,2014-02-11,2014-04-21,2014-04-21,,70,NA,NA,NA,,APPLICATION SITE REACTION,APPLICATION SITE REACTION,NA,APPLICATION SITE REACTION,NA,HLT_0339,NA,HLGT_0668,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,715,01-715-1321,Xanomeline High Dose,81,75,65-80,2,WHITE,1,F,Y,2014-02-11,2014-04-21,2014-04-22,,71,NA,NA,NA,,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,715,01-715-1405,Xanomeline Low Dose,54,69,65-80,2,WHITE,1,M,Y,2013-07-06,2013-07-07,2013-07-08,,3,2013-07-08,3,1,DAY,PALPITATIONS,PALPITATIONS,NA,PALPITATIONS,NA,HLT_0493,NA,HLGT_0593,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,715,01-715-1405,Xanomeline Low Dose,54,69,65-80,2,WHITE,1,M,Y,2013-07-06,2013-07-07,2013-07-08,,3,2013-07-08,3,1,DAY,HYPERHIDROSIS,SWEATING,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,715,01-715-1405,Xanomeline Low Dose,54,69,65-80,2,WHITE,1,M,Y,2013-07-06,2013-07-07,2013-07-08,,3,2013-07-08,3,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,715,01-715-1405,Xanomeline Low Dose,54,69,65-80,2,WHITE,1,M,Y,2013-07-06,2013-07-07,2013-07-08,,3,2013-07-08,3,1,DAY,CONFUSIONAL STATE,CONFUSION,NA,CONFUSIONAL STATE,NA,HLT_0642,NA,HLGT_0329,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,715,01-715-1405,Xanomeline Low Dose,54,69,65-80,2,WHITE,1,M,Y,2013-07-06,2013-07-07,2013-07-13,,8,2013-07-13,8,1,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,715,01-715-1405,Xanomeline Low Dose,54,69,65-80,2,WHITE,1,M,Y,2013-07-06,2013-07-07,2013-07-13,,8,2013-07-13,8,1,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,716,01-716-1024,Placebo,0,87,>80,3,WHITE,1,F,Y,2012-07-09,2013-01-20,2012-08-20,,43,2012-09-27,81,39,DAY,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1024,Placebo,0,87,>80,3,WHITE,1,F,Y,2012-07-09,2013-01-20,2012-08-20,,43,2012-09-27,81,39,DAY,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,716,01-716-1024,Placebo,0,87,>80,3,WHITE,1,F,Y,2012-07-09,2013-01-20,2012-12-16,,161,NA,NA,NA,,EMPHYSEMA,EMPHYSEMA,NA,EMPHYSEMA,NA,HLT_0698,NA,HLGT_0221,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1026,Placebo,0,73,65-80,2,WHITE,1,F,Y,2014-04-02,2014-10-16,2014-04-17,,16,NA,NA,NA,,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1026,Placebo,0,73,65-80,2,WHITE,1,F,Y,2014-04-02,2014-10-16,2014-04-17,,16,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1026,Placebo,0,73,65-80,2,WHITE,1,F,Y,2014-04-02,2014-10-16,2014-04-18,,17,2014-07-31,121,105,DAY,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERTED,NA,ELECTROCARDIOGRAM T WAVE INVERSION,NA,HLT_0289,NA,HLGT_0130,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1026,Placebo,0,73,65-80,2,WHITE,1,F,Y,2014-04-02,2014-10-16,2014-07-16,,106,2014-07-25,115,10,DAY,EAR INFECTION,EAR INFECTION,NA,EAR INFECTION,NA,HLT_0757,NA,HLGT_0760,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1026,Placebo,0,73,65-80,2,WHITE,1,F,Y,2014-04-02,2014-10-16,2014-07-31,,121,NA,NA,NA,,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,T WAVE FLATTENING OF,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,NA,HLT_0037,NA,HLGT_0030,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,716,01-716-1026,Placebo,0,73,65-80,2,WHITE,1,F,Y,2014-04-02,2014-10-16,2014-04-18,,17,2014-07-31,121,105,DAY,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERTED,NA,ELECTROCARDIOGRAM T WAVE INVERSION,NA,HLT_0289,NA,HLGT_0130,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,716,01-716-1026,Placebo,0,73,65-80,2,WHITE,1,F,Y,2014-04-02,2014-10-16,2014-08-15,,136,2014-08-27,148,13,DAY,EAR INFECTION,EAR INFECTION,NA,EAR INFECTION,NA,HLT_0757,NA,HLGT_0760,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,716,01-716-1044,Placebo,0,74,65-80,2,WHITE,1,M,Y,2013-04-27,2013-11-03,2013-05-21,,25,2013-05-26,30,6,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1044,Placebo,0,74,65-80,2,WHITE,1,M,Y,2013-04-27,2013-11-03,2013-05-21,,25,2013-05-26,30,6,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,716,01-716-1044,Placebo,0,74,65-80,2,WHITE,1,M,Y,2013-04-27,2013-11-03,2013-10-15,,172,NA,NA,NA,,CONFUSIONAL STATE,CONFUSION,NA,CONFUSIONAL STATE,NA,HLT_0642,NA,HLGT_0329,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1063,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,M,Y,2013-05-09,2013-08-25,2013-05-09,,1,NA,NA,NA,,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1063,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,M,Y,2013-05-09,2013-08-25,2013-07-01,,54,NA,NA,NA,,FATIGUE,TIREDNESS,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1063,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,M,Y,2013-05-09,2013-08-25,2013-07-04,,57,2013-07-28,81,25,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1063,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,M,Y,2013-05-09,2013-08-25,2013-07-04,,57,2013-07-28,81,25,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1063,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,M,Y,2013-05-09,2013-08-25,2013-07-28,,81,2013-07-31,84,4,DAY,RESTLESSNESS,RESTLESSNESS,NA,RESTLESSNESS,NA,HLT_0427,NA,HLGT_0510,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1063,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,M,Y,2013-05-09,2013-08-25,2013-07-31,,84,NA,NA,NA,,LETHARGY,LETHARGY,NA,LETHARGY,NA,HLT_0027,NA,HLGT_0448,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1063,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,M,Y,2013-05-09,2013-08-25,2013-07-28,,81,2013-07-31,84,4,DAY,RESTLESSNESS,RESTLESSNESS,NA,RESTLESSNESS,NA,HLT_0427,NA,HLGT_0510,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,716,01-716-1071,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,2013-06-08,2013-08-01,2013-07-13,,36,NA,NA,NA,,HYPERSOMNIA,SLEEP EXCESSIVE,NA,HYPERSOMNIA,NA,HLT_0231,NA,HLGT_0628,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1071,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,2013-06-08,2013-08-01,2013-07-13,,36,NA,NA,NA,,FATIGUE,TIREDNESS,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1071,Xanomeline High Dose,81,78,65-80,2,WHITE,1,F,Y,2013-06-08,2013-08-01,2013-07-31,,54,2013-07-31,54,1,DAY,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,716,01-716-1094,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2012-12-19,2013-01-24,2013-01-19,,32,NA,NA,NA,,ATRIAL FLUTTER,ATRIAL FLUTTER,NA,ATRIAL FLUTTER,NA,HLT_0477,NA,HLGT_0627,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1094,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2012-12-19,2013-01-24,2013-01-19,,32,NA,NA,NA,,BUNDLE BRANCH BLOCK RIGHT,INCOMPLETE RIGHT BUNDLE BRANCH BLOCK,NA,BUNDLE BRANCH BLOCK RIGHT,NA,HLT_0751,NA,HLGT_0597,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,716,01-716-1094,Xanomeline Low Dose,54,82,>80,3,WHITE,1,M,Y,2012-12-19,2013-01-24,2013-01-19,,32,NA,NA,NA,,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,NA,VENTRICULAR SEPTAL DEFECT,NA,HLT_0589,NA,HLGT_0747,NA,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS","CONGENITAL, FAMILIAL AND GENETIC DISORDERS",NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1103,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,M,Y,2014-03-20,2014-09-20,2014-07-09,,112,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1103,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,M,Y,2014-03-20,2014-09-20,2014-07-09,,112,2014-07-16,119,8,DAY,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1103,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,M,Y,2014-03-20,2014-09-20,2014-07-09,,112,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1103,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,M,Y,2014-03-20,2014-09-20,2014-08-17,,151,2014-08-24,158,8,DAY,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1103,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,M,Y,2014-03-20,2014-09-20,2014-08-17,,151,2014-08-24,158,8,DAY,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1108,Placebo,0,86,>80,3,WHITE,1,F,Y,2013-02-12,2013-08-10,2013-04-12,,60,NA,NA,NA,,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ST SEGMENT DEPRESSED,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,NA,HLT_0610,NA,HLGT_0220,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1108,Placebo,0,86,>80,3,WHITE,1,F,Y,2013-02-12,2013-08-10,2013-05-01,,79,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1151,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2013-02-01,2013-05-11,2013-02-19,,19,2013-03-22,50,32,DAY,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOMA,NA,MALIGNANT FIBROUS HISTIOCYTOMA,NA,HLT_0245,NA,HLGT_0507,NA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)","NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",NA,MILD,N,Y,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1151,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2013-02-01,2013-05-11,2013-03-15,,43,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1151,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2013-02-01,2013-05-11,2013-03-15,,43,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1151,Xanomeline Low Dose,54,83,>80,3,WHITE,1,F,Y,2013-02-01,2013-05-11,2013-02-19,,19,2013-03-22,50,32,DAY,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOMA,NA,MALIGNANT FIBROUS HISTIOCYTOMA,NA,HLT_0245,NA,HLGT_0507,NA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)","NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",NA,MILD,N,Y,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,716,01-716-1157,Xanomeline Low Dose,54,85,>80,3,WHITE,1,M,Y,2013-10-02,2014-04-04,2013-10-17,,16,2013-11-04,34,19,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1157,Xanomeline Low Dose,54,85,>80,3,WHITE,1,M,Y,2013-10-02,2014-04-04,2013-10-25,,24,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1157,Xanomeline Low Dose,54,85,>80,3,WHITE,1,M,Y,2013-10-02,2014-04-04,2013-10-25,,24,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1157,Xanomeline Low Dose,54,85,>80,3,WHITE,1,M,Y,2013-10-02,2014-04-04,2013-10-17,,16,2013-11-04,34,19,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,716,01-716-1160,Placebo,0,83,>80,3,WHITE,1,F,Y,2013-04-05,2013-10-11,2013-05-09,,35,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1160,Placebo,0,83,>80,3,WHITE,1,F,Y,2013-04-05,2013-10-11,2013-05-09,,35,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1167,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2012-10-08,2013-04-12,2012-11-17,,41,NA,NA,NA,,PRURITUS,ITCH,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1167,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2012-10-08,2013-04-12,2012-11-17,,41,NA,NA,NA,,SWELLING,SWELLING,NA,SWELLING,NA,HLT_0658,NA,HLGT_0484,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1167,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2012-10-08,2013-04-12,2012-12-03,,57,NA,NA,NA,,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1167,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2012-10-08,2013-04-12,2013-03-10,,154,2013-04-10,185,32,DAY,HYPERSENSITIVITY,ALLERGY,NA,HYPERSENSITIVITY,NA,HLT_0473,NA,HLGT_0765,NA,IMMUNE SYSTEM DISORDERS,IMMUNE SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1167,Xanomeline Low Dose,54,68,65-80,2,WHITE,1,M,Y,2012-10-08,2013-04-12,2013-03-10,,154,2013-04-10,185,32,DAY,HYPERSENSITIVITY,ALLERGY,NA,HYPERSENSITIVITY,NA,HLT_0473,NA,HLGT_0765,NA,IMMUNE SYSTEM DISORDERS,IMMUNE SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,716,01-716-1177,Placebo,0,72,65-80,2,WHITE,1,M,Y,2014-09-02,2015-03-05,2014-08-24,,-9,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1189,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,2012-10-09,2013-02-27,2012-11-24,,47,NA,NA,NA,,HALLUCINATION,HALLUCINATION,NA,HALLUCINATION,NA,HLT_0026,NA,HLGT_0649,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1189,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,2012-10-09,2013-02-27,2012-11-24,,47,NA,NA,NA,,DELUSION,DELUSIONS,NA,DELUSION,NA,HLT_0198,NA,HLGT_0565,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,716,01-716-1189,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,2012-10-09,2013-02-27,2013-01-05,,89,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1189,Xanomeline High Dose,81,81,>80,3,WHITE,1,M,Y,2012-10-09,2013-02-27,2013-02-07,,122,NA,NA,NA,,PROSTATE CANCER,PROSTATE CANCER,NA,PROSTATE CANCER,NA,HLT_0412,NA,HLGT_0190,NA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)","NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",NA,SEVERE,N,Y,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1229,Xanomeline High Dose,81,73,65-80,2,WHITE,1,F,Y,2013-02-20,2013-03-31,2013-02-20,,1,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1229,Xanomeline High Dose,81,73,65-80,2,WHITE,1,F,Y,2013-02-20,2013-03-31,2013-03-06,,15,NA,NA,NA,,BLOOD CHOLESTEROL INCREASED,HIGH CHOLESTEROL,NA,BLOOD CHOLESTEROL INCREASED,NA,HLT_0210,NA,HLGT_0430,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1298,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-08,2013-06-28,2013-04-22,,15,2013-07-06,90,76,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1298,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-08,2013-06-28,2013-04-22,,15,2013-07-06,90,76,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1298,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-08,2013-06-28,2013-06-08,,62,2013-07-06,90,29,DAY,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1298,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-08,2013-06-28,2013-04-22,,15,2013-07-06,90,76,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1298,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-08,2013-06-28,2013-04-22,,15,2013-07-06,90,76,DAY,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1298,Xanomeline Low Dose,54,76,65-80,2,WHITE,1,F,Y,2013-04-08,2013-06-28,2013-06-08,,62,2013-07-06,90,29,DAY,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1308,Placebo,0,76,65-80,2,WHITE,1,F,Y,2013-08-28,2013-10-07,2013-09-20,,24,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1311,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,2014-05-14,2014-09-21,2014-05-28,,15,2014-09-22,132,118,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1311,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,2014-05-14,2014-09-21,2014-07-22,,70,2014-08-02,81,12,DAY,ABDOMINAL PAIN,ABDOMINAL PAIN,NA,ABDOMINAL PAIN,NA,HLT_0217,NA,HLGT_0419,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1311,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,2014-05-14,2014-09-21,2014-08-02,,81,NA,NA,NA,,ULCER,ULCER,NA,ULCER,NA,HLT_0040,NA,HLGT_0245,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1311,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,2014-05-14,2014-09-21,2014-05-28,,15,2014-09-22,132,118,DAY,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1364,Xanomeline High Dose,81,84,>80,3,WHITE,1,F,Y,2013-07-04,2014-01-09,2013-08-18,,46,NA,NA,NA,,PRURITUS,ITCH,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1364,Xanomeline High Dose,81,84,>80,3,WHITE,1,F,Y,2013-07-04,2014-01-09,2013-09-02,,61,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1373,Xanomeline High Dose,81,74,65-80,2,WHITE,1,M,Y,2012-12-14,2013-02-27,2012-12-14,,1,NA,NA,NA,,COGNITIVE DISORDER,COGNITIVE IMPAIRMENT,NA,COGNITIVE DISORDER,NA,HLT_0265,NA,HLGT_0506,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1373,Xanomeline High Dose,81,74,65-80,2,WHITE,1,M,Y,2012-12-14,2013-02-27,2012-12-15,,2,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,2013-05-05,2013-11-20,2013-05-05,,1,2013-05-07,3,3,DAY,URTICARIA,WELTS,NA,URTICARIA,NA,HLT_0420,NA,HLGT_0705,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,2013-05-05,2013-11-20,2013-05-05,,1,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,2013-05-05,2013-11-20,2013-05-05,,1,2013-05-07,3,3,DAY,URTICARIA,WELTS,NA,URTICARIA,NA,HLT_0420,NA,HLGT_0705,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,2013-05-05,2013-11-20,2013-05-07,,3,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,2013-05-05,2013-11-20,2013-07-01,D,58,2013-09-26,145,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,2013-05-05,2013-11-20,2013-07-01,D,58,2013-10-04,153,NA,,VISION BLURRED,BLURRED VISION,NA,VISION BLURRED,NA,HLT_0120,NA,HLGT_0598,NA,EYE DISORDERS,EYE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,2013-05-05,2013-11-20,2013-07-01,D,58,2013-09-26,145,NA,,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,2013-05-05,2013-11-20,2013-07-01,D,58,2013-10-04,153,NA,,VISION BLURRED,BLURRED VISION,NA,VISION BLURRED,NA,HLT_0120,NA,HLGT_0598,NA,EYE DISORDERS,EYE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,2013-05-05,2013-11-20,2013-09-26,,145,2013-11-11,191,47,DAY,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,716,01-716-1418,Xanomeline High Dose,81,80,65-80,2,WHITE,1,F,Y,2013-05-05,2013-11-20,2013-09-26,,145,2013-11-11,191,47,DAY,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,10,Y,,,,,,,,
CDISCPILOT01,716,01-716-1441,Placebo,0,85,>80,3,WHITE,1,M,Y,2014-01-22,2014-07-22,2014-05-11,,110,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1447,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-12-16,2014-06-17,2014-01-01,,17,NA,NA,NA,,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,716,01-716-1447,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-12-16,2014-06-17,2014-01-14,,30,NA,NA,NA,,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,716,01-716-1447,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-12-16,2014-06-17,2014-01-14,,30,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,716,01-716-1447,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-12-16,2014-06-17,2014-03-14,,89,NA,NA,NA,,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERTED,NA,ELECTROCARDIOGRAM T WAVE INVERSION,NA,HLT_0289,NA,HLGT_0130,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,716,01-716-1447,Xanomeline High Dose,81,72,65-80,2,WHITE,1,F,Y,2013-12-16,2014-06-17,2014-04-05,,111,2014-04-09,115,5,DAY,CHEST PAIN,CHEST PAIN,NA,CHEST PAIN,NA,HLT_0717,NA,HLGT_0195,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2014-01-14,2014-07-16,2013-05-01,D,-258,NA,NA,NA,,ENURESIS,BED WETTING,NA,ENURESIS,NA,HLT_0107,NA,HLGT_0623,NA,RENAL AND URINARY DISORDERS,RENAL AND URINARY DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2014-01-14,2014-07-16,2014-01-13,,-1,2014-02-10,28,29,DAY,DIARRHOEA,SOFT STOOLS,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,,,,,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2014-01-14,2014-07-16,2014-01-15,,2,2014-02-18,36,35,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,Y,Y,Y,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2014-01-14,2014-07-16,2014-01-15,,2,2014-02-08,26,25,DAY,RHINORRHOEA,RUNNY NOSE,NA,RHINORRHOEA,NA,HLT_0635,NA,HLGT_0460,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2014-01-14,2014-07-16,2014-01-15,,2,NA,NA,NA,,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2014-01-14,2014-07-16,2014-01-15,,2,2014-02-09,27,26,DAY,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2014-01-14,2014-07-16,2014-01-15,,2,NA,NA,NA,,ANXIETY,ANXIETY,NA,ANXIETY,NA,HLT_0559,NA,HLGT_0570,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2014-01-14,2014-07-16,2014-01-15,,2,NA,NA,NA,,IRRITABILITY,IRRITABILITY,NA,IRRITABILITY,NA,HLT_0627,NA,HLGT_0461,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,Y,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2014-01-14,2014-07-16,2014-01-15,,2,2014-02-08,26,25,DAY,RHINORRHOEA,RUNNY NOSE,NA,RHINORRHOEA,NA,HLT_0635,NA,HLGT_0460,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2014-01-14,2014-07-16,2014-01-13,,-1,2014-02-10,28,29,DAY,DIARRHOEA,SOFT STOOLS,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,10,,,,,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2014-01-14,2014-07-16,2014-01-15,,2,2014-02-09,27,26,DAY,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,11,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2014-01-14,2014-07-16,2014-01-15,,2,2014-02-18,36,35,DAY,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,12,Y,,,,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2014-01-14,2014-07-16,2014-03-09,,55,2014-03-15,61,7,DAY,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,13,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2014-01-14,2014-07-16,2014-03-09,,55,2014-03-15,61,7,DAY,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,14,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2014-01-14,2014-07-16,2014-04-08,,85,NA,NA,NA,,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,15,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2014-01-14,2014-07-16,2014-04-21,,98,NA,NA,NA,,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,16,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2014-01-14,2014-07-16,2014-05-21,,128,NA,NA,NA,,BACK PAIN,BACK PAIN,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,17,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2014-01-14,2014-07-16,2014-06-03,,141,2014-06-10,148,8,DAY,WOUND,WOUND NOS,NA,WOUND,NA,HLT_0542,NA,HLGT_0540,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,18,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1004,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2014-01-14,2014-07-16,2014-06-03,,141,2014-06-10,148,8,DAY,WOUND,WOUND NOS,NA,WOUND,NA,HLT_0542,NA,HLGT_0540,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,19,Y,,,,,,,,
CDISCPILOT01,717,01-717-1109,Xanomeline High Dose,81,84,>80,3,WHITE,1,M,Y,2014-01-27,2014-07-28,2014-01-29,,3,2014-07-16,171,169,DAY,INCREASED APPETITE,INCREASED APPETITE,NA,INCREASED APPETITE,NA,HLT_0566,NA,HLGT_0769,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,717,01-717-1109,Xanomeline High Dose,81,84,>80,3,WHITE,1,M,Y,2014-01-27,2014-07-28,2014-02-15,,20,NA,NA,NA,,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,717,01-717-1109,Xanomeline High Dose,81,84,>80,3,WHITE,1,M,Y,2014-01-27,2014-07-28,2014-02-15,,20,2014-02-17,22,3,DAY,HYPERHIDROSIS,SWEATING INCREASED,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,717,01-717-1109,Xanomeline High Dose,81,84,>80,3,WHITE,1,M,Y,2014-01-27,2014-07-28,2014-02-20,,25,NA,NA,NA,,CONFUSIONAL STATE,CONFUSION,NA,CONFUSIONAL STATE,NA,HLT_0642,NA,HLGT_0329,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1109,Xanomeline High Dose,81,84,>80,3,WHITE,1,M,Y,2014-01-27,2014-07-28,2014-02-22,,27,NA,NA,NA,,INSOMNIA,INSOMNIA,NA,INSOMNIA,NA,HLT_0297,NA,HLGT_0469,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,717,01-717-1109,Xanomeline High Dose,81,84,>80,3,WHITE,1,M,Y,2014-01-27,2014-07-28,2014-03-04,,37,NA,NA,NA,,PRURITUS GENERALISED,GENERALIZED PRURITUS,NA,PRURITUS GENERALISED,NA,HLT_0123,NA,HLGT_0689,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1109,Xanomeline High Dose,81,84,>80,3,WHITE,1,M,Y,2014-01-27,2014-07-28,2014-04-18,,82,NA,NA,NA,,VENTRICULAR EXTRASYSTOLES,PREMATURE VENTRICULAR CONTRACTIONS,NA,VENTRICULAR EXTRASYSTOLES,NA,HLT_0050,NA,HLGT_0594,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1109,Xanomeline High Dose,81,84,>80,3,WHITE,1,M,Y,2014-01-27,2014-07-28,2014-01-29,,3,2014-07-16,171,169,DAY,INCREASED APPETITE,INCREASED APPETITE,NA,INCREASED APPETITE,NA,HLT_0566,NA,HLGT_0769,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,717,01-717-1174,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,2013-01-22,2013-07-24,2013-01-26,,5,NA,NA,NA,,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,717,01-717-1174,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,2013-01-22,2013-07-24,2013-02-03,,13,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1174,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,2013-01-22,2013-07-24,2013-04-17,,86,2013-04-19,88,3,DAY,INSOMNIA,INSOMNIA,NA,INSOMNIA,NA,HLT_0297,NA,HLGT_0469,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1174,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,2013-01-22,2013-07-24,2013-04-25,,94,2013-04-26,95,2,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1174,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,2013-01-22,2013-07-24,2013-01-26,,5,NA,NA,NA,,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1174,Xanomeline High Dose,81,73,65-80,2,WHITE,1,M,Y,2013-01-22,2013-07-24,2013-02-03,,13,NA,NA,NA,,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1201,Placebo,0,85,>80,3,WHITE,1,F,Y,2013-12-19,2014-02-21,2013-12-19,,1,NA,NA,NA,,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,717,01-717-1201,Placebo,0,85,>80,3,WHITE,1,F,Y,2013-12-19,2014-02-21,2014-01-15,,28,NA,NA,NA,,ALOPECIA,HAIR LOSS,NA,ALOPECIA,NA,HLT_0077,NA,HLGT_0234,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,Y,,,,,
CDISCPILOT01,717,01-717-1344,Placebo,0,64,<65,1,WHITE,1,F,Y,2014-01-11,2014-03-14,2014-02-01,,22,2014-02-06,27,6,DAY,NASAL CONGESTION,NOSE CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,717,01-717-1344,Placebo,0,64,<65,1,WHITE,1,F,Y,2014-01-11,2014-03-14,2014-02-01,,22,2014-02-18,39,18,DAY,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1344,Placebo,0,64,<65,1,WHITE,1,F,Y,2014-01-11,2014-03-14,2014-02-01,,22,2014-02-18,39,18,DAY,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,717,01-717-1344,Placebo,0,64,<65,1,WHITE,1,F,Y,2014-01-11,2014-03-14,2014-02-28,,49,2014-03-01,50,2,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1344,Placebo,0,64,<65,1,WHITE,1,F,Y,2014-01-11,2014-03-14,2014-02-28,,49,2014-03-01,50,2,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,717,01-717-1357,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-05-01,2013-10-14,1994-04-01,D,-6970,NA,NA,NA,,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,,,,,,,,,
CDISCPILOT01,717,01-717-1357,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-05-01,2013-10-14,2013-05-23,,23,NA,NA,NA,,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,717,01-717-1357,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-05-01,2013-10-14,2013-05-29,,29,NA,NA,NA,,OEDEMA PERIPHERAL,ANKLE EDEMA,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1357,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-05-01,2013-10-14,2013-06-11,,42,2013-10-15,168,127,DAY,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,NA,APPLICATION SITE PERSPIRATION,NA,HLT_0283,NA,HLGT_0403,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1357,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-05-01,2013-10-14,2013-05-23,,23,NA,NA,NA,,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1357,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-05-01,2013-10-14,2013-07-07,,68,2013-07-08,69,2,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1357,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-05-01,2013-10-14,2013-07-22,,83,2013-07-22,83,1,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,7,Y,,,Y,,,,,
CDISCPILOT01,717,01-717-1357,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-05-01,2013-10-14,2013-08-10,,102,2013-08-10,102,1,DAY,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1357,Xanomeline High Dose,81,77,65-80,2,WHITE,1,M,Y,2013-05-01,2013-10-14,2013-06-11,,42,2013-10-15,168,127,DAY,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,NA,APPLICATION SITE PERSPIRATION,NA,HLT_0283,NA,HLGT_0403,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,9,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1446,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,2013-09-01,2014-03-03,2013-09-15,,15,2013-09-16,16,2,DAY,ANXIETY,ANXIETY AGGRAVATED,NA,ANXIETY,NA,HLT_0559,NA,HLGT_0570,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,717,01-717-1446,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,2013-09-01,2014-03-03,2013-09-15,,15,2013-09-16,16,2,DAY,ANXIETY,ANXIETY AGGRAVATED,NA,ANXIETY,NA,HLT_0559,NA,HLGT_0570,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,717,01-717-1446,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,2013-09-01,2014-03-03,2013-09-19,,19,NA,NA,NA,,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,717,01-717-1446,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,2013-09-01,2014-03-03,2013-10-06,,36,2014-03-03,184,149,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1446,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,2013-09-01,2014-03-03,2013-10-07,,37,2013-10-11,41,5,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1446,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,2013-09-01,2014-03-03,2013-10-07,,37,2013-10-11,41,5,DAY,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,717,01-717-1446,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,2013-09-01,2014-03-03,2014-01-13,,135,2014-01-14,136,2,DAY,PAIN,STINGING,NA,PAIN,NA,HLT_0314,NA,HLGT_0478,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,717,01-717-1446,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,2013-09-01,2014-03-03,2014-01-28,,150,NA,NA,NA,,PAIN,STINGING,NA,PAIN,NA,HLT_0314,NA,HLGT_0478,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,717,01-717-1446,Xanomeline Low Dose,54,75,65-80,2,WHITE,1,F,Y,2013-09-01,2014-03-03,2013-10-06,,36,2014-03-03,184,149,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,718,01-718-1066,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,2013-07-07,2013-07-16,2013-07-16,,10,2013-07-20,14,5,DAY,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,N,N,N,N,Y,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,718,01-718-1066,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,2013-07-07,2013-07-16,2013-07-18,,12,NA,NA,NA,,AGITATION,AGITATION,NA,AGITATION,NA,HLT_0140,NA,HLGT_0170,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1066,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,2013-07-07,2013-07-16,2013-07-30,,24,NA,NA,NA,,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,N,N,N,N,Y,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,718,01-718-1066,Xanomeline Low Dose,54,79,65-80,2,WHITE,1,F,Y,2013-07-07,2013-07-16,2013-07-30,,24,NA,NA,NA,,INFLAMMATION,INFLAMMATION LOCALIZED,NA,INFLAMMATION,NA,HLT_0582,NA,HLGT_0004,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1079,Xanomeline Low Dose,54,67,65-80,2,WHITE,1,F,Y,2012-09-19,2012-10-31,2012-10-05,,17,NA,NA,NA,,CONFUSIONAL STATE,CONFUSION,NA,CONFUSIONAL STATE,NA,HLT_0642,NA,HLGT_0329,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,718,01-718-1079,Xanomeline Low Dose,54,67,65-80,2,WHITE,1,F,Y,2012-09-19,2012-10-31,2012-10-05,,17,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,718,01-718-1079,Xanomeline Low Dose,54,67,65-80,2,WHITE,1,F,Y,2012-09-19,2012-10-31,2012-10-05,,17,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1101,Xanomeline High Dose,81,82,>80,3,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-02-17,2013-07-31,2013-03-06,,18,2013-03-06,18,1,DAY,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,718,01-718-1101,Xanomeline High Dose,81,82,>80,3,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-02-17,2013-07-31,2013-04-13,,56,2013-05-12,85,30,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1101,Xanomeline High Dose,81,82,>80,3,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-02-17,2013-07-31,2013-04-14,,57,2013-07-06,140,84,DAY,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1101,Xanomeline High Dose,81,82,>80,3,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-02-17,2013-07-31,2013-04-13,,56,2013-05-12,85,30,DAY,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,718,01-718-1101,Xanomeline High Dose,81,82,>80,3,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-02-17,2013-07-31,2013-07-06,,140,NA,NA,NA,,MYOCARDIAL INFARCTION,INFERIOR MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,718,01-718-1101,Xanomeline High Dose,81,82,>80,3,BLACK OR AFRICAN AMERICAN,2,M,Y,2013-02-17,2013-07-31,2013-04-14,,57,2013-07-06,140,84,DAY,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,718,01-718-1139,Placebo,0,77,65-80,2,WHITE,1,M,Y,2013-05-19,2013-11-17,2013-06-03,,16,2013-07-16,59,44,DAY,SOMNOLENCE,SLEEPINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,718,01-718-1139,Placebo,0,77,65-80,2,WHITE,1,M,Y,2013-05-19,2013-11-17,2013-06-03,,16,2013-07-16,59,44,DAY,SOMNOLENCE,SLEEPINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,718,01-718-1139,Placebo,0,77,65-80,2,WHITE,1,M,Y,2013-05-19,2013-11-17,2013-11-16,,182,2013-11-16,182,1,DAY,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,2013-01-19,2013-07-29,2013-02-16,,29,2013-03-17,58,30,DAY,BRADYCARDIA,BRADYCARDIA,NA,BRADYCARDIA,NA,HLT_0640,NA,HLGT_0294,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,2013-01-19,2013-07-29,2013-03-06,,47,2013-03-26,67,21,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,2013-01-19,2013-07-29,2013-03-15,,56,2013-03-15,56,1,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,2013-01-19,2013-07-29,2013-02-16,,29,2013-03-17,58,30,DAY,BRADYCARDIA,BRADYCARDIA,NA,BRADYCARDIA,NA,HLT_0640,NA,HLGT_0294,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,2013-01-19,2013-07-29,2013-03-06,,47,2013-03-26,67,21,DAY,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,2013-01-19,2013-07-29,2013-05-10,,112,2013-07-07,170,59,DAY,BRADYCARDIA,BRADYCARDIA,NA,BRADYCARDIA,NA,HLT_0640,NA,HLGT_0294,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,2013-01-19,2013-07-29,2013-06-09,,142,NA,NA,NA,,FOOD CRAVING,CARBOHYDRATE CRAVING,NA,FOOD CRAVING,NA,HLT_0754,NA,HLGT_0376,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,7,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,2013-01-19,2013-07-29,2013-06-16,,149,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,2013-01-19,2013-07-29,2013-05-10,,112,2013-07-07,170,59,DAY,BRADYCARDIA,BRADYCARDIA,NA,BRADYCARDIA,NA,HLT_0640,NA,HLGT_0294,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,9,Y,,,,,,,,
CDISCPILOT01,718,01-718-1150,Placebo,0,73,65-80,2,WHITE,1,F,Y,2013-01-19,2013-07-29,2013-07-31,,194,NA,NA,NA,,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,CARDIAC DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,10,Y,,,Y,,,,,
CDISCPILOT01,718,01-718-1170,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2013-09-16,2013-10-12,2013-10-07,,22,2013-10-07,22,1,DAY,DIZZINESS,LIGHTHEADEDNESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,718,01-718-1170,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2013-09-16,2013-10-12,2013-10-11,,26,2013-10-12,27,2,DAY,HYPERHIDROSIS,DIAPHORESIS,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1170,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2013-09-16,2013-10-12,2013-10-11,,26,2013-10-12,27,2,DAY,BODY TEMPERATURE INCREASED,TEMPERATURE ELEVATION,NA,BODY TEMPERATURE INCREASED,NA,HLT_0734,NA,HLGT_0351,NA,INVESTIGATIONS,INVESTIGATIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1170,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2013-09-16,2013-10-12,2013-10-11,,26,2013-10-12,27,2,DAY,HYPERTENSION,HYPERTENSION,NA,HYPERTENSION,NA,HLT_0228,NA,HLGT_0476,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1170,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2013-09-16,2013-10-12,2013-10-12,,27,2013-10-13,28,2,DAY,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,Y,N,N,N,N,Y,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,,Y,Y,Y,Y,,
CDISCPILOT01,718,01-718-1170,Xanomeline Low Dose,54,80,65-80,2,WHITE,1,F,Y,2013-09-16,2013-10-12,2013-10-16,,31,NA,NA,NA,,AGITATION,INCREASED AGITATION,NA,AGITATION,NA,HLT_0140,NA,HLGT_0170,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,2013-09-21,2014-01-31,2013-10-09,,19,2013-11-15,56,38,DAY,BALANCE DISORDER,UNSTEADINESS,NA,BALANCE DISORDER,NA,HLT_0541,NA,HLGT_0101,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,2013-09-21,2014-01-31,2013-10-09,,19,2013-10-09,19,1,DAY,FALL,FALL,NA,FALL,NA,HLT_0168,NA,HLGT_0446,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,2013-09-21,2014-01-31,2013-10-15,,25,2013-11-02,43,19,DAY,CONTUSION,BRUISING OF FACE,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,2013-09-21,2014-01-31,2013-10-09,,19,2013-11-15,56,38,DAY,BALANCE DISORDER,UNSTEADINESS,NA,BALANCE DISORDER,NA,HLT_0541,NA,HLGT_0101,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,2013-09-21,2014-01-31,2013-10-15,,25,2013-11-02,43,19,DAY,CONTUSION,BRUISING OF FACE,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,,,,,,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,2013-09-21,2014-01-31,2013-10-09,,19,2013-11-15,56,38,DAY,BALANCE DISORDER,UNSTEADINESS,NA,BALANCE DISORDER,NA,HLT_0541,NA,HLGT_0101,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,2013-09-21,2014-01-31,2013-10-15,,25,2013-11-02,43,19,DAY,CONTUSION,BRUISING OF FACE,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS","INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,2013-09-21,2014-01-31,2013-11-15,,56,2013-11-15,56,1,DAY,COORDINATION ABNORMAL,INCOORDINATION,NA,COORDINATION ABNORMAL,NA,HLT_0315,NA,HLGT_0015,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,8,Y,,,Y,,,,,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,2013-09-21,2014-01-31,2013-12-29,,100,2014-02-19,152,53,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,9,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,2013-09-21,2014-01-31,2013-12-29,,100,2014-02-19,152,53,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,10,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1250,Xanomeline Low Dose,54,82,>80,3,WHITE,1,F,Y,2013-09-21,2014-01-31,2013-12-29,,100,2014-02-19,152,53,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,11,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1254,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,2013-07-10,2014-01-09,2013-07-13,,4,NA,NA,NA,,ARTHRALGIA,PAIN IN HIP,NA,ARTHRALGIA,NA,HLT_0375,NA,HLGT_0610,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,718,01-718-1254,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,2013-07-10,2014-01-09,2013-07-25,,16,2013-07-25,16,1,DAY,ARTHRALGIA,KNEE PAIN,NA,ARTHRALGIA,NA,HLT_0375,NA,HLGT_0610,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,2,Y,,,,,,,,
CDISCPILOT01,718,01-718-1254,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,2013-07-10,2014-01-09,2013-07-25,,16,2013-07-25,16,1,DAY,ARTHRALGIA,KNEE PAIN,NA,ARTHRALGIA,NA,HLT_0375,NA,HLGT_0610,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,3,Y,,,,,,,,
CDISCPILOT01,718,01-718-1254,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,2013-07-10,2014-01-09,2013-08-13,,35,NA,NA,NA,,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLORATION,NA,APPLICATION SITE DISCOLOURATION,NA,HLT_0121,NA,HLGT_0273,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,718,01-718-1254,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,2013-07-10,2014-01-09,2013-08-13,,35,NA,NA,NA,,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,5,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1254,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,2013-07-10,2014-01-09,2013-09-03,,56,2013-09-19,72,17,DAY,SOMNOLENCE,SOMNOLENCE,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,6,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1254,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,2013-07-10,2014-01-09,2013-09-03,,56,2013-09-19,72,17,DAY,SOMNOLENCE,SOMNOLENCE,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,718,01-718-1254,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,2013-07-10,2014-01-09,2013-10-31,,114,NA,NA,NA,,FOOD CRAVING,CARBOHYDRATE CRAVING,NA,FOOD CRAVING,NA,HLT_0754,NA,HLGT_0376,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,,,NOT RECOVERED/NOT RESOLVED,8,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1254,Xanomeline Low Dose,54,78,65-80,2,WHITE,1,M,Y,2013-07-10,2014-01-09,2013-10-31,,114,NA,NA,NA,,DYSPHAGIA,SWALLOWING DIFFICULT,NA,DYSPHAGIA,NA,HLT_0563,NA,HLGT_0405,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,,,NOT RECOVERED/NOT RESOLVED,9,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1328,Xanomeline High Dose,81,86,>80,3,WHITE,1,M,Y,2013-02-01,2013-04-18,2013-03-23,,51,2013-03-25,53,3,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,718,01-718-1328,Xanomeline High Dose,81,86,>80,3,WHITE,1,M,Y,2013-02-01,2013-04-18,2013-03-23,,51,2013-03-25,53,3,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1328,Xanomeline High Dose,81,86,>80,3,WHITE,1,M,Y,2013-02-01,2013-04-18,2013-04-02,,61,2013-04-21,80,20,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1328,Xanomeline High Dose,81,86,>80,3,WHITE,1,M,Y,2013-02-01,2013-04-18,2013-04-02,,61,2013-04-21,80,20,DAY,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,4,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2013-02-28,2013-08-29,2013-03-08,,9,2013-03-22,23,15,DAY,SKIN ULCER,SKIN EROSION,NA,SKIN ULCER,NA,HLT_0005,NA,HLGT_0017,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,1,Y,Y,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2013-02-28,2013-08-29,2013-03-08,,9,2013-03-22,23,15,DAY,SKIN ULCER,SKIN EROSION,NA,SKIN ULCER,NA,HLT_0005,NA,HLGT_0017,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,2,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2013-02-28,2013-08-29,NA,,NA,NA,NA,NA,,DERMATITIS ATOPIC,ATOPIC DERMATITIS,NA,DERMATITIS ATOPIC,NA,HLT_0480,NA,HLGT_0257,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2013-02-28,2013-08-29,2013-04-17,,49,NA,NA,NA,,CONFUSIONAL STATE,CONFUSION,NA,CONFUSIONAL STATE,NA,HLT_0642,NA,HLGT_0329,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,4,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2013-02-28,2013-08-29,2013-04-27,,59,2013-04-27,59,1,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2013-02-28,2013-08-29,2013-05-12,,74,2013-05-12,74,1,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2013-02-28,2013-08-29,2013-05-16,,78,2013-05-16,78,1,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,7,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2013-02-28,2013-08-29,2013-05-20,,82,2013-05-20,82,1,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,8,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2013-02-28,2013-08-29,2013-05-25,,87,NA,NA,NA,,SOMNOLENCE,SLEEPINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,9,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2013-02-28,2013-08-29,2013-06-23,,116,2013-08-13,167,52,DAY,APPLICATION SITE REACTION,APPLICATION SITE REACTION,NA,APPLICATION SITE REACTION,NA,HLT_0339,NA,HLGT_0668,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,10,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2013-02-28,2013-08-29,2013-06-23,,116,2013-08-13,167,52,DAY,APPLICATION SITE REACTION,APPLICATION SITE REACTION,NA,APPLICATION SITE REACTION,NA,HLT_0339,NA,HLGT_0668,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,11,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2013-02-28,2013-08-29,2013-08-15,,169,2013-08-29,183,15,DAY,HYPERTENSION,HYPERTENSION,NA,HYPERTENSION,NA,HLT_0228,NA,HLGT_0476,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,NOT RECOVERED/NOT RESOLVED,12,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1355,Placebo,0,79,65-80,2,WHITE,1,M,Y,2013-02-28,2013-08-29,2013-08-15,,169,2013-08-29,183,15,DAY,HYPERTENSION,HYPERTENSION,NA,HYPERTENSION,NA,HLT_0228,NA,HLGT_0476,NA,VASCULAR DISORDERS,VASCULAR DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,13,Y,,,,,,,,
CDISCPILOT01,718,01-718-1371,Xanomeline High Dose,81,69,65-80,2,WHITE,1,F,Y,2013-04-26,2013-08-01,2013-05-09,,14,2013-05-11,16,3,DAY,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,718,01-718-1371,Xanomeline High Dose,81,69,65-80,2,WHITE,1,F,Y,2013-04-26,2013-08-01,2013-05-09,,14,2013-05-11,16,3,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1371,Xanomeline High Dose,81,69,65-80,2,WHITE,1,F,Y,2013-04-26,2013-08-01,2013-05-24,,29,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,3,Y,,,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,718,01-718-1371,Xanomeline High Dose,81,69,65-80,2,WHITE,1,F,Y,2013-04-26,2013-08-01,2013-06-02,,38,2013-06-05,41,4,DAY,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALIZATION,NA,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NA,HLT_0603,NA,HLGT_0719,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,SEVERE,Y,N,N,N,N,Y,N,N,NONE,,RECOVERED/RESOLVED,4,Y,,Y,Y,Y,Y,Y,,
CDISCPILOT01,718,01-718-1371,Xanomeline High Dose,81,69,65-80,2,WHITE,1,F,Y,2013-04-26,2013-08-01,2013-06-02,,38,2013-06-03,39,2,DAY,"HALLUCINATION, VISUAL",VISUAL HALLUCINATIONS,NA,"HALLUCINATION, VISUAL",NA,HLT_0369,NA,HLGT_0663,NA,PSYCHIATRIC DISORDERS,PSYCHIATRIC DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1371,Xanomeline High Dose,81,69,65-80,2,WHITE,1,F,Y,2013-04-26,2013-08-01,2013-05-24,,29,NA,NA,NA,,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,6,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2012-12-17,2013-02-11,2012-12-18,,2,2012-12-18,2,1,DAY,BACK PAIN,BACK PAIN,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,1,Y,Y,Y,Y,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2012-12-17,2013-02-11,2012-12-26,,10,2012-12-26,10,1,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,REMOTE,,RECOVERED/RESOLVED,2,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2012-12-17,2013-02-11,2013-01-01,,16,2013-01-19,34,19,DAY,AMNESIA,SHORT-TERM MEMORY LOSS,NA,AMNESIA,NA,HLT_0501,NA,HLGT_0641,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,NOT RECOVERED/NOT RESOLVED,3,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2012-12-17,2013-02-11,2013-01-03,,18,2013-01-09,24,7,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,4,Y,,,,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2012-12-17,2013-02-11,2013-01-05,,20,2013-01-05,20,1,DAY,LETHARGY,LETHARGY,NA,LETHARGY,NA,HLT_0027,NA,HLGT_0448,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,5,Y,,,Y,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2012-12-17,2013-02-11,2013-01-16,,31,2013-01-16,31,1,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,6,Y,,,,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2012-12-17,2013-02-11,2013-01-01,,16,2013-01-19,34,19,DAY,AMNESIA,SHORT-TERM MEMORY LOSS,NA,AMNESIA,NA,HLT_0501,NA,HLGT_0641,NA,NERVOUS SYSTEM DISORDERS,NERVOUS SYSTEM DISORDERS,NA,MILD,N,N,N,N,N,N,N,N,NONE,,RECOVERED/RESOLVED,7,Y,,,,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2012-12-17,2013-02-11,2013-01-21,,36,2013-01-24,39,4,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,SEVERE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,8,Y,,,,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2012-12-17,2013-02-11,2013-01-27,,42,2013-01-28,43,2,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,9,Y,,Y,Y,,,,DERMATOLOGIC EVENTS,Y
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2012-12-17,2013-02-11,2013-01-27,,42,2013-01-27,42,1,DAY,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,10,Y,,,Y,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2012-12-17,2013-02-11,2013-01-27,,42,2013-01-28,43,2,DAY,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,N,N,N,N,N,N,N,PROBABLE,,RECOVERED/RESOLVED,11,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2012-12-17,2013-02-11,2013-01-29,,44,NA,NA,NA,,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,N,N,N,N,N,N,N,PROBABLE,,NOT RECOVERED/NOT RESOLVED,12,Y,,,,,,,DERMATOLOGIC EVENTS,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2012-12-17,2013-02-11,2013-02-04,,50,2013-02-25,71,22,DAY,DECREASED APPETITE,DECREASED APPETITE,NA,DECREASED APPETITE,NA,HLT_0574,NA,HLGT_0231,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,13,Y,,Y,Y,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2012-12-17,2013-02-11,2013-02-04,,50,2013-02-25,71,22,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,NOT RECOVERED/NOT RESOLVED,14,Y,,,,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2012-12-17,2013-02-11,2013-02-04,,50,2013-02-25,71,22,DAY,DECREASED APPETITE,DECREASED APPETITE,NA,DECREASED APPETITE,NA,HLT_0574,NA,HLGT_0231,NA,METABOLISM AND NUTRITION DISORDERS,METABOLISM AND NUTRITION DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,15,Y,,,,,,,,
CDISCPILOT01,718,01-718-1427,Xanomeline High Dose,81,74,65-80,2,BLACK OR AFRICAN AMERICAN,2,F,Y,2012-12-17,2013-02-11,2013-02-04,,50,2013-02-25,71,22,DAY,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,N,N,N,N,N,N,N,POSSIBLE,,RECOVERED/RESOLVED,16,Y,,,,,,,,
